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Part! 
INTRODUCTION 

Chapter 1 
Normal pulmonary development 
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Chapter 1 
1.1 Introduction 
One of the prerequisites of life is the process of respiration in which an organism 
exchanges carbon dioxide for oxygen in order to obtain energy through the oxygenation 
of molecules containing carbon. The interfaces used by different organisms for gas 
exchange vary from simple diffusion between prokaryotic bacteria and the medium in 
which they reside, to a much more complex diffusible interface, namely a gas-exchanging 
organ also known as the lung used by higher eukaryotes, such as humans. The human 
lungs have an estimated 300.000.000 alveoli with a surface area of approximately 70 m2 
by 0.1 flm in early adulthood (Comroe, 1965; Weibel, 1963) and is comprised of at least 
40 differentiated cell types. The alveolar surface of the lung is surrounded by a capillary 
network that develops in close apposition. This enables gas exchange to occur with the 
blood that delivers the oxygen to the tissues. Therefore a 70 kg adult human can use 14.5 
L oxygen per hour or 1020 molecules per second at rest. The oxygen demand can rise to 
approximately 330 L per hour during exercise (Comroe, 1965; Weibel, 1963). To 
establish such a highly complex organ, well-orchestrated cell interactions are required 
during development to generate a functional lung. 
A disturbance at any part of the respiratory chain may lead to respiratory 
insufficiency which can eventually end in lethality. One of the main clinical respiratory 
problems leading to a disturbance of this chain is puhnonary hypoplasia, which is an 
underdevelopment of the lung due to a decreased cell number. It is associated with 
different clinical conditions, such as congenital diaphragmatic hernia (CDR), 
oligohydramniOS based on renal malformations or leakage of anmiotic fluid, and 
anencephaly. In order to better understand pulmonary hypoplasia and possible means to 
reverse this condition, a further understanding of the fundamental basis of normal 
puhnonary development is necessary. Rerein, several aspects of normal pulmonary 
development are reviewed. First, the respiratory structures of several organisms are 
described and compared, since successful developmental processes are conserved through 
evolution. This will provide a background for the description of the developmental 
anatomy and embryology of normal mammalian puhnonary development. Subsequently, 
the molecular mediators involved in puhnonary development, such as genes, transcription 
factors and growth factors will be described. 
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1.2 Evolutiou of respiratory structures 
In order to assimilate oxygen and use it for the production of energy, organisms use 
different respiratory structures ranging from a diffusing membrane, to tracheae, gills or 
lungs. Which respiratory structure is used depends mainly on the size of the organism. 
The very small protozoans use their entire surface to exchange carbon dioxide for oxygen 
from the environment. The larger multicellular organisms use different strategies. Aquatic 
worms lengthen and flatten their bodies to refresh their external surfaces with new 
oxygen. Sessile sponges rely on the ebb and flow of ambient water. When organisms 
became too large and dense for such sirople external exchange, special respiratory 
structures were implemented. 
Insects use a trachea for gas exchange. The trachea consists of branching tubes that 
deliver oxygen to and remove carbon dioxide from the tissues, without an intermediate 
circulatory system. The tubular system opens to the outside through pores, called 
spiracles. There are two spiracles in the thorax and eight in the abdomen. The limitations 
of the tracheal system are slow gas diffusion in long and narrow tubes, and effective gas 
transport can only occur if the tubes do not exceed a certain length. Recently, an extensive 
study of Drosophila using screens to find genes involved in tracheal development has 
yielded new insights into manunalian pulmonary development. The FGF signaling 
pathway used for branching morphogenesis in Drosophila tracheal development is also 
used in manunalian pulmonary development [for review see (Metzger and Krasnow, 
1999)]. 
Most fish use gills as a means for respiration. Gills are evaginations of the body 
surface, in contrast to lungs, which are invaginations of the body surface. Interestingly, 
both gills and lungs are formed from outpouchings of the gut wall during embryogenesis. 
Usually gills are used for water breathing and lungs for air breathing. As in lungs, gills 
usually have a large surface area in relation to their mass and both are thin-walled 
structures, which are well supplied with blood vessels. In gills deoxygenated blood from 
the heart flows in a direction opposite to that of the water flow across the exchange 
surfaces, which makes gas exchange efficient. 
A transitional form between water- and air breathing organisms are lungfishes 
(Dipnoi), which are remnants of the Devonian period (Jesse et aI., 1967). They have both 
gills and lungs, so that in a period of drought they can rely on their lungs for oxygenation 
of their blood. Amphibians are another example of the transition between aquatic and 
terrestrial life. Amphibians begin life under water with gas exchange occurring through 
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the thin, gas-penneable skin and gills. As amphibian larvae develop, the gills degenerate 
and paired Inngs develop. Finally, mammalian species do not use their skin for gas 
exchange. An exception, that has been fonnd recently is the Julia Creek dunnart 
(Sminthopsis douglasz), a marsupial mouse, which has nonnal Inngs, but completely 
depends on gas exchange through the skin during the fIrst days after birth. (Mortola et aI., 
1999). (See Figure I) 
In contrast to the simple saclike Inngs of InngfIshes and amphibians, higher 
vertebrates have achieved an increasing subdivision of the airways and a greater Inng 
surface area. This complexity is necessary to support the elevated metabolic rates of 
mammals. An important property of these Inngs is elasticity. A surface coating 
(surfactant) composed oflipids and proteins prevents the collapse of the small alveoli on 
expiration. The maximum capacity of human Inngs is about six litres. During nonnal 
respiration, the tidal volume is about 500 millilitres. Subsequent to expiration, an 
additional 1200 millilitres can be expelled with additional effort, and then another 1200 
millilitres remains inside the Inngs as a residual volume. With extra effort an additional 
3000 millilitres can be drawn into the Inngs at the end of inspiration. 
Figure 1 Sminthopsis douglasi (Julia Creek dunnart, a marsupial mouse) embryo of one day old. 
Note the fme air bubbles at the side of the thorax. Despite the visible presence of lungs in the 
thorax, at this time no breathing movements can be observed. 
(Taken from Nature (I 999) 397:660) 
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13 Anatomy and embryology 
Mammalian lung development starts with the outgrowth from the foregut endoderm of 
two lung buds into the surrounding splanchnic mesenchyme. Prior to this, a certain area of 
the foregut is specified to become the area where the lung (and not, the thyroid or 
pancreas) will develop. The origin and fate of the cells forming the lung anlage within the 
primitive foregut are as yet unknown. In human, the lung originates as an outpouch of the 
ventral wall of the posterior end of the laryngotracheal tube and divides into two 
bronchial buds at 3-4 weeks of gestation (Hopper and Hart, 1985). In the mouse and rat at 
10 and 11.5 days of gestation, respectively (term mouse = 19 days; term rat = 22 days), 
the respiratory system develops from paired endodermal buds in the primitive foregut, just 
proximal to the developing stomach (Ten Have-Opbroek, 1981; Ten Have-Opbroek, 
1991). As the two buds elongate, the primitive tubular foregut tube begins to pinch into 
two tubes, namely, the dorsal esophagus and the ventral trachea (Spooner and Wessells, 
1970). Further outgrowth of the lung buds produce the secondary bronchi. In the mouse, 
the right lung characteristically has four major lobes (dorsal, caudal, medial and cranial 
lobes) whereas the left lung consists of only one small lobe. This arrangement also holds 
in the rat except the right lung lobes are termed cranial, medial, accessory and caudal. In 
human, the right lung has three lobes whereas the left lung is composed of two lobes 
(upper, middle and lower on the right; upper and lower on the left). The early branching 
of the primary bronchial buds tends to be monopodia!. Each secondary bronchus 
subsequently undergoes progressive dichotomous branching as each branch bifurcates 
repeatedly. Reproducible branching is complete at 16 generations by 16 weeks of 
gestation in humans (Boyden, 1972). The final seven generations of airways (for a total of 
23) in human are completed during the latter part of gestation. Alveolization begins after 
about 28-30 weeks in humans and is completed postnatally. This branching process will 
ultimately yield a functional lung with its very large surface area for gas exchange after 
birth. Already in 1967 Reid nicely summarized this process in her Laws of Development 
of the Human Lung (Reid, 1967): 
(a) The bronchial tree is developed by the 16th week of intrauterine life. 
(b) Alveoli, as commonly understood, develop after birth, increasing in number until the 
age of eight years and in size until growth of the chest wall is finished. 
(c) Blood vessels are remodeled and increase, certainly while new alveoli are forming and 
probably until the growth of the chest is complete. 
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During pulmonary development, four histological stages can be distinguished: the 
pseudo glandular stage, in which the bronchial tree develops and an undifferentiated 
primordial system forms; the canalicular stage, terminal sacs develop and vascularization 
occurs during this period; the saccular or terminal sac stage, in which the number of 
terminal sacs increases, vascularization proceeds and differentiation of type I and type II 
cells occurs; and the alveolar stage, in which there is a huge multiplication ofthe alveoli 
establishing the extensive surface area (see Table I for comparison of gestational stages 
between human, mouse and rat). In humans (as in guinea pigs and sheep), alveolization 
begins in utero and is completed after birth. In contrast, in rats and mice, alveolization 
occurs predominantly postnatally. 
Table 1. Stages oflung development 
Stage of pulmonary Human age Mouse age Rat age 
development (weeks of gestation) (days of gestation) (days of gestation) 
Pseudoglandular 3-16 10-16.5 11.5-18.5 
Canalicular 16-26 16.5-17.5 18.5-19.5 
Saccular 24-38 17.5-19 to 5 days 19.5-22 to I week 
Alveolar 28 to 7 years Days 5-30 Weeklt05 
Comparison of stages of pulmonary development and gestational ages between human, mouse 
and rat. 
Epithelial cell differentiation is initiated in the saccular stage and occurs in a 
proximo-distal pattern. The trachea and the upper airways are lined with pseudostratified 
ciliated columnar epithelium with scattered mucus secreting goblet cells. In between the 
epithelial cells, small foci of pulmonary neuroendocrine cells can be found. The lower 
airways are lined with ciliated columnar epithelium and Clara cells. The alveoli are lined 
with alveolar type I cells, which are very thin for an efficient gas exchange and type II 
cells, which produce the surface tension reducing surfactant. 
Surrounding the epithelium lies the pulmonary interstitial tissue, which contains 
fibroblasts, myofibroblasts and smooth muscle cells. In addition, the pulmonary 
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interstitium comprises the pulmonary vasculature, consisting of arteries, veins and a large 
capillary network in close apposition to the alveoli. It also includes the lymphatic system 
and the nervous system. In the following sections the molecular mechanisms involved in 
the different phases of pulmonary development will be reviewed. The review will focus 
on mouse development, since this is the most studied species. Subjects such as lung 
neovascularization and lung cell differentiation in pulmonary development will not be 
covered in great detail, since they are beyond the scope of this thesis. 
1.4 Endoderm specification 
Even before the lung bud outgrowth occurs, endodermal cells from the primitive foregut 
are specified to become committed to respiratory epithelial cells. It is generally thought 
that HNF-3~, TTF-l and GATA6 transcription factors play an important role in this 
process (Whitsett and Tichelaar, 1999) (see Figure 2). Interestingly, these factors are 
marmnalian homologues of transcription factors that are involved in organogenesis of the 
pharynx in C. elegans (Kalb et al., 1998). 
HNF3-0 GATA-5 
~~~ ;:YGATA-6 
,If 
TTF-l 
Figure 2 Factors assumed to be involved in pulmonary endoderm specification of the primitive 
murine foregut. 
HNF-3~ belongs to the winged-helix HNF (hepatocyte nuclear factor) family of 
transcription factors which is related to the forkhead family in Drosophila and plays a 
critical role in the formation and specification of foregut endoderm (Ang et al., 1993; 
Monaghan et al., 1993; Sasaki and Hogan, 1993; Sasaki and Hogan, 1994). HNF-3~ is 
expressed in the pulmonary epithelium starting from 10 days of gestation throughout 
development and HNF-3~ null mutants die early in embryonic development because of a 
disturbance in the formation of foregut endoderm and its derivatives (Ang and Rossant, 
1994; Monaghan et aI., 1993; Weinstein et aI., 1994; Zhou et aI., 1996b). In addition, 
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HNF binding sites have been identified in the promoter regions of lung specific genes, 
such as the surfactant proteins (SP)-A, -B, -C and -D and the Clara cell marker-IO (CC-
10), suggesting an important role for this factor in lung development [for review see 
(Hackett et aI., 1996)]. 
TTF-l (thyroid transcription factor), also known as Nkx2.1, belongs to a family of 
homeodomain transcription factors and are homologous to the Drosophila NK-2 gene 
(Guazzi et aI., 1990; Kim and Nirenberg, 1989; Oguchi et al., 1995). Expression ofTTF-l 
is confined to the thyroid, areas of the forebrain, the pituitary, and lung endoderm and 
epithelium throughout lung development starting from 10 days of gestation (Damante and 
Di Lauro, 1994; Guazzi et al., 1990; Lazzaro et aI., 1991; Mizuno et aI., 1991). Null 
mutation of TTF-1 results in a failure of tracheo-esophageal separation and branching 
morphogenesis resulting in pulmonary hypoplasia (Kimura et al., 1996; Minoo et al., 
1999). Moreover, the epithelial cells of these hypoplastic lungs have not undergone 
proper differentiation. In addition, the thyroid, pituitary and parts of the forebrain are 
absent. Like HNF, TTF-1 functions as a regulator of transcription oflung specific genes 
such as SP-B and -C and CC-10 [for review see (Hackett et aI., 1996)]. Despite the 
described roles for TTF-1 in tracheo-esophageal separation and pulmonary development, 
there is no functional data available on the role of TTF-l in endoderm formation and 
specification. 
Recently, GATA6 has been implicated in puhnonary endoderm specification 
(Morrisey et al., 1998; Whitsett and Tichelaar, 1999). GATA6 belongs to a family of zinc 
finger containing transcription factors which bind to a DNA consensuS sequence 
AlTGATAlG (Charron and Nemer, 1999; Orkin, 2000). Expression of GATA6 is 
localized in smooth muscle cells, the developing bronchi, the urogenital ridge and the 
bladder (Morrisey et al., 1996). Genetic ablation of GATA6 results in early embryonic 
lethality. Defects in extraembryonic development suggest that GATA6 plays a role in 
visceral endoderm formation (Koutsourakis et al., 1999; Morrisey et aI., 1998). One 
experiment using GATA6-1- chimeric mouse embryos suggests that GATA6 is essential 
for the formation of endodermally derived respiratory epithelium (Morrisey et aI., 1998). 
Again, in several lung specific promoter regions GATA6 binding sites have been 
recognized, and transcriptional regulation of some of these genes (SP-A, -C, and TTF-1) 
has been demonstrated in vitro (Bruno et al., 2000; Shaw-White et al., 1999). 
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1.5 Luug bud outgrowth and establishment of left-right asymmetry 
The exact mechanisms controlling lung bud outgrowth are not completely understood. 
However, evidence is accumulating that fibroblast growth factor (FGF)-IO is critical for 
this process (see also Figure 3). First, FGF-IO is expressed in the splanchnic mesenchyme 
surrounding the evaginating lung buds (Bellusci et aI., I 99Th). Second, FGF-IO null 
mutant mice have no lung buds and limbs, whereas the trachea is normally formed in 
these mice (Min et aI., 1998; Sekine et aI., 1999). And third, FGF-IO has been 
demonstrated to have chemotactic effects on lung epithelium in vitro (park et aI., 1998; 
Weaver et aI., 2000). FGF receptor (R)2-IIIb, which is expressed in foregut and lung 
endoderm mediates the FGF-IO signal (peters et al., 1992). Mice null mutant for this 
receptor display similar pulmonary phenotypes as FGF -10 knockout mice (De Moerlooze 
et al., 2000). Taken together, these data provide a nice example of conserved gene 
function between Drosophila and the mouse. Drosophila branchless (FGF ligand 
homologue) (Sutherland et al., 1996) and breathless (FGFR homologue) (Glazer and 
Shilo, 1991) are genes that have been shown to be essential for tracheal cell migration and 
thus branching of the Drosophila trachea (Lee et al., 1996). 
Despite preliminary data suggesting a possible interaction between the FGF- and 
sonic hedgehog (Shb) pathway (Bellusci et aI., 199Th; Lebeche et aI., 1999), there is not 
much known about the downstream target genes of the FGF signaling pathway. However, 
because FGF-IO may be involved in setting up a spatial master plan for the future lung 
buds, it is attractive to speculate about an interaction between FGF-IO and Homeobox-
containing (Hox) genes. Hox genes have been implicated in regional conditional 
specification of morphogenetic progenitor fields, which are defined as regions in an 
embryo where cells give rise to a morphological structure (Davidson, 1993). Hox genes 
are characteristically organized in four clusters on different chromosomes and the 3' to 5' 
position of each gene within a cluster corresponds with the expression along the anterior-
posterior axis of the developing body (Kappen, 1996; Krumlauf, 1994). Several Hox 
genes, specifically genes of the 3' regions of the Hox clusters a and b, have been shown to 
be expressed in the lung (Kappen, 1996). Also knockout studies suggest an essential role 
for HoxaS in pulmonary development (Aubin et aI., 1997) although a precise role has not 
been established and no interaction between Hox- and FGF-signaling has yet been 
demonstrated. 
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HFH-4 
~ 
;;( 
FGF-IO 
Retinoic acid 
Jt' 
'\ 
Hox genes 
Pitx-2 
Figure 3 Factors involved in lung bud outgrowth and establishment ofleft-/right-asymmetry. 
Interestingly, the hormone retinoic acid, whose role in pulmonary development and 
embryonic development is known since the early fifties (Wilson et aI., 1953), might 
function as the mediator between Rox- and FGF-signaling. Retinoic acid has been shown 
to induce Roxa5, b5 and b6 gene expression in lungs (Bogue et aI., 1994). Furthermore, 
vitamin A deficiency during pregnancy results in varying anomalies, including the FGF -
10 -1- phenotype of no lung buds and a blunt ending trachea (Dickman et al., 1997). 
Recently, both retinoic acid production and expression of retinoic acid receptors (RARs) 
have been shown to coincide with the early events of lung bud evagination from the 
primitive foregut (Malpel et al., 2000; Niederreither et al., 1999; Zhao et al., 1996a). In 
addition, evidence for a direct interaction between retinoic acid signaling and FGF-1O 
signaling has been observed (Bellusci et al., 1 997b; MaIpel et aI., 2000). 
Subsequent to the initial symmetrical lung bud outgrowth, an asymmetry in the 
left-right axis of the lung is established. In general, the right bronchus is slightly larger 
than the left one and is oriented more vertically. The right lung bud gives rise to four 
secondary buds and the left bud to only one (in human there are tlu-ee secondary buds on 
the right and two on the left). From then on left-right asymmetry is established in the 
lungs. Only recently, some light has been shed on this subject. Data from a bone 
morphogenetic protein (BMP)-4lLacZ reporter suggest that even before the lung buds 
have grown out of the primitive foregut, left-right asymmetry is already established. The 
group of Rogan has shown that BMP-4lLacZ is asymmetrically expressed in the ventral 
mesoderm overlying the outgrowing lung buds until 11.5 days of gestation (Weaver et al., 
1999). Factors involved in the specification of the left-right axis are hepatocyte nuclear 
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factor/forkhead homologue (HFH)-4, lefty-I, 1efty-2, nodal, Pitx2 and 
Growth/differentiation factor-1 (Gdf-1) (Chen et aI., 1998; Gage et aI., 1999; Lu et aI., 
1999; Rankin et aI., 2000; Supp et al., 1997). All of these genes are normally expressed on 
the left side of the body and therefore determine "left-ness" of the body. Interestingly, 
null mutation of one of these genes Pitx2 (a homeobox gene) results in right pulmonary 
isomerism. Pitx2 is the gene responsible for situs inversus in Rieger syndrome (Lu et aI., 
1999) 
Another syndrome associated with situs inversus (and additionally ciliary 
dyskinesia) is Kartagener syndrome. The candidate gene for this syndrome is HFH-4 
which is involved in the formation of ciliated cells. Targeted mutation ofHFH-4 results in 
ciliary dyskinesia and random left-right laterality of the visceral organs (Chen et aI., 
1998). 
1.6 Tracheo-esophageal separation 
As stated above, the formation of a separate trachea and esophagus occurs differently in 
mice and man. In mice, two paired endodermal buds grow out of the primitive foregut and 
as the two buds elongate, the primitive foregut tube begins to pinch into two tubes, 
namely a dorsal esophagus and a ventral trachea (Ten Have-Opbroek, 1981). In human 
however, the trachea is first separated from the esophagus by a laryngotracheal groove. 
After elongation of the tracheal outgrowth, the end of it bifurcates and forms two 
bronchial lung buds (Sutliff and Hutchins, 1994). 
Several genes that are involved in pulmonary development have also been 
implicated in tracheo-esophageal separation. Based on knockout studies the most 
important genes are Shh-, Gli2/Gli3- and TTF-l. Shh is one of the mammalian 
homologues of the Drosophila hedgehog gene, discovered in a screen for genes involved 
in segmentation of Drosophila embryos (Nusslein-Volhard and Wieschaus, 1980). Shh is 
expressed in respiratory epithelium, with high levels at the tips of the branching lung buds 
(Bellusci et aI., 1997a). Besides its role in branching morphogenesis, Shh is involved in 
tracheo-esophageal separation. In mice null for Shh, the trachea and esophagus remain 
fused and two rudimentary sacs attached to this tube form the llli,gs (Litingtung et aI., 
1998; Pepicelli et a!., 1998). 
Glil,2 and 3 are the murine homologues of Drosophila cubitus interruptus (Hui et 
a!., 1994). All three are expressed in pulmonary mesoderm and they have been implicated 
in transducing the Shh signal (Grindley et aI., 1997). Glil-I- mice do not display a lung 
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phenotype. In contrast, Gli2 and Gli3 have been demonstrated to be essential for normal 
foregut and pulmonary morphogenesis (Motoyama et a!., 1998). Gli2-1- mice have 
unilobar lungs on the left and right side. Gli3-I- mice have hypoplastic lungs. 
Interestingly, in Gli2-1-;Gli3+1- compound mice, the situation is different, because this 
genetic background results in esophageal atresia with tracheo-esophageal fistula. A severe 
lung phenotype, namely fusion of the left and right lung in the midline was observed in 
these mice (Motoyama et a!., 1998). 
The fmal gene implicated in separation of the esophagus and trachea is TTF-l. As 
described before, genetic ablation of TTF -1 results in absence of the thyroid, pituitary, 
parts of the forebrain, and inhibition of branching morphogenesis of two rudimentary sac-
like structures which are attached to a single tube esophago-trachea (Kimura et a!., 1996; 
Minoo et a!., 1999). 
Similar anomalies have been observed in embryos exposed to severe vitamin A 
deficiency (Wilson et al., 1953) and in RARa and RARJ32 double knockout mice 
(Mendelsohn et a!., 1994). However, it is not clear whether these malformations are the 
result of direct effects of disturbed vitamin A metabolism or are due to the effects of 
vitamin A on Hox gene expression. Moreover, seeing the above described phenotypes of 
Shh, Gli2/Gli3 and TTF-l knockout mice, it is tempting to speculate about the effects of 
vitamin A on the ShhiGli pathway and TTF-l expression. 
1.7 Branching morphogenesis 
The morphogenesis of many organs such as the gut, kidney and mammary gland is highly 
dependent on controlled interactions between two tissue layers, epithelium and 
mesenchyme. The process in pnlmonary development, known as branching 
morphogenesis is also dependent on interactions between epithelium and mesenchyme. 
The highly characteristic branching pattern of the bronchial epithelial buds of embryonic 
lungs has long been known to depend on a specific interaction with bronchial 
mesenchyme (Alescio and Cassini. 1962; Rudnick, 1933). The effect of bronchial 
mesenchyme on epithelial branching is organ- and species-specific and is temporally 
regulated (Masters, 1976; Spooner and Wessells, 1970; Wessells, 1970). In addition, 
proximal (trachea and main bronchi) and distal (lung bud) mesenchyme differ in their 
ability to support branching morphogenesis (Wessells, 1970). Moreover, ectopically 
induced buds on the trachea express specific distal lung genes (Shannon, 1994). These 
grafting experiments led to the assumption that epithelial-mesenchymal interactions must 
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be mediated by well-orchestrated signals between the mesenchyme and the epithelium. 
Recently, several growth factors, their receptors and other signaling molecules have been 
shown to act as inductive signals mediating these epithelial-mesenchymal interactions and 
regnlating pulmonary morphogenesis (see Figure 4). 
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Figure 4 Schematic representation of several growth factors and receptors involved in branching 
morphogenesis. 
1.7.1. Fibroblast growth factor family 
Fibroblast growth factors (FGFs) are known to play key roles in embryonic growth and 
morphogenesis. As earlier mentioned, the FGF system has been shown to play an 
important role in primary tracheal branching of Drosophila. Loss-of-function of either 
breathless (Glazer and Shilo, 1991), an FGF receptor gene, or branchless (Sutherland et 
aI., 1996), an FGF gene, leads to abnormal tracheal branch formation. The mammalian 
FGF family consists of at least 18 ligands and their signals are mediated through four 
tyrosine kinase FGF receptors. The most important ligands for pulmonary development 
(FGF -7 and FGF-1 0) are expressed in the developing mesenchyme (Bellusci et aI., 1997b; 
Post et aI., 1996), whereas the associated receptor (FGFR-2) is expressed in the 
pulmonary epithelium (Peters et aI., 1992). 
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The importance of FGF signaling was nicely demonstrated by the complete 
inhibition of branching morphogenesis in the lung tubes of transgenic mice expressing 
dominant negative forms ofFGFR-2 (peters et a!., 1992). Both FGFR-l and FGFR-2 gene 
ablation result in early embryonic lethality (Arman et a!., 1998; Deng et a!., 1994; 
Yamaguchi et a!., 1994). Studies using chimeric FGFR-2-1- embryos indicate that this 
receptor is essential for limb bud outgrowth and lung branching morphogenesis, which 
corroborates with the FGF-1O knockout mice (Arman et a!., 1999). The ligands for the 
FGFR-2 receptor are both FGF-7 and FGF-IO. Mice null for FGFR-3 (Colvin et a!., 1996; 
Deng et a!., 1996) or FGFR-4 (Weinstein et a!., 1998) exhibit no pulmonary phenotype. 
However, FGFR-3 and FGFR-4 compound mutant mice display pulmonary emphysema 
and deficient alveolization (Weinstein et aI., 1998). Previously, the chemotactic role of 
FGF-1O for pulmonary epithelium has been mentioned (Park et al., 1998; Weaver et a!., 
2000). Based on the dynamic expression of FGF -10 in the mesenchyme overlying the 
newly formed lung buds, an important role for FGF-1O in controlling lung bud outgrowth 
and elongation is now generally accepted. This role for FGF-1O is underscored by the 
blunt ending trachea and complete absence oflung buds in mice null mutant for FGF-1O 
(Min et al., 1998; Sekine et a!., 1999). FGF-7 (also know as keratinocyte growth factor, 
KGF) is also expressed in pulmonary mesenchyme, and shares sequence homology with 
FGF-IO (post et a!., 1996; Yamasaki et a!., 1996). However, in contrast to FGF-I 0, FGF-7 
has no chemotactic effects on puhnonary epithelium, but is involved in patteming, 
proliferation and differentiation of the epithelium (Cardoso et a!., 1997; Park et al., 1998; 
Shiratori et al., 1996; Simonet et a!., 1995). Surprisingly, mice bearing a null mutation of 
the FGF-7 gene have no obvious lung abnormalities (Guo et a!., 1996), suggesting that 
FGF-7 can be replaced by other factors, such as FGF-l and FGF-I0. FGF-l is also 
expressed in pulmonary mesenchyme and has been shown to stimulate embryonic 
epithelial cell proliferation (Bellusci et a!., 1997b; Park et a!., 1998). In addition to its role 
in epithelial cell proliferation, there is evidence that FGF-l also possesses chemotactic 
properties for puhnonary epithelium, albeit less sttong than that seen with FGF -10 (Park 
et al.. 1998). 
The complexity of lung morphogenesis has been underscored recently by the 
identification of a negative regulator of FGF signaling. In Drosophila one of the 
downstteam targets of branchless and breathless was found to be sprouty (Hacohen et al., 
1998). Inactivation of sprouty results in increased ttacheal branching, indicating that 
sprouty functions as an antagonist of the branchlesslbreathless pathway (Hacohen et a!., 
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1998). At present, four murine and three human sprouty homologues have been identified. 
Only murine sprouty-2 (pulmonary endoderm) and -4 (pulmonary mesenchyme) are 
expressed in the lung (de Maximy et aI., 1999; Hacohen et aI., 1998; Tefft et aI., 1999). 
Inhibition of sprouty-2 function with antisense oligonucleotides in organ explant cultures 
leads to increased branching and surfactant protein gene expression (Tefft et aI., 1999). 
Although the mechanism of sprouty function is still not completely understood, it is most 
likely that sprouty-2 inhibits FGF -10 expression through inhibition of signal transduction 
pathways (Casci et aI., 1999; Kramer et aI., 1999; Reich et al., 1999). 
1.7.2. Shh/patched receptor/smoothened/Gli pathway 
Shh is the mammalian homologue of the Drosophila segment polarity gene hedgehog. It 
belongs to a family of hedgehog proteins consisting of Sonic, Indian, Desert and Tiggy-
Winkle [for review see (Hammerschmidt et aI., 1997)]. Shh is expressed throughout 
pulmonary development in the respiratory epithelium being highest in the endodermal tips 
during branching morphogenesis (Bellusci et a!., 1997a). Genetic ablation of Shh function 
results in the disturbance of dorsal ventral axis patterning during early embryogenesis 
(Chiang et al., 1996). As stated before, in Shh null mice the trachea and esophagus remain 
fused and two rudimentary sacs are attached to this tube forming the lungs (Litingtung et 
aI., 1998; Pepicelli et aI., 1998). In the two rudimentary sacs, epithelial cell differentiation 
along the proximO-distal axis occurred normally (Pepicelli et aI., 1998). Overexpression 
of Shh in distal epithelial cells suggests that Shh functions as a mitogen (Bellusci et aI., 
1997a). 
The Shh signal is transmitted by patched, a multi-membrane-spanning protein 
identified as the receptor for hedgehog in Drosophila (Chen and Struhl, 1996; Marigo et 
a!., 1996; Stone et aI., 1996). Patched is predominantly expressed in the mesenchyme 
surrounding the endodermal tips expressing highest Shh levels (Bellusci et aI., 1997a; 
Pepicelli et aI., 1998). Shh induces patched expression (Bellusci et aI., 1997a). Abrogation 
of patched function with antisense oligonucleotides results in diminished branching 
morphogenesis in vitro. When Shh binds to patched, the latter releases another segment 
polarity gene, smoothened. Smoothened then activates the zinc finger Gli proteins to 
function as a transcriptional activator (Murone et al., 1999). Gli 1, Gli2 and Gli3 are the 
mammalian homologues of Drosophila cubitus interruptus (Hui et aI., 1994). As 
described before, the Gli proteins have essential functions during normal embryonic 
foregut development and lung morphogenesis (Motoyama et aI., 1998). The downstream 
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target genes of the Gli proteins are as yet unknown. Taken together, it is clear that the 
ShhipatchedismoothenediGli pathway plays an essential role in morphogenesis of the 
foregut and the lung. 
1.7.3. Epidermal growth factor family 
Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-a), and 
amphiregulin (AR) are members of the EGF family of growth factors that act through the 
common EGF receptor (EGFR). The mRNAs of all three are localized in the mesenchyme 
(Ruocco et a!., 1996; Snead et a!., 1989), and the proteins in the epithelium (Ruocco et a!., 
1996; Snead et a!., 1989; Strandjord et a!., 1995a; Strandjord et a!., 1994), suggesting that 
they are produced in the mesenchyme, but act on the epithelium. The EGFR is expressed 
in the epithelium (Ruocco et a!., 1996; Strandjord et a!., 1995a; Strandjord et a!., 1994; 
Warburton et a!., 1992). All three proteins stimulate growth and branching morphogenesis 
of embryonic murine lung in vitro (Warburton et a!., 1992). However, genetic ablation of 
EGFR in mice has led to conflicting interpretations regarding a role of EGFITGF-a in 
branching morphogenesis. Mice homozygous for an EGFR null mutation have been 
reported to die postnatally of respiratory failure which was attributed to lung immaturity 
(Miettinen et a!., 1995; Miettinen et aI., 1997). In contrast, another null EGFR mutation 
with a different genetic background did not display any major lung abnormality during 
development (Threadgill et al., 1995). Also, expression of a dominant negative EGF 
receptor under control of the SP-C promoter does not alter lung morphogenesis in 
transgenic mice (Hardie et aI., 1996). Moreover, mice having EGFR signaling 
deficiencies, wa-2Iwa-2 mice (Fowler et aI., 1995), have normal lung morphology (Hardie 
et aI., 1996). Thus, it appears that EGFR signaling is not essential for lung branching 
morphogenesis although it is possible that other receptors have taken over EGFR 
signaling in these loss-of-function experiments. 
1.7.4. Insulin-like growth factor family 
The insulin-like growth factor (IGF) family consists of two related peptides, IGF-I and 
IGF-II, six IGF binding proteins (IGFbps) and two specific IGF receptors. The type 1 
receptor transmits most biological responses, such as proliferation and differentiation, 
while the type 2 IGF/mannose-6-phosphate receptor appears to function in internalizing 
and transporting IGF-II to the lysozomes (Jones and Clemmons, 1995). Ample evidence 
suggests that the IGF system has a role in pulmonary development (Stiles and D'Ercole, 
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1990). All components of the IGF system, IGF-I and -II, their receptors, and the IGFbps 
are expressed in both rodent and hnman Inng. During pulmonary development, there is 
hardly any change in distribution or level of expression ofIGF-I and -II or their receptors. 
IGF-I is expressed in the pulmonary mesenchyme (Han et aI., 1987; Klempt et aI., 1992; 
Retsch-Bogart et aI., 1996), and IGF-II predominantly in the pulmonary epithelium 
(Retsch-Bogart et al., 1996). The type I receptor is expressed in almost all cells of the 
Inng (Retsch-Bogart et aI., 1996), whereas expression of the type 2 receptor is limited to 
pulmonary mesenchyme (Retsch-Bogart et aI., 1996). In contrast, the IGFbps are 
differentially regulated and dynamically expressed during pulmonary development 
(Moats-Staats et al., 1995; Retsch-Bogart et aI., 1996). The function of each IGFbp is not 
completely known yet, but their spatial and temporal expression patterns suggest a role in 
controlling IGF action at specific sites during pulmonary development. Studies with 
transgenic mice argue against a direct role for IGFs in branching morphogenesis. Mice 
carrying a disrupted IGF-I gene are growth retarded and die at birth from respiratory 
failure. However, no obvious histopathological defect of pulmonary deVelopment other 
than nninflated Inngs, is observed (Liu et aI., 1993). Mice with no functional type I IGF 
receptor display a similar phenotype (Liu et aI., 1993). Transgenic mice with a disrupted 
IGF-II gene are small and have smalllnngs, but no abnormallnng morphology is noted 
(DeChiara et aI., 1990). The type 2 IGF receptor is paternally imprinted and mice with a 
maternally inherited disrupted type 2 IGF receptor gene, which die shortly after birth from 
heart failure, have abnormal alveoli but no major branching defect (Lau et aI., 1994; 
Wang et aI., 1994). In conclusion, although the IGFs may playa role during pulmonary 
development, they appear not to be a major determinant in early lnng morphogenesis. 
1.7.5. Hepatocyte growth factor 
A heparin-binding mitogen with morphogenetic and motogenic activities is hepatocyte 
growth factorlscatter factor (HGF ISF). During mouse development, HGF ISF and its 
receptor c-met, are expressed in different but adjacent tissues, suggesting that they 
transduce mesenchymal-epithelial signaling (Rosen et aI., 1994; Sonnenberg et aI., 1993). 
HGF/SF is produced by fetallnng fibroblasts and stimulates the proliferation of adult type 
II cells (Mason et aI., 1994; Panos et aI., 1993; Shiratori et aI., 1995). In vitro, exogenous 
HGF/SF or a neutralizing antibody to HGF/SF has no effect on early branching 
morphogenesis of mouse Inng (Shiratori et aI., 1996). These data are consistent with 
genetic ablation experiments. Mouse bearing a null mutation in the HGF/SF gene do not 
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survive beyond 14.5 days of gestation in utero, but show normal branching 
morphogenesis until that gestational age (Schmidt et aI., 1995; Uehara et ai., 1995). Also, 
branching and growth appears normal when lungs of day 14.5 mutant embryos are 
cultured in vitro (Uehara et ai., 1995). 
1.7.6. Platelet-derived growth factor family 
Platelet-derived growth factor (PDGF) has been implicated in embryonic development 
(Goustin et aI., 1985; Mercola et aI., 1990). It is a dimeric molecule composed of two 
distinct but related polypeptides (A and B). The two chains assemble as a heterodimer, 
PDGF-AB, or as homodimers, PDGF-AA or PDGF-BB (Raines et aI., 1991). PDGF 
exerts its effect via specific cell surface receptors (Claesson-Welsh, 1994). Two related 
transmembrane tyrosine kinase receptors, PDGF-a and PDGF-~ receptors have been 
characterized. The PDGF-a receptor binds all three isoforms of PDGF whereas the 
PDGF-~ receptor binds only PDGF-BB with high affinity (Claesson-Welsh, 1994). Both 
PDGF homodimers, AA and BB, and both PDGF receptors are present in the early 
embryonic rat lung (Han et aI., 1993; Han et al., 1992). At this early stage of pulmonary 
development, the mesenchyme is enriched in the expression of both receptors (Souza et 
al., 1995). In contrast. expression of both PDGF homodimers, AA and BB, is confined to 
the epithelium of the embryonic lung (Han et aI., 1992; Souza et aI .• 1995; Souza et aI., 
1994). However, PDGF-A and PDGF-B transcripts and proteins are detected in both 
tissue layers with advancing gestation (Han et aI., 1992; Souza et al., 1995; Souza et aI., 
1994). Expression in separate but adjacent tissue layers ofligands and receptors for PDGF 
has been noted in many tissues during development, including mouse lung (Orr-Urtreger 
and Lonai, 1992), submandibular salivary gland (Orr-Urtreger and Lonai, 1992) and 
placenta (Holmgren et al.. 1991). 
The appositional expression of PDGF and its receptors during early lung 
development is compatible with a role for PDGF in epithelial-to mesenchymal signaling 
during branching morphogenesis. The physiological function of PDGF in lung branching 
morphogenesis has been partly delineated. Translation arrest of endogenous PDGF-B with 
antisense oligonucleotides in embryonic rat lung results in smaller lungs but the degree of 
branching is not affected (Souza et aI., 1994). Similarly, antisense PDGF-~ receptor 
oligonucleotides reduce lung size without affecting branching (Souza et aI., 1996). Mice 
deficient for PDGF-B (Leveen et aI., 1994) and PDGF-~ receptor (Soriano. 1994) show 
no abnormal lung branching phenotype, suggesting that PDGF-BB is not involved in the 
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regulation oflung branching. Using an antisense strategy, Souza et al. (Souza et aI., 1995) 
reported that PDGF-AA influences early lung branching morphogenesis. The number of 
terminal buds of embryonic rat lung exp1ants was significantly reduced in the presence of 
antisense PDGF-A oligonucleotides. Addition of PDGF-AA, but not PDGF-BB, to the 
culture system attenuated the inhibitory effect of antisense PDGF-A on early lung 
branching. Also, antisense PDGF -a receptor oligonucleotides inhibited early lung 
branching (Souza et al., 1996). It should be noted that blocking of function ofPDGF-A or 
PDGF-a receptor does not completely block branching, indicating that other factors are 
involved in regulating this morphogenetic process. 
A null mutant for PDGF-A is lethal at two restriction points: one prenatally prior to 
10.5 days of gestation, implying a role in early embryonic development, and one 
postnatally (Bostrom et al., 1996). The lung phenotype of PDGF-A null embryos dying 
prior to 10.5 days of gestation was not further investigated and, thus, it is not completely 
clear whether PDGF-AA is involved in the early formation of the lung. The observation 
that PDGF-A-deficient mice surviving postnatally have normal fetal and early postnatal 
pulmonary development argues against PDGF-AA being a major determinant in lung 
branching morphogenesis. However, it is possible that the role of PDGF -A is replaced by 
other non-PDGF factors or that maternal leakage of PDGF rescues the early 
developmental events in the knockout mice. Interestingly, homozygous mice that survive 
the first bottleneck at 10.5 days of gestation develop postnatally lung emphysema 
secondary to the failure of alveologenesis attributed to a lack of alveolar myofibrob1ast 
differentiation (Bostrom et al., 1996). Homozygous mutant mice carrying a targeted 
disruption in the PDGF-a receptor gene die during embryonic development and exhibit 
severe developmental defects. Most interestingly, the phenotype of the PDGF-a receptor 
mutant mice differs from that of the PDGF-A mutant mice. However, early pulmonary 
development proceeds normally in the PDGF-a receptor null mutants. Patch mutant mice 
which are homozygous for a large deletion of the PDGF-a receptor gene (Bostrom et aI., 
1996), also die prenatally before 10.5 days of gestation (Orr-Urtreger et al., 1992). 
Heterozygotes, expressing only 50% of the PDGF-a receptor on their cells compared with 
their wild-type littermates, develop normal lungs. Recently, the role of the PDGF-a 
receptor was better specified. Using a human Y AC transgene to overexpress the PDGF-a 
receptor in PDGF-a receptor knockout mice, researchers were able to overcome the early 
embryonic lethality in the knockout mice. However, the mice died after birth because of 
respiratory failure, since the transgene did not rescue the lung phenotype, suggesting an 
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important role in prenatal pulmonary development (Sun et aI., 2000). Hence, although the 
genetic data support a role for the PDGF-AAfa receptor complex in embryonic 
development, further studies such as double mutant mice for ligands and receptors are 
needed to determine whether the PDGF /receptor complex has a regulatory role in lung 
branching morphogenesis. 
1.7.7. Trans/orming growth/actor beta/amity 
Transforming growth factor beta (TGF-P) is a multifunctional peptide that elicits a wide 
variety of morphogenetic responses in many organs. Several lines of evidence suggest that 
TGF-p is also important for fetal pulmonary development. All three mammalian TGF-p 
subtypes (PI, p2, and P3) have been detected in the developing murine lung (pelton et al., 
1990; Schmid et aI., 1991). TGF-p I rnRNA expression is prominent throughout the 
mesenchyme while TGF-p2 message is mainly localized to the epithelium of the 
developing distal airways. The TGF-p3 transcripts are initially found in the tracheal 
mesenchyme, but are also found in the epithelium of the growing bronchioles during the 
pseudoglandular stage of murine pulmonary development. Both TGF-pl and TGF-p2 
inhibit branching morphogenesis in vitro (Serra et al., 1994; Zhao et al., 1996b). Although 
numerous TGF-p binding proteins have been identified, type I and type II receptors are 
responsible for most, ifnot all, biological activities ofTGF-ps (Attisano et aI., 1994). Just 
recently, the group of Post has extensively investigated the role of the three mammalian 
TGF-p subtypes and their receptors in early pulmonary organogenesis in vitro. By using 
antisense oligonucleotides and neutralizing antibodies in lung explant culture, they 
demonstrated that TGF-p2, but not TGF-pi and TGF-p3 are essential for regulating 
pattern formation in the early lung. The siguals are thereby predominantly mediated via 
the ThetaR-I(ALK-5)/ThetaR-II heteromeric complex (Liu et aI., 2000). 
TGF-p can exert a variety of biological effects, including regulation of 
extracellular matrix (ECM) production and integrin expression (Roberts and Sporn, 
1991). Thus TGF-p may increase cell-ECM interactions and, by doing so, influence 
branching morphogenesis (Minoo and King, 1994). A recent study has shown that 
TGF-p 1 co-localizes with collagen I and II, fibronectin, and glycoaminoglycans at the 
epithelial-mesenchymal interface of clefts of branching lung (Heine et aI., 1990). High 
dosages of exogenous TGF-p 1 inhibit lung branching morphogenesis in vitro (Serra et 
aI., 1994). The mechanism of inhibition of branching by TGF-pi is unknown. TGF-pl 
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has been suggested to inhibit tbe action of N-myc protein in lung growth (Serra et aI., 
1994), which has been implicated in lung growth and branching (Moens et aI., 1992; 
Sawai et al., 1993). Interestingly, mice bearing a partial mutation of tbe N-myc gene 
display severe puhnonary hypoplasia resulting in neonatalletbality (Moens et aI., 1993). 
Recent studies have demonstrated tbat PDGF a receptor expression in lung fibroblasts is 
also negatively modulated by TGF-~1 (Bonner et aI., 1995). As tbe PDGF-ANa receptor 
complex may playa role in lung branching morphogenesis in vitro (Souza et al., 1995; 
Souza et aI., 1996), anotber possibility is tbat high dosages of TGF-~1 disrupt this 
complex by adversely influencing PDGF a receptor expression in embryonic 
mesenchymal cells. Whetber TGF-~2 and TGF-~3 have similar effects on N-myc or 
PDGF a receptor expression as TGF-~ I remains to be elucidated. Studies with transgenic 
mice have implicated TGF-~ in regulating late but not early lung organogenesis. 
Overexpression of TGF-~I in lung epitbelium of transgenic mice causes a 
pseudoglandular arrest of lung development (Zhou et aI., 1996a). However, caution is 
warranted in extrapolating tbese data to normal development as TGF-~I is mainly 
expressed in tbe lung mesenchyme of developing lung (Pelton et aI., 1990; Schmid et aI., 
1991). Surprisingly, inactivation of tbe mouse TGF-~1 gene does not affect lung 
branching (Kulkarni et al., 1993; Shull et aI., 1992). Mice lacking TGF-~3 die witbin 
several hours after birtb and exhibit an arrest in pulmonary development at tbe late 
pseudoglandular stage (Kaartinen et aI., 1995). The TGF-~2 null mice exhibit perinatal 
mortality and a wide range of developmental defects (Sanford et aI., 1997). Prenatal lung 
morphology of tbe mutant mice appeared to be normal while newborn mice had collapsed 
conducting airways. Togetber, tbese genetic analyses suggest tbat none of tbe TGF-~ 
isoforms play a major biological role in early lung branching morphogenesis. 
Alternatively, it is possible tbat redundancy or maternal leakage of TGF-~s rescues the 
early developmental events in these knockout mice. Analysis of double or triple mutants 
is now feasible, which may help to further understand tbe requirements ofTGF-~s during 
pulmonary development. 
BMPs are members of tbe TGF-~ family tbat are important for pulmonary 
development. BMP-3, 4 and 7 are expressed in tbe lung during embryonic development 
(Bellusci et aI., 1996; Takahashi and Ikeda, 1996). BMP-4 transcripts are expressed in tbe 
epitbelium at tbe tips of terminal lung buds (Bellusci et al., 1996). Transgenic studies witb 
mice overexpressing BMP-4 in distal epitbelium results in smaller lungs witb dilated 
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terminal sacs, with a reduced number of differentiated type II cells (Eellusci et aI., 1996). 
Recently, BMP-4 signaling was blocked using a dominant negative approach and a BMP-
4 inhibitor, Xenopus Noggin in transgenic mice. This resulted in a disruption of distal 
differentiation and thus proximalization of the lung (Weaver et aI., 1999). These data 
indicate that BMP-4 is involved in specifying cell fates along the proximo-distal axis. 
Furthermore, the interaction between FGF-IO and BMP-4 signaling has been investigated 
intensively (Lebeche et al., 1999; Weaver et al., 2000). BMP-4 expression is induced by 
FGF-IO in vitro (Lebeche et al., 1999). In addition, BMP-4 has been demonstrated to 
serve as an inhibitor for FGF-IO induced lung bud outgrowth (Weaver et aI., 2000). There 
are two other factors involved in regulation ofBMP-4, namely TTF-I (Minoo et al., 1999) 
and Pod-I (Quaggin et al., 1999). Pod-I belongs to the basic helix-loop-helix transcription 
factors. Its expression is confined to the mesenchyme of organs where epithelial-
mesenchymal interactions occur, such as the kidney, lung, intestine and pancreas 
(Quaggin et al., 1998). Blocking Pod-I function with antisense oligonucleotides results in 
diminished mesenchymal cell condensation in embryonic kidney culture (Quaggin et al., 
1998). Genetic ablation of Pod-I results in pulmonary hypoplasia and disruption of 
epithelial cell differentiation (Quaggin et aI., 1999). In the null mutants, BMP-4 
expression is downregulated, whereas FGF-IO expression is not altered (Quaggin et al., 
1999). 
1.8. Extracellular matrix and lung branching 
Extracellular matrix (ECM) plays a complex role in regulating the behavior of cells that 
contact it, influencing their development, migration, proliferation, and morphology, as 
well as metabolic functions. In particular, the basement membrane (EM), which separates 
the epithelium from the surrounding mesenchyme, has been implicated in mediating 
morphogenetically significant tissue interactions. The epithelial-mesenchymal interface 
contains laminin, fibronectin, proteoglycans, and collagen as major matrix components. 
1.8.1. Collagens 
In addition to their structural roles, collagens may have numerous developmental and 
physiological functions (Bienskowski, 1991; Hay, 1991). In the adult lung, collagen 
accounts for 60% of the lung connective tissue protein mass. Collagen types I and III are 
predominantly associated with mesenchymal connective tissue in the lung. Lung collagen 
types IV and V are mainly found in BMs, although the latter may also be associated with 
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the interstitial matrix (Clarke et aI., 1983). The amount of collagen has been shown to 
increase with development (Bradley et aI., 1974). Several in vitro studies with inhibitors 
of collagen have suggested that it is important for branching morphogenesis of the lung 
(Spooner and Faubion, 1980). However, these results have not yet been confIrmed in 
studies with mice that do not produce collagen (Kratochwil et aI., 1986), and therefore, 
the precise role of collagen in pulmonary development remains obscure. 
1.8.2. Laminins 
Laminins are structurally related glycoproteins found mainly in BMs. Laminins are large 
multidomainglycoproteins composed of three polypeptide subunits: a, ~, and y (Burgeson 
et aI., 1994). Structural isoforms exist for each of these subunits and the association of 
these isoforms in heterotrimers gives rise to different laminins. Laminins stimulate cell 
adhesion and migration, growth, and morphology, as well as gene expression in a variety 
of cells (Timpl and Brown, 1994). At least 10 laminin variants are involved in pulmonary 
development. The precise role of the different laminins during pulmonary development is 
not yet completely understood. Laminin-I (aI, ~1, y1), laminin-2 (0.2, ~I, y1) and 
1aminin-3 (aI, ~2, y1) have been implicated in branching probably through their 
involvement in the organization of the basement membrane (Schuger et aI., 1990a; 
Schuger et aI., 1990c). The laminin domains involved in cell attachment (cross-
intersection of laminin structure and carboxy terminus of a chain) and heparin binding 
activity (inner globular region of ~ 1 chain) may facilitate lung branching morphogenesis 
(Schuger et aI., 1991). Recent studies suggest that an interaction between laminin and 
heparan sulfate proteoglycan (HSPG) is critical for the development of epithelial 
polarization and lumen formation (Schuger et aI., 1990b; Schuger et aI., 1996). Taken 
together, the exact mechanism of laminin function in pulmonary development has to be 
detennined, however, preliminary evidence suggests that it is a key regulatory matrix 
component in branching morphogenesis. 
1.8.3. Fibronectin 
Fibronectin is an adhesive glycoprotein that plays a major role during morphogenesis by 
promoting cell attachment (Ruos1ahti, 1988a). In the developing mouse lung, fIbronectin 
is localized to areas of airway bifurcations (Roman and McDonald, 1992). Inhibition of 
ligand binding to the fIbronectin receptor with synthetic peptides diminishes but does not 
abolish lung branching (Roman et aI., 1991a; Roman et aI., 1991 b). 
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1.8.4. Anti-adhesive ECMproteins 
Since adhesion of cells to the extracellular matrix appears to be critical for lung 
branching, molecules that disrupt cellular adhesion may also modulate this morphogenetic 
process. Anti-adhesive properties have been ascribed to several ECM proteins, such as 
SPARC (secreted protein, acidic and rich in cysteine), and tenascin (Sage and Bomstein, 
1991). SPARC is expressed in the pulmonary epithelium during early rat pulmonary 
development (Strandjord et a!., 1995b). Inhibition of SP ARC function results in inhibition 
of branching morphogenesis in vitro (Strandjord et a!., 1995b). The tenascins are a family 
of extracellular matrix glycoproteins of typical multidomain structure (Chiquet-
Ehrismann, 1995). Only tenascin-C has been implicated in lung organogenesis (Young et 
al., 1994). Antibodies against tenascin-C inhibit branching in vitro (Young et a!., 1994). 
In contrast, disruption of the tenascin-C gene in mice does not affect normal pulmonary 
development (Saga et aI., 1992). The latter finding makes it questionable whether tenascin 
plays an essential role during lung branching morphogenesis. However, it is possible that 
the other members of the tenascin family compensate for the loss oftenascin-C. 
1.8.5. Proteoglycans 
Proteoglycans (PGs) are major components of the basal laminae. The PGs constitute a 
family of multidomain core proteins to which glycosaminoglycans (GAGs) are attached. 
GAGs bind to other matrix components, cell adhesion molecules, and growth factors (Juul 
et al., 1991; Ruoslahti, 1988b; Ruoslahti, 1989). These properties suggest that GAGs may 
mediate, at least in part, cell adhesion, structural organization, and cell proliferation 
during fetal pulmonary development. Inhibitors of GAG synthesis such as 6-diazo-5-oxo-
L-norleucine and azaserine inhibit branching morphogenesis of cultured embryonic lung 
rudiments (Spooner et al., 1986). The exact mechanism by which PG/GAGs direct 
branching morphogenesis is unknown. Increasing evidence suggests that PG/GAGs play 
an important role as modulators of growth factor activities. Several isoforms of FGF bind 
to high-affinity receptors and are active when bound to specific cell-surface heparan 
sulfate proteoglycans (KJagsbrun and Baird, 1991). Similarly, the membrane proteoglycan 
betaglycan increases the binding of TGF-J3 to the signaling TGF-J3 receptor (Lopez-
Casillas et a!., 1993). These properties suggest that PG/GAG may mediate morphogenetic 
actions of growth factors, such as FGF and TGF -13, on cell adhesion and cell proliferation 
during early pulmonary development. 
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1.8.6. Integrins 
Integrins are cell surface proteins that have been identified to serve as receptors for ECM 
molecules (Albelda and Buck, 1990; Hynes, 1992). Integrins are transmembrane 
glycoproteins that consist of a~ heterodimers. The response of a cell to a particular form 
of an ECM molecule will depend on the number and subunit composition of integrins 
expressed on its surface and their binding properties. The integrins al~1 and a2~1 
function as collagen-binding receptors in fetal rat lung fibroblasts (Caniggia et al., 1995). 
The al integrin subunit is not crucial for lung branching as a null mutation in the al 
integrin gene does not result in any loss of viability or obvious phenotype (Gardner et a!., 
1996). The expression of the fibronectin receptor a5~1 in the developing lung has been 
reported (Roman and McDonald, 1992) and inhibition of ligand binding to fibronectin 
receptor affects lung branching in vitro (Roman et al., 1991 b; Roman and McDonald, 
1992). A null a5 mutation leads to embryonic death prior to lung formation (Yang et a!., 
1993). As discussed earlier, laminin appears to be a key determinant for regulating lung 
branching morphogenesis. Several larninin integrins have been identified (Mercurio and 
Shaw, 1991), of which a2~1, a3~1, and a6~1 are expressed in the developing human 
lung (Virtanen et a!., 1996). Recently, genetic ablation of the a3 integrin gene has been 
shown to result in reduced bronchial branching (Kreidberg et a!., 1996). This suggests that 
the larninin! a3 ~ I interaction is crucial for lung organogenesis. 
1.9 Differentiation and maturation of pulmonary tissues 
At the end of the pseudoglandular stage, when branching morphogenesis has almost come 
to an end, the airways are lined by undifferentiated columnar epithelium (Ten Have-
Opbroek, 1981). Subsequently, this primordial epithelium gives rise to the prospective 
bronchial columnar epithelium and the prospective respiratory low columnar/cuboidal 
epithelium (Ten Have-Opbroek, 1981). This event establishes a proximal conducting 
region and a distal gas exchange region. The process of differentiation and maturation 
then continues in the canalicular, terminal sac and alveolar periods. The cuboidal cells 
lining the pulmonary acinus are type II (precursor) cells. These cells will eventually 
mature into surfactant-producing type II cells or differentiate into flattened type I cells 
(Otto-Verbeme et a!., 1988). 
Surfactant is a compound that lowers the surface tension of the alveoli, so that 
collapse of the alveoli is prevented on expiration (Hawgood, 1991). As mentioned, type II 
cells produce surfactant. These type II cells have matured from precursor type II cells 
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during the canalicular phase of pulmonary development. The main characteristic that 
distinguishes precursor type II cells from mature type II cells is the decrease in glycogen 
content which in turn gives rise to an increase in number and size of lamellar bodies, 
which are the storage pools of pulmonary surfactant (Kresch and Gross, 1987). Surfactant 
consists of approximately 90% phospholipids, 5-10% proteins, and a small amount of 
carbohydrate (Kresch and Gross, 1987; Post and van Golde, 1988). The phospholipid 
fraction is composed of 75% phosphatidylcholine (PC) and 70% of this is saturated 
(Kresch and Gross, 1987; Post and van Golde, 1988; Rooney et aI., 1994). The main 
enzyme involved in PC synthesis is cholinephosphate cytidylyltransferase (CT), which 
forms also the rate-limiting step of PC synthesis (Kresch and Gross, 1987; Post and van 
Golde, 1988; Viscardi and McKenna, 1994; Zinunermann et aI., 1993). 
Four different surfactant-associated proteins can be distinguished: Surfactant 
protein-A (SP-A), -B (SP-B), -C (SP-C), and -D (SP-D) [for review see (Johansson et aI., 
1994)]. SP-A is the most abundant surfactant protein. It is synthesized by type II cells, but 
also by the Clara cells of the respiratory bronchioles. Interestingly, SP-A has no surface 
tension-reducing properties. It is involved in pulmonary host defense processes, and 
functions as a cytokine and opsonin (Ikegami et aI., 1997; Ikegami et aI., 1998; LeVine et 
aI., 1999; LeVine et aI., 1998). SP-D has also no function in reducing the surface tension. 
It functions as a cytokine, and is involved in regulation of the function of pulmonary 
macrophages (Botas et aI., 1998; Ikegami et aI., 2000; Wert et aI., 2000). The other two 
surfactant proteins, SP-B and SP-C are involved in reducing the surface tension of the 
alveoli. SP-B is mainly involved in processing of the surfactant pools and regulates 
surfactant homeostasis (Akinbi et al., 1997; Stahlman et al., 2000; Tokieda et aI., 1999; 
Tokieda et aI., 1997). SP-C promotes the rapid adsotption of phospholipid films, thereby 
reducing the alveolar surface tension at the air-liquid interface. 
1.10. Hormonal modulation of pulmonary growth 
Several growth factors and hormones have been demonstrated to be involved in regulating 
fetal pulmonary maturation. Glucocorticoids, thyroid hormones, epidermal growth factor, 
adenosine 3', 5'-cyclic monophosphate (cAMP), estrogens, and prolactin all positively 
regulate lung maturation (Gross, 1990). On the other hand, insulin, androgens and 
transforming growth factor-~ have all been implicated in negatively influencing 
pulmonary maturation (Gross, 1990). Herein, we will only focus on the influence of 
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glucocorticoids and thyroid hormones, since they have actually made it to clinical 
practice, whereas the other mentioned factors have been investigated only experimentally. 
1.10.1. Glucocorticoids 
Since the early seventies, the influence of hormones on pulmonary maturation has been 
well recognized. At that time, Liggins (Liggins, 1969) demonstrated that administration of 
glucocorticoids to premature fetal sheep results in less respiratory distress and a better 
survival. Since then, the application of hormonal modulation of fetal pulmonary growth 
has been studied extensively. It is now well established that steroids, i.e. 
glucocorticosteroids, as well as thyroid hormones playa role in fetal lung development 
and in pulmonary surfactant production. Glucocorticoids playa critical role in regulating 
numerous physiological and developmental processes (Ballard and Ballard, 1995). During 
fetal and postnatal development, glucocorticoids function as signaling molecules to 
modulate the orderly sequence of differentiation in most tissues. From mid-gestation 
onwards, the fetus is exposed to increasing levels of cortisol of primarily fetal origin. 
Both in humans and in other mammals there is strong evidence that the administration of 
glucocorticoids to the immature fetus results in an accelerated maturation of the fetal 
lungs. Also, "physiological stressors" such as infection and preterm prelabor rupture of 
the membranes have been shown to accelerate fetal lung maturation (Bauer et aI., 1974; 
Kotas, 1973). However, there is also strong evidence that endogenous glucocorticoids do 
not initiate alveolar epithelial maturation, but that they are involved in the modulation of 
genes responsible for surfactant production [for review see (Ballard, 1987)]. 
The positive effects of glucocorticoids on pulmonary maturation are attributed to 
an increase in surfactant protein synthesis, but also to an increased collagen and elastin 
content, both resulting in an improved lung compliance (Ballard and Ballard, 1995; 
Kresch and Gross, 1987). Together with these positive effects on surfactant production, 
glucocorticoids stimulate antioxidant enzyme activity, resulting in higher levels of 
antioxidant enzymes (Frank et aI., 1985; Walther et aI., 1991). The exact mechanisms by 
which glucocorticoids exert these positive effects are not completely understood. The 
effects have been suggested to be mediated via a Fibroblast Pneumocyte Factor (FPF), 
that is produced by pulmonary fibroblasts and stimulates surfactant synthesis by type II 
cells (Smith and Post, 1989). All these effects are mediated through specific 
glucocorticoid receptors that, upon binding of glucocorticoids, regulate transcription of 
the different involved genes, such as the surfactant protein genes (Ballard, 1983). 
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Concomitant with a rise in glucocorticoid plasma levels near tenn, a developmentally 
timed enhancement of glucocorticoid receptor gene expression has been shown by 
Sweezy and coworkers in the fetal rat (Sweezey et aI., 1995; Sweezey et aI., 1998). 
Autoradiographic localization studies demonstrate that glucocorticoid receptor gene 
expression is increased in the mesenchyme, and more specifically in the mesenchymal 
cells that are adjacent to the tenninal saccular epithelium, the cell population responsible 
for fibroblast-pneumocyte factor production (Beer et aI., 1984; Caniggia et aI., 1991). 
Already in 1972, Liggins and Howie reported the first trial of antenatal 
glucocorticoid treatment in humans. Antenatal glucocorticoids significantly decreased the 
incidence of respiratory distress syndrome (RDS) in pretenn born infants (Liggins and 
Howie, 1972). Meta-analysis of published studies on antenatal glucocorticoids 
demonstrated statistically significant beneficial effects on neonatal outcome for infants 
born at less than 34 up until 24 weeks of gestation (Crowley, 2000; Crowley, 1995). 
Hence, the NIH consensus recommends antenatal administration of corticosteroids for 24 
hours, but if possible, for 48 hours, to all fetuses between 24 and 34 weeks of gestation at 
risk of pretenn delivery (1 995b ). 
I. JO.2. Thyroid hormones 
The beneficial effects of the thyroid honnones tri-iodothyronine (T3) and thyroxine (T4) 
on pulmonary maturation are more controversial. On the one hand thyroid honnones have 
been demonstrated to stimulate PC synthesis and CT activity, and hence stimulate 
surfactant synthesis (Kresch and Gross, 1987; Post and van Golde, 1988). On the other 
hand, there is no regulatory effect on surfactant protein synthesis and moreover, a 
negative effect on fatty acid synthase (Gross, 1990; Kresch and Gross, 1987). Since 
thyroid honnones do not nonnally cross the blood-placenta barrier, thyrotropin-releasing 
honnone (TRH) is administered to mothers in order to increase T3 levels in the fetus 
(Thorpe-Beeston and Nicolaides, 1993). However, TRH only stimulates surfactant 
excretion, and not synthesis (Post and van Golde, 1988). Moreover, TRH has been 
demonstrated to negatively influence the activity of antioxidant enzymes, such as catalase, 
glutathione peroxidase, and superoxide dismutase (Chen et aI., 1993). These enzymes are 
required for the detoxification of reactive O2 metabolites such as O2 free radicals (Frank 
and Sosenko, 1987a; Frank and Sosenko, 1987b). These O2 metabolites are likely to be 
produced when premature born neonates are exposed to high oxygen concentrations 
during artificial ventilation (Fardy and Silvennan, 1995; Frank and Sosenko, 1987a). 
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In the early nineties, the administration of glucocorticoids combined with thyroid 
honnones was advocated for their supposed synergistic effects. However, the extra effect 
of adding thyroid honnones to glucocorticoids is becoming more controversial. The 
combined administration of glucocorticoids and TRH was presumed to have effects on 
surfactant synthesis. However, these synergistic effects were not confIrmed in multicenter 
clinical trials. The negative effects of TRH on antioxidant enzyme expression and the 
unclear synergistic effects do not justify the addition of TRH to glucocorticoids in clinical 
practice these days [for review see (Keijzer et a!., 2000)]. 
The rationale for clinical studies with TRH was based on numerous animal and in 
vitro studies, but the clinic itself also gave some suggestions for the involvement of 
thyroid honnones in lung development. Lower circulating T3 levels were observed in 
human pretenn infants who develop RDS as compared to healthy neonates of similar 
gestation (Abbassi et a!., 1977). More evidence that thyroid honnones are directly 
involved in lung development came from the observations that, in the human fetus, the 
lungs have been shown to contain high levels of T3 receptors (Bernal and Pekonen, 
1984), and 13 receptors have been demonstrated in adult type II cells (Smith and 
Hitchcock, 1983). deMello et a!. found that fetal and neonatal lung maturation is delayed 
in mice with primary hypothyroidism (deMello et a!., 1994). Using a different 
experimental mouse model of fetal hypothyroidism, van Tuyl et a!. could not demonstrate 
an effect on fetal surfactant proteins; yet, based on morphometric analysis, we found a 
striking delay in differentiation from day 7 to 28 postnatally (unpublished results, van 
Tuyl personal communication). 
In 1992, Ballard et a!. published the results of a multicenter, blinded, randomized 
trial (Ballard et a!., 1992). TRH plus betamethasone treatment signifIcantly reduced the 
development of chronic lung disease in infants weighing less than 1500 g, but TRH 
treatment alone did not affect the incidence ofRDS. In contrast, the ACTOBAT study, the 
Australian multicenter randomized trial, showed that the combined use of glucocorticoids 
and TRH in pretenn labor resulted in an increased frequency of RDS and increased need 
of ventilation in the newborn. Moreover, this study reported a signifIcant increase in 
maternal side effects, such as nausea, vomiting, lightheadedness, and a rise in blood 
pressure to 140/90 mm Hg or higher (1995a). The collaborative Santiago Surfactant 
Group was also not able to [md any additional benefIt of a combined antenatal use of 
TRH and corticosteroids over corticosteroids alone in the prevention of RDS (1998). In 
1998, Ballard et a!., now including all treated infants, could not show any benefIcial effect 
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of antenatal TRH and gJucocorticoids treatment over glucocorticoid treatment alone 
(Ballard et aI., 1998). Taken together, these data indicate that the additional effects of 
TRH observed in experimental models have not been substantiated in clinical trials and 
the antenatal use of TRH should therefore be abandoned until further data become 
available. 
1.11 Vascularization 
In contrast to the large amount of information on the development of the pulmonary 
tissues and their interaction, much less is known about vascularization of the lung. As in 
differentiation of pulmonary tissues, pulmonary vascularization is guided by a well-
orchestrated interplay between extracellular matrix proteins, cell adhesion receptors, 
growth factors and their receptors (Baldwin, 1996). In a classical study, deMello et al. 
investigated neovascularization of the lung using Electron Microscopy. They postulate 
that pulmonary vascularization is dependent on two processes: vasculogenesis and 
angiogenesis. In the first process, vasculogenesis, blood vessels develop de novo from 
blood lakes present in the mesenchyme of the E9 embryonic mouse lung. Subsequently, 
the blood lakes coalesce and form irregular sinusoidal structures. The second process, 
angiogenesis, starts a few days later around E12, when arteries and veins start to sprout 
from the central puhnonary vessels. At a certain point during development (around EI4), 
the peripheral sinusoids and central vessel sprouts will connect and establish a vascular 
network in the lung (deMello et aI., 1997). This connecting of peripheral and central 
vascular structures is accompanied by extensive branching of the vessels which follow the 
branching pattern of the airways (deMello et aI., 1997). However, it is not clear whether 
branching morphogenesis of the airways dictates branching of the vessels, or vice versa. 
Just recently, the first factors involved in puhnonary endothelial cell differentiation 
have been identified. In addition to growth factors that were already known for their role 
in puhnonary tissue differentiation, such as members of the FGF-, TGF-~- and PDGF-
family, new growth factors such as Vascular Endothelial Growth Factor (VEGF) and its 
receptors flk-l and fit-I, have been implicated in puhnonary vessel formation (Drake and 
Little, 1995; Flamme et aI., 1995a; Flamme et aI., 1995b; Gebb and Shannon, 2000; 
Yamaguchi et aI., 1993). Overexpression ofVEGF in pUlmonary epithelium using the SP-
C promoter in transgenic mice, results in abnormal puhnonary morphogenesis combined 
with an increase in vascularization surrounding the airways (Zeng et aI., 1998). This 
indicates that neovascularization and lung morphogenesis are closely related. 
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Very recently, Endothelial Monocyte Activating Polypeptide (EMAP) II was 
identified as an important anti-angiogenic factor preventing unorganized vessel growth in 
the fetal lung (Schwarz et a!., 1999), In vitro, EMAP II inhibits fetal lung 
neovascularization and alters lung epithelial morphology. In conclusion, pulmonary 
neovascularization is dependent on a balanced interplay between positive and negative 
modulators of angiogenesis. In addition, pulmonary vascularization and pulmonary 
morphogenesis are closely related duting fetal development, and disturbing normal vessel 
formation results in abnormal puhnonary morphogenesis. 
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Chapter 2 
2.1 Introdnction 
Disturbance of the nonnal order of developmental events during pulmonary 
organogenesis results in abnonnal pulmonary development, or most frequently to 
underdevelopment of the lungs, which is generaIly referred to as pulmonary hypoplasia. 
Pulmonary hypoplasia can occur as an isolated entity, but is usuaIly part of a congenital 
anomaly. The most important ones discussed herein are, oligohydramnios sequence, 
Potter syndrome, obstructive uropathy, anencephaly, and congenital diaphragmatic hernia 
(CDH). When children suffering from these anomalies are born, pulmonary hypoplasia is 
in many cases the most important prognostic factor, due to the resulting respiratory 
insufficiency which may eventually lead to therapy resistant respiratory failure and death. 
During the past decades, tremendous progress has been made in treating congenital 
anomalies due to the increase in sophisticated technological treattnent modalities which 
are nowadays at the disposal of neonatologists and pediatric surgeons. Amongst the most 
recent treattnent modalities are for instance extracorporeal membrane oxygenation 
(ECMO), high frequency oscillation (HFO) and fetal surgery. However, this increased 
assortment of treattnents did not reaIly influence survival in the children suffering from 
severe pulmonary hypoplasia. Therefore, instead of finding alternative aids for treating 
pulmonary hypoplasia, the emphasis of research is (and should be) shifted towards 
understanding pulmonary hypoplasia better. In this way, future treattnent modalities can 
be designed at preventing or reversing pulmonary hypoplasia, which wiIl hopefuIly prove 
to be better than 'just" treating respiratory insufficiency postoatally. Herein, the 
characteristics of pulmonary hypoplasia and the most iroportant congenital anomalies that 
are associated with pulmonary hypoplasia will be described. In addition, one of the 
anomalies, CDH, wiIl be discussed in more detail, because an important part of the work 
described in this thesis was motivated by the remaining questions in the pathogenesis of 
pulmonary hypoplasia in CDH and consequently perfonned in an animal model for CDH. 
2.2 Pulmonary hypoplasia 
Hypoplasia is derived from the Greek word hypop/asis, which means "undennolding" or 
underdevelopment. UsuaIly this is due to a decrease in the number of ceIls. Hence, 
pulmonary hypoplasia can be described as underdevelopment of the lungs. The criteria for 
pulmonary hypoplasia have frrst been described by Askenazi and Perlman (Askenazi and 
Perlman, 1979). 
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They are: 
• decreased lung-body weight ratios 
• decreased radial alveolar counts (RAC), which is a measure of the complexity of the 
pulmonary acinus (Emery and Mithal, 1960; George et aI., 1987; Nakamura et aI., 
1991; Reale and Esterly, 1973) 
• lower number of airway generations (Areechon and Reid, 1963; Kitagawa et aI., 1971) 
• lower number of vascular generations (Kitagawa et aI., 1971) 
• greater muscularity of the peripheral arteries (Naeye et aI., 1976). 
The first three criteria are observed as part of different congenital anomalies, such as 
oligohydramnios, Potter syndrome, anencephaly, and CDH. However, the latter two 
criteria are only observed in pulmonary hypoplasia associated with CDH, and not with the 
other congenital anomalies (Hislop et aI., 1979). 
In case of oligohydramnios, there is less than normal or virtually no amniotic fluid, 
due to a leakage of amniotic fluid or insufficient production of urine. This clinical 
condition is often caused by congenital malformations of the urinary tract especially 
obstructive uropathy (Hislop et aI., 1979; Perlman and Levin, 1974; Potter, 1965). In the 
classical description of the Potter syndrome, oligohydramnios is the result of bilateral 
agenesis of the kidneys (Potter, 1965). Because of the absence of kidneys, no urine is 
produced. The prevalence of Potter syndrome is approximately 1 in every 3000 births. 
Next to oligohydramnios, characteristic facial changes and limb deformities, together with 
pulmonary hypoplasia are associated with this syndrome (Potter, 1965). The facial 
changes and limb deformities are thought to be caused by compression of the face and 
limb in utero. The absence of liquid in the lungs during development and interference 
with fetal breathing movements are held responsible for resulting in pulmonary 
hypoplasia, which is the cause of death in these children. For normal pulmonary 
development to occur, the presence of liquid in the lungs as well as fetal breathing 
movements are absolutely required (Harding, 1997; Hooper and Harding, 1995; Lawrence 
and Rosenfeld, 1986). Hence, the absence of both probably results in pulmonary 
hypoplasia in case of anencephaly also. Because these children cannot swallow amniotic 
fluid nor perform normal fetal breathing movements, they are born with hypoplastic lungs 
(Reale and Esterly, 1973). 
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2.3 Congenital diaphragmatic hernia 
2.3.1. Introduction and embryology 
The most common congenital anomaly associated with pulmonary hypoplasia is CDH. 
The first literature on CDH dates back to 1679, when Lazarus Riverius described the 
postmortem findings of a 24-year old man (Riverius, 1679). Subsequently, Sir Charles 
Holt described the first pediatric case ofCDH in 1701 (Holt, 1701). In 1761, Giovanni 
Battista Morgagni was the first to describe the association of pulmonary hypoplasia with 
CDH (Morgagni, 1769). In 95% of the cases the diaphragmatic defect is localized 
posterolateral. This fonn of CDH is called a hernia of Bochdalek after the Hungarian 
anatomist who first described this fonn of CDH and the localization of the remaining 
foramen in 1848 (Bochdalek, 1848). Approximately 60 years after the first speculation on 
surgical repair of CDH by Laennec (Laennec, 1827), the first (unsuccessful) attempt was 
undertaken (Naumann, 1888). The first series of survivors is attributed to Robert Gross 
based on his experience in the Boston Children's Hospital (Gross, 1946). Since then, 
numerous reports have been published on the surgical repair of CDH, and with the 
increased peri-operative care in the twentieth century, the operation itself is not longer 
considered the limiting factor for survival. However, overall survival remained 
troublesome, due to the inability to treat pulmonary hypoplasia, persistent pulmonary 
hypertension and the negative effects of artificial ventilation. 
The diaphragmatic defect occurs eight times more often on the left side than on the 
right (Benjamin et aI., 1988; Tibboel and Gaag, 1996). This is due to the fact that closure 
of the diaphragm occurs earlier on the right side than on the left. The foramen of 
Bochdalek nonnally closes during development, however, a disturbed development of the 
pleuroperitoneal fold results in defective closure (Greer et aI., 2000). Besides this 
pleuroperitoneal fold, the diaphragm originates from the septum transversum, the body 
wall, and the dorsal mesentery of the esophagns (Allan and Greer, 1997). As a 
consequence of defective closure of the foramen, herniation of abdominal viscera into the 
thorax can occur. Classically the herniation of abdominal organs is held responsible for 
the occurrence of pulmonary hypoplasia, because of a competition for intrathoracic space 
between the developing lungs and the herniated abdominal organs (Molenaar et aI., 1991) 
leaving the original theory of compression of the developing lungs behind. However, 
since the introduction and extensive study of an animal model for CDH, an alternative 
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hypothesis has been proposed (Iritani, 1984). This hypothesis will be discussed in detail 
below when the animal models for CDH are described. 
2.3.2. Clinical background 
The prevalence of CDH is 1 in 3000 total births (Torfs et aI., 1992). Even recently 
developed management techniques, such as fetal surgery, ECMO, BFO, Nitric oxide 
inhalation and the concept of gentle handling, have not significantly influenced the 
mortality rate of CDH in high-risk patients and consequently, CDH remains a major 
problem in pediatric surgery and neonatology. A recent review shows that the mortality 
remains high at 50 to 60% in high-risk patients (Katz et aI., 1998). However, very recent 
reports suggest a modest reduction in mortality to approximately 30% in comparable 
series of patients (Azarow et al., 1997; Kays et al., 1999; Reickert et aI., 1998; Wung et 
aI., 1995). In particular, the degree of pulmonary hypoplasia is almost impossible to 
evaluate pre- and inunediately postnatal, and in a number of cases the degree of 
pulmonary hypoplasia is an important determinant of the outcome (Thebaud et al., 1998). 
Today, even severe cases of pulmonary hypoplasia can sustain life for a limited period of 
time, but will die due to the high vulnerability for ventilation induced lung damage and 
the inability to dilate the abnormal pulmonary vasculature. 
The pathogenesis and etiology of CDH are incompletely understood (Tibboel and 
Gaag, 1996). Familial cases of CDH have been described (Norio et aI., 1984), however, 
the recurrence rate in a family is only 3% (Crane, 1979). Besides the description of 
isolated cases of CDH as the result of prenatal use of thalidomide, anticonvulsants and 
quinine in mothers (Hobolth, 1962; Kup, 1967; Powell and Johnstone, 1962), no 
environmental factors have been identified to be involved in the etiology of CDH in 
humans. In 50% of the cases, CDH is associated with other malformations such as neural 
tube defects and cardiac abnormalities (Benjamin et aI., 1988; Fauza and Wilson, 1994) 
and (genetic) abnormalities, albeit not uniform (Sweed and Puri, 1993; Tibboel and Gaag, 
1996). These associated major malformations negatively influence survival of the 
children. The most common chromosomal abnormalities found in CDH patients are: 
trisomy 18, 13,21, or monosomy 9p and 4p (Cunniff et aI., 1990). A special syndrome 
associated with CDH is the so-called Fryns syndrome (Lubinsky et aI., 1983). 
As stated above, the main limiting prognostic factors are determined by the degree 
of pulmonary hypoplasia and persistent pulmonary hypertension. Although the exact 
underlying pathogenetic events are not clear, pulmonary hypoplasia was found to be 
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based on a decrease in the number of tenninal bronchioli and volume of alveoli in CDH 
(Areechon and Reid, 1963). On the other hand, persistent pulmonary hypertension is 
caused by abnonnal muscularity of the pulmonary arteries (Kitagawa et aI., 1971; Naeye 
et aI., 1976), and in addition, increased sensitivity of the vascular tissue to regulators of 
vascular tone (Stolar et al., 1985). 
2.3.3. Pathogenesis and animal models for CDH 
The pathogenesis of pulmonary hypoplasia and CDH remains unclear. At present, there 
are two hypotheses (see Figure 1). The first is classical and considers pulmonary 
hypoplasia as a result of the diaphragmatic defect. Subsequent to the appearance of the 
diaphragmatic defect, the abdominal organs herniate into the thorax, thereby hindering 
nonnal pulmonary development due to a competition for intrathoracic space (Molenaar et 
aI., 1991). The second (alternative) hypothesis suggests that primary disturbance of 
pulmonary growth into the pleuroperitoneal canal results in abnonnal diaphragm 
development, leading to the diaphragmatic defect. This alternative hypothesis was first 
postulated by Irritani based on his observations made in a mouse model of CDH using a 
teratogenic agent (Iritani, 1984). 
There are various animal models to investigate either one of the hypotheses. One 
model is based on a strain of pigs in which CDH occurs naturally (Ohkawa et aI., 1993). 
The involved gene is not cloned yet, but the authors postulate that it has an autosomal 
recessive mode of inheritance. Naturally, this is the most promising one, since it offers the 
possibility to clone the responsible genes and generate transgenic animals. Recently, 
compound null mutations of retinoic acid receptor (RAR) genes, the receptor through 
which vitamin A exerts its effects, were described with variable foregut anomalies. Some 
mice displayed a CDH-like phenotype, whereas others suffered from an absent 
tracheoesophageal septum and left lung agenesis with hypoplasia of the left and/or right 
lungs (Mendelsolm et aI., 1994). Besides these "real" genetic models, all other animal 
models for CDH are either based on mechanical (surgical) or teratogenic interference with 
diaphragm development. 
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Classical hypothesis Alternative hypothesis 
Figure 1 Schematic representation of the two hypotheses regarding the pathogenesis of 
pulmonary hypoplasia and CDR. On the left the classical hypothesis, which states that the 
diaphragmatic defect is the primary defect, and pulmonary hypoplasia is the result of herniation 
of the abdominal organs into the thorax. On the right the alternative hypothesis stating that 
pulmonary hypoplasia is the primary defect, and abnormal diaphragm development occurs 
separately or as a result of abnonnal pulmonary development. 
The surgical model has been extensively studied in sheep and to a lesser extent in 
rabbits. De Lorimer et ai. were the first to describe the surgical model for CDH in sheep. 
In fetal lambs, a hole in the diapbragm is surgically created during the late 
pseudoglandular or canalicular stage of lung development and the bowels are manipulated 
into the thoracic cavity, in order to mimic the herniation of abdominal viscera (De 
Lorimier et at:, 1967). Most aspects of pulmonary hypoplasia seen in the human infant 
with CDH were also seen in the lambs with surgically created CDH (Harrison et aI., 
1980). However, this does not hold true for the pulmonary vascular morphologic changes 
(Adzick et ai., 1985). The group of Harrison slightly modified the model, since they 
positioned an inflated balloon in the thorax in order to simulate intrathoracic herniation of 
the abdominal organs (Harrison et ai., 1980). The sheep model has proven extremely 
valuable in investigating several aspects of the late-gestational and perinatal 
pathophysiology, as well as in utero repair of the diaphragmatic defect. With the 
increased use of antenatal ultrasound, more fetuses with CDH are being diagnosed before 
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birth. The high mortality from CDH has prompted approaches to correct the malformation 
in utero (Mychaliska et aI., 1996). Whereas anatomical repair of the defect is possible in 
utero with open fetal surgery, such an approach proved possible only when the liver was 
not herniated into the thorax. In utero surgical correction of cases with "liver up" did not 
result in a reduced mortality rate when compared to postnatal treatment results (Harrison 
et aI., 1993). Another antenatal therapeutic strategy that has been introduced recently is 
known as 'Plug the Lung Until it Grows' (PLUG) (Hedrick et aI., 1994) and is 
materialized also in the application of a tracheal ligation technique as described by Wilson 
and colleagues (DiFiore et aI., 1994). There have been reported survivors using this 
approach, but there are concerns that tracheal occlusion may delay the maturation of the 
lungs and the risks of preterm birth associated with in utero surgical interventions 
continue to limit fetal interventions (Benachi et aI., 1998). Harrison et al. recently 
suggested that high-risk fetuses with CDH, those with liver in the chest or low lung to 
head ratios, can be successfully treated with fetoscopic temporary tracheal occlusion by a 
detachable balloon (Harrison et al., 1998). However, the results of this NIH sponsored 
FETENDO technique have to be awaited. 
Despite these positive characteristics of the sheep model, the most important 
shortcoming of this model is that the defect is created relatively late in gestation, and as a 
consequence it is not really possible to investigate the pathogenesis of CDH. In addition, 
because of the limited number of fetuses in a litter in sheep it is difficult to design 
adequate controlled studies leading to statistically significant results. Moreover, there are 
considerable amounts of money associated with this animal model, which makes it less 
attractive. The latter might be overcome by the use of rabbits instead of sheep for the 
surgical model. In rabbits (with an average litter size of approximately 6), it is also 
possible to create a left diaphragmatic defect during the pseudo glandular stage of lung 
development (Fauza et aI., 1994; Wu et aI., 2000). The group of Deprest has even 
demonstrated that it is possible to repair this defect in utero or perform tracheal ligation 
later on during gestation (personal communication). 
The other widely used animal model for CDH is based on the teratogenic effects of 
the herbicide 2,4-dichlorophenyl-p-nitrophenyl ether (Nitrofen). When administered to 
pregnant rodents, disturbed organogenesis of the diaphragm, lungs, heart and kidneys will 
occur (Ambrose et al., 1971). In 1984 Iritani published the first data on using Nitrofen to 
induce CDH and puhnonary hypoplasia in fetal mice through administration of Nitro fen 
to the mother during pregnancy (Iritani, 1984). lritani was also the first one to propose 
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pulmonary hypoplasia to be the primary defect in CDR, and he even suggested that 
pulmonary hypoplasia might be causing the diaphragmatic defect in CDR (Iritani, 1984). 
This model was later adjusted by Kluth (Kluth et aI., 1990) and by Tenbrinck (Tenbrinck 
et aI., 1990), who demonstrated that Nitrofen has similar effects in rats. Subsequently, the 
rat model has been extensively studied in order to gain more insight into the pathogenetic 
events in CDR. Interestingly, whereas all fetuses exposed in utero display pulmonary 
hypoplasia, only in 80-90% of the fetuses a diaphragmatic defect is obtained. The fact that 
pulmonary hypoplasia is more severe when a diaphragmatic defect is present and also 
more severe on the ipsilateral side of the diaphragmatic defect suggests that there might 
indeed be a causative relationship between pulmonary hypoplasia and the diaphragmatic 
defect (Brandsma et aI., 1994a; Nakao and Ueki, 1990; Tenbrinck et aI., 1990). Just 
recently, studies with a Nitrofen mouse model were published (Cilley et aI., 1997; 
Coleman et aI., 1998). This will make it possible to use Nitrofen in transgenic mice and 
thus, making a whole new set of research tools available for investigating Nitrofen and its 
effects on lung and diaphragm development. 
The exact mechanism of action of Nitrofen is not completely understood. There 
have been speculations about the finding that Nitrofen might function through alteration 
of the thyroid hormone status (Manson, 1986). The significance of thyroid hormones on 
lung development in this CDR model, however, is based on the following observations. 
Nitrofen has a high stereochemical similarity' to thyroid hormones and Manson et al. 
demonstrated that following concomitant administration of thyroxine and Nitrofen to 
pregnant rats, a drastic reduction (70%) in the number of malformations in the offspring 
was observed (Manson et al., 1984). Brandsma et al. showed that Nitrofen in vitro 
decreases the binding of triiodothyronine to the alpha I and beta I form of the thyroid 
hormone receptor in a non-competitive manner (Brandsma et aI., 1994b). They concluded 
that rat lung hypoplasia might result from the decreased binding of triiodothyronine to its 
receptor via exposure to Nitrofen during fetal development. Despite this, no evidence has 
been published that demonstrates the direct interaction of Nitrofen with thyroid hormone 
metabolism. Of interest is the recent finding that antenatal treatment with vitamin A of 
Nitrofen-induced CDR rats, reduces the incidence and severity of CDR, and improves 
pulmonary growth and maturation (Thebaud et aI., 1999). 
The main advantage of the Nitrofen model is that CDR in this case is induced very 
early in gestation, enabling the investigation of early pathogenetic events. Other 
advantages of this model are the large litter sizes, the short duration of gestation and the 
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relative low costs of rodents. A disadvantage of the model is that the small size of the 
fetuses limits the possibilities for functional studies such as artificial ventilation and 
surgical interventions. Despite the proven usefulness of the Nitrofen model over the years 
in particular for characterizing abnormal lung growth and pulmonary vascular 
abnormalities, no correlation between either Nitrofen or thyroid hormone status has been 
proven to playa pivotal role in the etiology of CDH in humans (Bos et aI., 1994; Tibboel 
and Gaag, 1996). Hence, the results obtained with the Nitrofen model should be 
extrapolated to the human situation with a certain amount of reserve. 
2.3.4. Main characteristics of pulmonary hypoplasia in the animal models for CDH 
As stated above, the sheep model of surgically-induced CDH has been mainly used for 
functional and in utero repair studies, and to a lesser extent for structural and 
morphological studies. The degree of pulmonary hypoplasia is dependent on the time of 
gestation when the diaphragmatic defect is produced. The earlier the defect is produced, 
the more severe is the hypoplasia. However, one should bear in mind that the defect in the 
diaphragm is produced after normal closure, and pulmonary development was up till that 
moment normal. 
Pulmonary hypoplasia associated with surgically-induced CDH is characterized by 
the same morphological abnormalities as seen in the human situation (Harrison et al., 
1980). In addition, disturbed alveolar cell' differentiation results in diminished pulmonary 
maturation, which is characterized by surfactant deficiency (Glick et aI., 1992; Wilcox et 
aI., 1995). Surprisingly, normal lecithin/sphingomyelin (lis) ratios and 
phophatidylglycerol concentrations, both markers of lung maturity, have been found in 
the amniotic fluid of CDH lambs (Wilcox et al., 1995). In humans, these markers have 
been reported to be decreased (Hisanaga et aI., 1984; Sullivan et al., 1994). In contrast, 
Pringle et al. found an increase in number and size of type II cells when they investigated 
the hypoplastic lungs of CDH lambs using electromnicroscopy (Pringle et aI., 1984). 
Furthermore, the muscle mass is increased in the pulmonary vessels of CDH lambs, 
mimicking the findings in persistent pulmonary hypertension (Harrison et al., 1986). 
Since the introduction of the Nitrofen model, speculations have been made about 
pulmonary hypoplasia being the primary defect in CDH. Iritani has even postulated the 
idea that Nitrofen interferes with normal pulmonary development, and hence, the lung 
buds cannot grow normally into the pleuroperitoneal canal, thereby disturbing normal 
development of the posthepatic mesenchymal plate. It is this posthepatic mesenchymal 
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plate that forms the main tissue of origin for the diaphragm, and the disturbance of its 
normal development will result in a diaphragmatic defect (Iritani, 1984). However, Iritani 
did not provide any direct evidence to show an interaction between lung and diaphragm 
development. Moreover, Nitrofen was given on a daily basis from day 9 of gestation till 
term. 
Only a limited amount of information is available on the contribution of 
diminished expression of growth factors, transcription factors and neuropeptides to 
pulmonary hypoplasia and CDH. Most of this data has been obtained in the Nitrofen 
model. Just recently, the expression of some of the key lung morphogenetic genes (FGF-
10 and Bmp-4) was demonstrated to be disturbed in the Nitrofen CDH model, whereas the 
expression of others (Shh and Sprouty2) was not (Thebaud, personal communication). 
Different studies focused more on the delayed maturation and cell differentiation of 
hypoplastic lungs of Nitrofen treated rats. These lungs display altered SP-A protein 
expression indicating that type II cell differentiation into type I cells is altered (Brandsma 
et aI., 1994a). Recently it was shown that Nitrofen induced pulmonary hypoplasia results 
in diminished expression of SP-B and SP-C mRNA (Guilbert et aI., 2000). However, 
others have shown that this surfactant deficiency is no longer present at term (Batenburg 
et aI., 1996). Interestingly, there was no difference in the amount of lamellar bodies in 
Nitrofen lungs, however, the appearance of these lamellar bodies was abnormal 
(Brandsma et aI., 1993). In addition, conflicting results have been obtained when markers 
for lung maturation were investigated (Brandsma et aI., 1993; Hisanaga et aI., 1984; 
IJsselstijn et aI., 1998b; Moya et aI., 1995; Nakamura et aI., 1991; Sullivan et aI., 1994). 
Preliminary data of Brandsma et ai. demonstrated that the expression of several 
extracellular matrix proteins is not altered in Nitrofen--exposed lungs (personal 
communication). Recently, the group of Chinoy has demonstrated in their Nitrofen mice 
model that laminin protein is reduced in late gestation hypoplastic lungs when compared 
to control lungs (personal communication). 
Antenatal hormonal modulation of pulmonary growth and maturation has been 
investigated in both the surgical and Nitrofen CDH model. The administration of 
glucocorticoids and thyrotropin releasing hormone (TRH) to Nitrofen-treated pregnant 
rats resulted in an increase in di-saturated PC in the fetal rats, but had no effect on the 
glycogen concentration, lung compliance or lung morphology (Losty et aI., 1996; Losty et 
aI., 1995; Suen et aI., 1994a; Suen et aI., 1994b). In addition, the combination of 
dexamethasone and TRH treatment in the Nitrofen CDH model did not change survival of 
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the affected pups when compared to sham-treated rats. (Ijsselstijn et aI., 1997b). As 
corticosteroids are known to exert their effect primarily on mesenchymal cells, the group 
of Martin Post performed a number of experiments using isolated type II cells 
(unpublished results, personal communication). The rate-limiting enzymes for surfactant 
synthesis together with the effect of corticosteroids on mesenchymal cells in Nitrofen-
induced CDH pulmonary cells and age-matched controls were evaluated. They observed 
that mesenchymal cells in CDH could not be stimulated by corticosteroids in the same 
marmer as controls. This raises intriguing questions on the effects of corticosteroids at the 
cellular level. 
After a period of uncertainty about the optimal way to modulate lung growth 
andlor differentiation by hormones, nowadays consensus exists on the role of 
corticosteroids in threatened preterm births. Based on this consensus, some clinicians 
have started to use corticosteroids in antenatally diagnosed cases of CDH. So far, the few 
reports that are available consist of personal communications, individual case reports or 
small series, but no properly designed randomized trial. The rationale for using 
corticosteroids in CDH is based on observations in the surgical CDH sheep model, or the 
Nitrofen-based rat model. In these models, changes in morphometric measurements, 
rnRNA levels of surfactant proteins and functional changes following artificial ventilation 
have been investigated. Researchers have even suggested that, in the Nitrofen model, 
antenatal use of corticosteroids changes the pUlmonary vascular architecture. However, no 
reports on the expression of the glucocorticoid receptor in the hypoplastic lung are 
available thus far. 
In the clinical setting, a randomized clinical trial evaluating the use of 
corticosteroids in antenatally diagnosed CDH has recently been started. Under the 
guidance of Dr. Kevin Lally, Texas, over 30 centers both in Europe and the U.S. plan to 
include 150 cases in both arms of the study to obtain an answer to the question whether 
antenatal corticosteroids are of benefit in human CDH. Mothers with fetuses diagnosed 
with CDH will be given multiple courses ofbetamethasone after 34 weeks of gestation. 
The antioxidant enzyme system appears to be unaltered in the Nitrofen CDH 
model during development. However, when CDH rats were exposed to high oxygen 
artificial ventilation, their lungs displayed more pronounced oxygen-induced lung damage 
(Ijsselstijn et aI., 1997b; Sluiter et aI., 1992). Of interest is the finding that infants with 
CDH have decreased vitamin A (a major antioxidant) blood levels (Major et aI., 1998). 
This corroborates with a recently published study that demonstrated a better survival and 
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decreased congenital anomalies in litters which had received vitamin A together with the 
Nitrofen treatment (Thebaud et aI., 1999). Neuropeptide expression was shown to be 
increased and delayed in the rat model of CDH (Usselstijn et aI., 1998a; Usselstijn et aI., 
1995). This corresponds to the increased bombesin immunoreactivity in infants with CDH 
(Ijsselstijn et aI., 1997a), but is in contrast to the decreased expression of gastrin-releasing 
peptide (Durbin et aI., 1996). 
The importance of abnormal vascular development as a determinant of survival in 
CDH has just recently been appreciated. The results of studies on this subject are just 
beginning to emerge. In the rat model similar abnonnalities have been observed in the 
pulmonary vessels as in infants: increased muscle mass and muscle found in arteries of 
smaller diameter as normal (Kitagawa et aI., 1971; Naeye et aI., 1976). One of the 
important determinants of vascular development which has been shown to be absent in 
lungs of CDH rats is VEGF (Okazaki et aI., 1997). However, contrasting results have 
been obtained for VEGF and its receptors flk-I and flt-1 by others using roR.NA in situ 
hybridization (Guilbert et aI., 2000). To make the situation even more confusing, VEGF 
expression was shown to be enhanced in lungs of humans with CDH when compared to 
age-matched controls (Shehata et aI., 1999) 
Besides studies investigating the structural morphological factors in Nitrofen-
induced abnormal pulmonary vascular development, many other studies have focused 
more on the presumed altered pulmonary vascular reactivity as the underlying mechanism 
of persistent pulmonary hypertension in CDH. It was shown that one of these regulators, 
endothelin-I and its receptor A were upregulated in lungs of CDH rats (Okazaki et aI., 
1998). In a different study, both decreased Nitric oxide synthase (NOS) expression and 
NOS activity were observed in CDH rat lungs (Karamanoukian et aI., 1996). As in the 
human situation (Nakayama et aI., 1992), several lung eicosanoids are increased after 
birth in CDH rats when compared to controls (Ijsselstijn et aI., 1997c). 
2.4 Concluding remarks and aims of the studies 
A non-conclusive overview of the (in my opinion) most important and interesting aspects 
of normal and abnormal pulmonary development which have been already investigated 
was given herein. In most clinical studies on pulmonary hypoplasia associated with CDH, 
decreasing the high mortality and morbidity was the primary goal mainly by searching for 
new treatment modalities. However, even sophisticated new techniques such as ECMO 
and fetal surgery did not bring the long-awaited significant improvement in survival of 
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high-risk CDR patients. Over the past years, research in the field has shifted into the 
direction of finding ways to better understand the abnonnal lung from a developmental 
perspective. In order to better understand abnonnal development it is most important to 
have a good understanding of the processes involved in nonnal development. 
This thesis describes studies which are aimed at unraveling certain aspects of 
nonnal and abnonnal pulmonary development. Therefore, the studies in this thesis were 
designed in order to answer the following questions: 
1. What role does the transcription factor GATA6 play during fetal pulmonary 
development? 
2. What is the role of proliferation and apoptosis in nonnal lung morphogenesis and 
does the balanced interplay between the two influences this process? 
3. Row are the thyroid honnone receptors involved in fetal (pulmonary) 
organogenesis? 
4. What are the direct effects of Nitro fen on pulmonary development, and how is this 
related to the diaphragmatic defect? 
5. Are members of the steroid honnone receptor superfamily differently expressed in 
Nitrofen-induced hypoplastic lungs? 
The first three questions are discussed in the studies described in Part II of this thesis, and 
the last two questions in the studies described in Part III. 
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3.1 Abstract 
Recent loss-of-function studies in mice show that the transcription factor GATA6 is 
important for visceral endoderm differentiation. It is also expressed in early bronchial 
epithelium and the observation that this tissue does not receive any contribution from 
GATA6 double mutant embryonic stem (ES) cells in chimeric mice suggests that GATA6 
may playa crucial role in lung development. The aim of this study was to determine the 
role of GATA6 in fetal pulmonary development. We show that GATA6 mRNA is 
expressed predominantly in the developing puhnonary endoderm and epithelium, but at 
E15.5 also in the puhnonary mesenchyme. Blocking or depleting GATA6 function results 
in diminished branching morphogenesis both in vitro and in vivo. TTFI expression is 
unaltered in chimeric lungs whereas SPC and CCIO expression are attenuated in 
abnormally branched areas of chimeric lungs. Chimeras generated in a ROSA26 
background show that endodermal cells in these abnormally branched areas are derived 
from GATA6 mutant ES cells, implicating that the defect is intrinsic to the endoderm. 
Taken together, these data demonstrate that GA TA6 is not essential for endoderm 
specification, but is required for normal branching morphogenesis and late epithelial cell 
differentiation. 
3.2 Introduction 
The formation of a lung requires a well organized program to coordinate the balanced 
interplay between activation and repression of gene transcription as it develops from a 
cluster of cells in the floor of the primitive foregut to the highly vascularized gas 
exchange organ (Hogan, 1999; Warburton et aI., 2000). Several evolutionarily conserved 
sigualing pathways have been implicated in the different stages of fetal puhnonary 
development. In particular members of the fibroblast growth factor, bone morphogenetic 
protein, hedgehog/Gli, wingless and epidermal growth factor families have been 
demonstrated to be key regulatory factors for lung morphogenesis and epithelial 
differentiation, but lung endoderm specification is less well understood (for review see 
Hogan, 1999; Warburton et aI., 2000). Recently, a member of the GATA family of 
transcription factors, GATA6, has been implicated in endoderm specification (Morrisey et 
aI., 1998). In vertebrates, the GATA family of transcription factors contains a conserved 
zinc-finger motif that binds to the consensus sequence AlTGATAIG resulting in 
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transcriptional regulation of genes in different cell lineages (for review see Charron and 
Nemer, 1999; Evans, 1997; Jordan and Van Zant, 1998; Orkin, 2000). The GATA 
transcription factors can be subdivided into two main groups. First, GATAI, GATA2 and 
GATA3, which all have unique functions in the hematopoietic system (Leonard et aI., 
1993; Pandolfi et aI., 1995; Pevny et aI., 1991; Simon et aI., 1992; Ting et aI., 1996; Tsai 
et aI., 1994; Weiss et al., 1994; Whyatt et aI., 2000) and, in case ofGATA2 and GATA3, 
in many other tissues, including the nervous system and the kidneys. Second, GATA4, 
GATA5 and GATA6, which are mainly expressed and involved in the formation of the 
extra-embryonic and embryonic endoderm, as well as in the cardiogenic mesoderm 
(Arceci et aI., 1993; Koutsourakis et al., 1999; Laverriere et aI., 1994; Morrisey et al., 
1996; Morrisey et aI., 1997a; Morrisey et aI., 1997b; Morrisey et aI., 1998). 
Radioactive in situ hybridization experiments have demonstrated that GATA6 
mRNA is expressed in the developing embryonic bronchial epithelium and in chimeric 
experiments this endodermally derived tissue did not receive any contribution from 
GATA6-/- ES cells (Morrisey et aI., 1996; Morrisey et al., 1998). The conclusion of these 
studies was that GA TA6 is required for specification oflung endoderm. In addition, the 
promoters of several lung specific genes, such as the genes for human thyroid 
transcription factor 1. human surfactant protein C, mouse surfactant protein A and mouse 
Clara cell marker 10, contain GATA motifs (Ikeda et aI., 1995; Korfhagen et aI., 1992; 
Ray et al., 1993; Wert et aI., 1993) and GATA6 has also been shown to activate both 
surfactant protein A and thyroid transcription factor I reporter gene transcription in vitro 
(Bruno et aI., 2000; Shaw-White et aI., 1999). Taken together, these data strongly suggest 
that GATA6 plays an important role during lung development. 
We therefore searched to identifY the specific role(s) ofGATA6 in fetal pulmonary 
development. In order to obtain a more detailed insight into the spatial-temporal 
distribution of GATA6 mRNA, non-radioactive in situ hybridization during fetal lung 
development in vivo was performed. The observed expression patterns in early embryonic 
lungs suggest a role for GATA6 in branching morphogenesis, that we investigated using 
organotypic explant cultures with antisense oligonucleotides. To confirm and further 
investigate the role of GATA6 in lung development in vivo, we also generated highly 
chimeric embryos by injecting wild-type blastocysts with GATA6-/- embryonic stem (ES) 
cells. The latter experiments enabled us to overcome the early embryonic lethality in 
GATA6-/- mice, which is due to extra-embryonic defects (Koutsourakis et aI., 1999; 
Morrisey et al., 1998), because in such chimeras, the extra-embryonic tissues are provided 
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by the wild-type host blastocyst. Highly chimeric lungs were histologically analyzed, and 
the expression of molecular markers for endoderm specification and epithelial cell 
differentiation (thyroid transcription factor I, surfactant protein C and Clara cell marker 
10) was investigated using immunohistochemistry and in situ hybridization. 
Branching morphogenesis was dramatically affected in vitro when antisense 
oligonucleotides for GATA 6 were added to lung cultures. In chimeric embryos, pulmonary 
endoderm was formed but it branched abnormally and failed to undergo late epithelial cell 
differentiation, based on diminished surfactant protein C (SP C; Sftpc-Mouse Genome 
Informatics) and Clara cell marker 10 (CC 10; Utg-Mouse Genome Informatics) 
expression. Using ROSA26 recipient blastocysts, we demonstrate that this abnormal 
epithelium is derived from GATA6-1- ES cells. We conclude that GATA6 is essential for 
the later stages of branching morphogenesis and late epithelial cell differentiation, but not 
for lung endoderm specification. 
3.3 Materials and methods 
Whole-mount in situ hybridization 
Wild-type embryonic day (E) 10.5 and E12.5 embryos were isolated from pregnant FVB 
female mice according to standard methods (Hogan et aI., 1994) and the lungs were 
dissected from these embryos using microsurgical techniques. The lungs were fixed in 4% 
(w/v) paraformaldehyde in phosphate-buffered saline (PBS) at 4°C for 4 to 6 hours, 
dehydrated in a graded series of ethanol and kept in 100% methanol at -20°C until used. 
The whole-mount in situ hybridization protocol was adapted from the protocol described 
by Wilkinson (Wilkinson, 1993). In short, following hydration, the lungs were bleached 
for I hour in 6% (v/v) hydrogen peroxide in PBS containing 0.1 % (v/v) Tween-20 (PBT) 
and permeabilized with proteinase K (10 flg.mr1 in PBT) for 15 minutes at room 
temperature. Subsequently, the lungs were post-fixed in 4% (w/v) paraformaldehyde in 
PBS and prehybridized in hybridization mixture, containing 50% formamide, 5x SSC 
(NaCl 0.75 molJL, sodium citrate 0.075 molJL, pH 4.5), 1% sodium dodecyl sulphate, 5 
flg.ml,l yeast tRNA, 50 flg.mr1 heparin in water for I hour at 70°C. Hybridization was 
carried out for 16 to 18 hours at 70°C using the same hybridization mixture, but now 
containing a digoxigenin (DIG)-Iabeled sense or antisense GATA6 RNA probe. A 1.5 kb 
fragment of the 5' end of the mouse GATA6 gene that was described previously (Brewer 
et aI., 1999) was used to generate a probe for in situ hybridization on sections. A PstI -N otI 
82 
GATA6 and lung development 
subclone from the 5' part of this 1.5 kb fragment was used to generate a probe for whole-
mount in situ hybridization. The cDNA fragments were DIG labeled according to a 
protocol provided by the manufacturer (Roche Diagnostics, Almere, The Netherlands). 
The next day, the lungs were stringently washed and treated with RNAse to avoid 
aspecific background staining. Following a blocking step using 10% (v/v) sheep serum in 
0.14 moVL NaCl, 2.7 mmoVL KCI, 25 mmoVL TrislHCI pH7.5 and 0.1 % (v/v) Tween-20 
in water (TBST) including 2 mmoVL levamisole, the lungs were incubated with an 
alkaline phosphatase-coupled antibody, 1:2000, against DIG for 16 to 18 hours at 4°C. 
For at least 3 days the lungs were then washed in TBST and 2 mmoVL levamisole. The 
lungs were changed to 0.1 moVL NaCl, 0.1 moVL TrisIHCI, pH 9.5, 0.05 moVL MgCI, 
and 0.1% (v/v) Tween-20 (NTMT) and the hybridized probe was visualized using 337.5 
J.!g.mr' NBT and 175 J.!g.mr' BCIP mixture as a substrate. Nonspecific labeling was 
removed in 95% ethanol, and the lungs were kept at 4°C in PBT containing I mmoVL 
EDTA. 
Branching morphogenesis in vitro with antisense oligonucleotides 
EI1.5 and E12.5 lungs were harvested from wild-type embryos under a dissection 
microscope. The lungs were transferred to porous membranes (8 J.!m pore size) from 
Nucleopore (Whatman, NY), and incubated in 12-well culture plates from Costar 
(Coming, NY). The membranes were pre-soaked in MEM (Gibco) for I hour before the 
explants were placed on them. The explants were incubated as floating cultures in 500 J.!I 
Dulbecco's modified Eagle's medium, nutrient mixture F-12 (Gibco) supplemented with 
100 J.!g/ml streptomycin, 100 units/ml penicillin and 0.25 mg/ml ascorbic acid. The 
explants were cultured at 37°C in 95% air and 5% CO,. Ten cultured lungs were treated 
with 40 j.!M phosphorothioated oligonucleotides, targeted against the translation initiation 
site of the murine GATA6 mR.NA in the antisense direction with the following sequence: 
GTCAGTCAAGGCCAT. Ten cultured lungs were treated with the same concentration 
sense-orientated oligonucleotides with the following sequence: ATGGCCTTGACTGAC. 
Ten untreated cultured lungs served as controls. The lungs were cultured for up to 72 
hours and branching morphogenesis was monitored daily and images captured using a 
dissecting microscope (Leica MZ12) and the Leica Digital Imaging Systems. 
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Generation of chimeric embryos 
In contrast to standard procedures, we injected more than 20 GATA6-1-, or GATA+I- for 
the control experiment, ES cells into each blastocyst in order to obtain highly chimeric 
embryos. These injections were performed either in CS7BLl6 or ROSA26 (Friedrich and 
Soriano, 1991) blastocysts and the ES cell lines used have been previously described 
(Koutsourakis et aI., 1999). Chimeric lungs were dissected at EI2.S, EI3.S, ElS.5 or 
ElS.S and either processed for explant cultures (El3.S), as described above, or fixed and 
used for histological analysis and in situ hybridization, as described above (EI2.S, ElS.S 
and ElS.5). Head or tail tissue of the embryos was used to determine the percentage of 
chimerism using Glucose Phosphate Isomerase (GPI) electrophoresis (Hogan et aI., 1994). 
In situ hybridization and immunohistochemistry 
Non-radioactive in situ hybridization on 6 fim thick sections with SP C and CC 10 RNA 
probes was carried out essentially as described before by Motoyama et al. (Motoyama et 
aI., 1995). In short, tissue sections were rehydrated and washed in PBS. Pretreatment 
included postfixation in 4% paraformaldehyde for IS minutes, followed by proteinase K 
digestion (20 mg/ml) for IS minutes at room temperature and acetylation (0.1 mollL 
triethanolamine and O.2S% acetic anhydride) for 10 minutes at room temperature. 
Sections were then dehydrated and air-dried before addition of the hybridization solution. 
Digoxigenin-labeled probes were added to freshly prepared hybridization solution (SO% 
deionized formamide, 10% dextran sulfate, l.5x Denhardt's reagent, O.S mg/ml of yeast 
tRNA, 0.3 mollL NaCl, S mmollL EDTA and 25 mmollL Tris, pH 7.S) at a concentration 
of 1 ng/fil. Following denaturation at 80°C, the probe was added to the tissue section and 
incubated for 16 to IS hours at SsoC. After brief washes with Sx SSC and 50% 
formamide at SsoC, the tissue was treated with RNase A (10 fig/ml) for 30 minutes at 
37°C. The digoxigenin nucleic acid detection kit (Roche Diagnostics, Almere, The 
Netherlands) was used for immunological detection of the hybridized probe. Tissue was 
then counterstained with Methyl Green and prepared for viewing. 
Mouse specific SP C and CC 10 cDNA fragments (330 and 31S bases, 
respectively) were DIG labeled according to a protocol provided by the manufacturer 
(Roche Diagnostics, Almere, The Netherlands). Immunohistochemistry with a 
monoclonal antibody against TTF 1 (Neomarkers, CA, USA) in a concentration of 1 in 
100 was carried out as described before (Keijzer et aI., 2000). 
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3.4 Results 
Spatial-temporal expression of GATA6 mRNA during fetal lung development 
Starting from EIO.5, when five primary lung buds have just evaginated from the foregut, 
GATA6 mRNA was detected in developing lung endoderm (Fig. IA). At this stage the 
GATA6 mRNA was predominantly expressed at the tips of the growing lung buds. Two 
days later at EI2.5, when branching morphogenesis of the lung buds is proceeding rapidly 
in order to establish the future bronchial tree, GATA6 mRNA was still observed in the 
branching endoderm. However, at this stage the signal was observed in the entire 
endoderm lining the developing lung buds, instead of being limited only to the tips of the 
growing buds (Fig. IB). On sections of wild-type E15.5 lungs, in which branching 
morphogenesis is almost completed, and differentiation and vascularization are beginning, 
GATA6 mRNA was expressed in the endoderm lining the growing airways, as well as in 
parts of the mesenchyme surrounding these airways, albeit at a lower level (Fig. I C). At 
EIS.5, when the bronchial tree is complete, and the lung tissues are differentiating into the 
different cell types that will constitute the lung after birth, GATA6 mRNA was observed 
mainly in epithelial cells lining the bronchioli, but also to a lesser extent in the epithelial 
cells lining the sacculi (Fig. ID). At this stage, the signal in the mesenchyme was difficult 
to distinguish, possibly because of the thinning of this tissue layer. Hybridization with 
sense RNA GATA6 probes generated no specific signal in either whole-mount or section 
in situ hybridization experiments at all stages (results not shown). 
Antisense oligonucleotides against GATA6 reduce branching morphogenesis in vitro 
Based on the mRNA expression pattern of GATA6, in particular expression in the 
endoderm lining the early lung buds, an important role for GA TA6 in branching 
morphogenesis was anticipated. Antisense oligonucleotides targeted against the 
translation initiation site of GATA6 were used in explant cultures of isolated fetal lungs to 
investigate this role. When EIl.5 lungs were cultured for 72 hours in the presence of 
antisense GATA6 oligonucleotides (Fig. 2B), branching morphogenesis of these lungs 
was clearly reduced when compared with the patterns of branching morphogenesis of 
lungs exposed to sense GATA6 oligonucleotides (Fig. 2A) or to lungs cultured in medium 
alone without oligonucleotides (not shown). A similar reduction in branching 
morphogenesis was observed when E12.5 lungs were cultured for 72 hours with antisense 
(Fig. 2D) oligonucleotides. Again, lungs exposed to sense oligonucleotides (Fig. 2C) and 
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control lungs (not shown), which were cultured without oligonucleotides, demonstrated 
similar patterns of normal branching morphogenesis. 
ElO.5 E12.5 
A B 
1015.5 E1.8.5 
Figure 1 
Spatial-temporal distribution of GATA6 mRNA during embryonic and fetal pulmonary 
development. At EIO.5 GATA6 mRNA is predominantly expressed at the tips of the primary 
lung buds (A). Two days later at E12.5 GATA6 mRNA expression has expanded and is now 
expressed in the entire endodenn lining the actively branching lung buds (B). When branching 
morphogenesis is almost completed at E15.5, GATA6 mRNA is observed in the endodenn lining 
the growing airways, and in particular in the distal endoderm (C). In the mesenchyme GATA6 
mRNA is also observed, but at a lower level. Finally during maturation and differentiation at 
EI8.S, GATA6 mRNA is expressed in epithelial cells lining the sacculi (D). 
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Antisense 
Figure 2 
GATA6 antisense oligonucleotides inhibit branching morphogenesis in vitro. Representative 
pictures of experiments with Ell.S (A,B) or EI2.S (C,D) wild-type lungs, cultured as organotypic 
explants in the presence of sense (A,C) or antisense (B,D) oligonucleotides targeted against the 
translation initiation site of GATA6. All pictures were taken at the same magnification. 
GATA6-1- chimeric lungs display diminished branching morphogenesis in vitro 
In all experiments highly chimeric (more than 50%) embryos and lungs were selected 
based on GPI analysis (results not shown). Isolated EI2.S GATA6-1- chimeric lungs were 
smaller in size and had less lung buds (Fig. 3B) when compared with non-chimeric 
littermates (Fig. 3A). From a different litter, E13.S GATA6-1- chimeric and non-chimeric 
lungs were cultured for 4 days as organotypic explants. At the time of isolation, both 
lungs were comparable in size, but the GATA6-1- chimeric lungs had fewer branches (Fig. 
3D) than the non-chimeric lungs (Fig. 3C). After 4 days of culture, the GATA6-1- chimeric 
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lungs demonstrated diminished branching morphogenesis in certain areas of the lung (Fig. 
3F, arrow), whereas in other areas, branching morphogenesis patterns were the sarne as 
wild-type (Fig. 3E). 
GATA6-/- chimeric lungs display diminished branching morphogenesis iu vivo 
resultiug in respiratory insufficiency 
When GATA6-/- chimeric lungs were isolated at E15.5 they appeared similar to lungs 
isolated from non-chimeric littermates. The size was comparable, the lungs had four lobes 
on the right, one lobe on the left side and no defect in branching morphogenesis was 
observed macroscopically (Fig. 4A,B). However, when these lungs were analyzed 
microscopically, a clear defect in branching morphogenesis indicated by the large 
airspaces was observed in the GATA6-/- chimeric lungs (Fig. 4D, arrow), when compared 
with non-chimeric lungs (Fig. 4C). When chimeras were generated with the parental 
heterozygous ES cells, which were used to generate the double mutant lines 
(Koutsourakis et aI., 1999), no abnormalities were observed in highly chimeric El5.5 
lungs (results not shown). Chimeric EI8.5 lungs, generated with GATA6-/- ES cells (Fig. 
4F) were again the sarne size as the non-chimeric lungs (Fig. 4E) from their littermates. In 
addition, chimeric lungs had four lobes on the right and one lobe on the left. However, at 
this stage a clear defect in branching morphogenesis was observed macroscopically in 
some GATA6-/- chimeric lungs (Fig. 4F, arrows). This defect in branching morphogenesis 
was confrrmed at the microscopic level (Fig. 4H). 
Eight pups were delivered by Caesarian section at E18.5 following blastocyst 
injection. Without knowing their chimerism, the pups were stimulated to breathe. Out of 
the eight pups, two were mummified and three were born dead. Out of the three pups that 
were born alive, two appeared purplish-blue, and one was pink. All three breathed 
normally. OPI electrophoresis demonstrated that only the pink pup was non-chimeric, and 
all the other pups were highly chimeric (results not shown). 
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Figure 3 
GATA6-/- chimeric lungs display diminished branching morphogenesis in vitro. When isolated at 
EI2.5, GATA6-/- chimeric lungs (B) are smaller and have less branches than wild-type lungs 
isolated from a littermate (A). E13.5 wild-type (e) and GATA6-/- chimeric (D) lungs at day 0 of 
culture as organotypic explants. After 4 days of culture (E,F), the GATA6-/- chimeric lungs had 
areas of nonnal and areas of diminished branching morphogenesis (F), whereas in the wild-type 
lung branching morphogenesis had occurred normal (E). All pictures are representative of a series 
of experiments, and are at the same magnification. (Arrow indicates area with diminished 
branching morphogenesis) 
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Figure 4 Branching mOIphogenesis in vivo is diminished in GATA6-/- chimeric lungs when 
compared to wild-1ype lungs. At E15.5 (A-D), lungs appeared macroscopically indistinguishable 
when isolated from wild-1ype (A) or GATA6-/- chimeric embryos (B). However, when 
microscopic sections were analyzed, GATA6-/- chimeric lungs had bigger airspaces (D) while 
lungs of wild-1ype embryos did not (C). At EI8.5, GATA6-/- chimeric lungs (F,G) displayed 
diminished branching morphogenesis both macroscopically (F) and microscopically (H) when 
compared to lungs of wild-1ype littermates (E,G). All pictures are representative for a series of 
experiments and are at the same magnification. (Arrow indicates area with diminished branching 
morphogenesis) 
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mRNA distribution of molecular markers for distal (surfactant protein-C) (A-F) and proximal 
(Clara cell marker-IO) (G-!) epithelial cell differentiation. In both E15.5 (A-C) and E18.5 (D-F) 
surfactant protein-C mRNA was expressed in normally branched areas of wild-type (A,D) and 
GATA6-1- chimeric (B,E) lungs. No surfactant protein-C mRNA expression was observed in 
abnormally branched areas of GATA6-1- chimeric lungs (B,C,F). At E18.5 Clara cell marker-IO 
mRNA was expressed in normally branched areas of both wild-type (G) and GATA6-1- chimeric 
lungs (H), whereas in abnormally branched areas of GATA6-1- chimeric lungs no Clara cell 
marker-IO mRNA expression could be observed. All pictures are at the same magnification, 
except (B), which is a low power overview of (C). (SP C indicates surfactant protein-C; CC 10 
indicates Clara cell marker-IO) 
Expression ofSP C, CC 10 and TTF 1 in GATA6-1- chimeric luugs 
In order to investigate if cell differentiation was altered in GATA6-1- chimeric lungs, non-
radioactive in situ hybridization with probes for SP C, a marker for type II cells that 
indicates distal epithelial cell differentiation, and CC 10, a marker for Clara cells that 
indicates proximal epithelial cell differentiation, was performed. The promoters of the 
genes for both these proteins have previously been demonstrated to contain GATA motifs, 
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indicating that the transcription of these genes may be regulated by GAT A transcription 
factors (Ray et aI., 1993; Wert et aI., 1993). Another epithelial cell marker which has been 
shown to be regulated by GATA6 in vitro is TTF 1. Localization of TTF I protein was 
investigated in the GATA6-/- chimeric lungs. 
At E1S.S (Figs. SA-C) and E1S.S (Figs. SD-F), normal SP C expression was 
observed in GATA6-/- chimeric lungs in the areas that appeared to have branched 
normally (Fig. SB,C,E). In contrast, no SP C expression was observed in areas with 
abnormal big sacculi (Fig. SB,C,F). Normal SP C expression was observed in the wild-
type lungs in distal epithelium at EIS.S (Fig. SA) and in type II cells at E1S.S (Fig. SD). 
At E1S.5, no CC 10 expression was observed in either wild-type or GATA6-/-
chimeric lungs, which was expected, because the gene for CC 10 is not expressed at that 
stage (results not shown). At EIS.S, CC 10 was expressed in the proximal airways of 
wild-type lungs, as well as in the normally branched parts of the GATA6-/- chimeric lungs 
(Fig. SG,H). In the abnormally branched parts of the GATA6-/- chimeric lungs, no CC 10 
expression was observed (Fig. SI). 
At E1S.S and E1S.5 TTF I protein was localized normally in epithelial cells of 
both wild-type and GATA6-/- chimeric lungs (Figs. 6A-F). No differences were observed 
between areas with normal or abnormal branching morphogenesis in the GATA6-/-
chimeric lungs. 
Contribution of GATA6-/- ES cells in chimeric luugs 
In order to identifY the origin of the endoderm of the abnormally branched areas, GATA6-
/- ES cells (white) were injected into ROSA26 blastocysts (blue). In the targeted ES cell 
clones we used for generation of the chimeras, GATA6 was inactivated by insertion of a 
LacZ marker gene (Koutsourakis et aI., 1999). However, when we investigated ~­
galactosidase activity in early embryonic lungs, we could not detect activity in developing 
airways lined with pulmonary endoderm (results not shown). In contrast, ~-galactosidase 
activity was detected in developing major vessels later during lung development (results 
not shown). Therefore, we did not expect any interference between ~-galactosidase 
activity in ROSA26- and ES cell-derived endoderm. 
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Thyroid transcription factor-I (TTF I) protein distribution as a marker for pulmonary endoderm 
specification. In wild-type (A,C,E) and GATA6-/- chllneric (B,D,F) lungs sintilar patterns ofTTF 
I protein distribution were observed at EIS.5 (A-D) and E18.5 (E,F). (A,B) are a low power 
overview ofEIS.S and (C-F) are at same magnification. 
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Figure 7 
Distribution of GATA6-1- ES cell contribution into ROSA26 host lungs. (A) GATA6-1- ES cells 
(white) contribute to both mesenchyme and endodenn ofE12.5 chimeric lungs (right), which are 
smaller and have less branches than lungs from wild-type littennates (left). In a section (B) of the 
chimeric lung, blue (wild-type ROSA26), mixed white and blue, and white (GATA6-1-) endoderm 
are observed, clearly indicating that GATA6-1- ES cells do contribute to pulmonary endoderm 
(please note, as opposed to the usual experiment, that the white areas are abnormal and the blue 
areas normal). Arrows indicate white endoderm derived from GATA6-1- ES cells. 
Using this approach, a similar phenotype of E12.5 lungs was observed upon isolation as 
in the previous experiments. The GATA6-1-<->ROSA26 chimeric lungs were smaller and 
had developed fewer lung buds (Fig. 7A). More interestingly, after detection of ~­
galactosidase activity, completely white endodermal buds as well as mixtures of white 
and blue endodermal cells and completely blue endodermal buds were observed in higbly 
chimeric lungs (Fig. 7B). In E15.5 GATA6-1-<->ROSA26 chimeric lungs, the same 
observations were made (Fig SA,B). Areas with reduced branching morphogenesis had 
almost completely white endoderm derived from GATA6-1- ES cells (Fig. SA,B, arrows), 
whereas areas with normal branching morphogenesis had completely blue endoderm, 
derived from the wild-type ROSA26 host blastocyst cells (Fig. SA,B). 
3.5 Discussion 
Based on experiments using chimeric embryos and extrapolation of results obtained in 
other organs and model systems, GATA6 was presumed to be essential for the 
specification offoregut endoderm into pulmonary endoderm (Kalb et aI., 1995; Morrisey 
et al., 1995). Using experiments with antisense oligonucleotides in organotypic explant 
cultures, and (in particular) using chimeric experiments with GATA6-1- ES cells, we 
provide evidence for a different and more extensive role for GATA6 in fetal pulmonary 
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development than the previously proposed role of endoderm specification. In lung 
explants with already specified lung endoderm (wild-type) we could abrogate branching 
morphogenesis in vitro by culturing the explants in the presence of antisense 
oligonucleotides against GATA6. In agreement with this, highly chimeric lungs displayed 
diminished branching morphogenesis both in vitro and in vivo at different gestational 
ages. Proximal and distal epithelial cell differentiation was attenuated in chimeric lungs, 
as indicated by diminished expression of markers for distal and proximal epithelial cell 
differentiation, SP C and CC 10 rnRNA, respectively. TTF I, an early pulmonary 
epithelial cell marker that has also been shown to be regulated by GATA6 in vitro, was 
expressed as normal in chimeric lungs both at E15.5 and EI8.5, indicating that endoderm 
specification occurred normally. In accordance with this, we found that GATA6-/- ES 
cells contribute to pulmonary endoderm in highly chimeric lungs, and, consequently, the 
observed phenotype of reduced branching morphogenesis and attenuated epithelial cell 
differentiation is the result of loss of function of GATA6 in pulmonary endoderm. 
A B 
Figure 8 
Distribution of GATA6-1- ES cell contribution in E15.5 lungs. Both sections of different GATA6-
/- chimeric lungs contain areas with abnormal branching morphogenesis which have white 
endoderm (GATA6-1-) and areas with normal branching morphogenesis which have blue 
endoderm coming from the wild-type ROSA 26 blastocyst. (Arrow indicates white endoderm 
derived from GATA6-/- ES cells) 
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GATA6 is essential for branching morphogenesis 
Using both in vitro and in vivo experiments, we demonstrate here that GATA6 plays an 
essential role during certain stages of branching morphogenesis in the lung. Specification 
of foregut endodenn into pulmonary endodenn occurred nonnally in the chimeric lungs, 
because we obtained highly chimeric embryos with lungs that had undergone 
morphogenesis. Outgrowth of two endodennally derived primary lung buds initiates the 
process oflung fonnation. Thus, highly chimeric lungs successfully completed the earliest 
phase oflung development, i.e. the specification of pulmonary endodenn, The next event 
in lung development, fonnation of four primary lung buds on the right and one primary 
lung bud on the left in mice also occurred nonnally in highly chimeric lungs, since all 
isolated lungs at EI2.S, E13.S, EIS.5 and E18.5 had four lobes on the right and one lobe 
on the left side. This indicates that primary branching morphogenesis does not require 
GATA6. Consequently, the observed phenotype of reduced branching morphogenesis in 
lungs of highly chimeric embryos is the result of an essential role for GATA6 in 
secondary branching morphogenesis, the next stage of early pulmonary development. 
Either by blocking wild-type GATA6 translation with antisense oligonucleotides, or by 
depleting GATA6 function in chimeric lung endodenn, we demonstrate that absence of 
GATA6 gives rise to reduced branching morphogenesis. This resulted in lungs with very 
big airspaces. However, these lungs appeared no smaller than wild-type lungs, and when a 
marker for proliferation (Ki-67) was investigated in chimeric and wild-type lungs no 
differences were observed (results not shown). Thus the observed defect in branching 
morphogenesis is not the result of growth or proliferation inhibition by GATA6. For 
future studies it will be very interesting to investigate expression patterns of other 
molecules that have been demonstrated to play an important role during branching 
morphogenesis. Endodennally expressed markers like sonic hedgehog (SHH) (Litingtung 
et aI., 1998), bone morphogenetic protein 4 (BMP 4) (Bellusci et a!., 1996) and 
hepatocyte nuclear factor/forkhead homologue 4 (HFH 4) (Chen et a!., 1998), as well as 
mesenchymally expressed markers like fibroblast growth factor 10 (FGF 10) (Sekine et 
al., 1999) and GATAS (Morrisey et aI., I 997a) are likely candidates. 
GATA6 is essential for late epithelial cell differentiation, but not endoderm 
specification 
In highly chimeric lungs, we could not detect expression of SP C and CC 10 mRNA in 
abnonnally branched arcas, indicating that both proximal and distal epithelial cell 
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differentiation is disturbed in these parts of the lungs. In areas that had undergone normal 
branching morphogenesis SP C and CC 10 were normally expressed. These data provide 
evidence for a functional role of the GAT A motifs in the promoters of the gene for human 
SP C and murine CC 10 in vivo (Ray et aI., 1993; Wert et aI., 1993). Another gene that is 
thought to be regulated by GATA6 on the basis of in vitro studies is TTF 1 (Shaw-White 
et aI., 1999). In addition, TTF I alone has been demonstrated to regulate transcription of 
SP C and CC 10 (Kelly et al., 1996; Zhang et aI., 1997). Nevertheless, we could not detect 
any differences in protein expression of TTF 1 between chimeric and wild-type lungs 
using immunohistochemistry with an antibody against TTF 1. This indicates that 
downregulation of the expression of the late epithelial markers SP C and CC 10 does not 
function through down-regulation of TTF 1, which suggests that if GATA6 and TTF I 
regulate SP C and CC 10 gene transcription, they do it through different pathways. The 
fact that we observed normal expression of TTF I protein, a marker for lung endoderm 
specification, indicates that specification of foregut endoderm into pulmonary endoderm 
occurred normally in the chimeric lungs. Hence, we conclude that GATA6 is not involved 
in pulmonary endoderm specification, as has been suggested before (Morrisey et aI., 
1998). This conclusion corroborates with recent data obtained in experiments with 
Xenopus in which both GATA4 and GATA5 were demonstrated to induce early 
endodermal marker genes, whereas GATA6 was demonstrated not to induce these 
endodermal markers (Weber et aI., 2000). 
GATA6-1- ES cells do contribute to pulmonary endoderm 
Using ROSA26 blastocysts (blue) as host blastocysts for GATA6-1- ES cells (white), we 
were able to demonstrate contribution of GATA6-1- ES cells to pulmonary endoderm. 
Abnormally branched areas in E15.5 chimeric lungs had consistently white endoderm 
(GATA6-1-) and normally branched areas blue endoderm (wild-type) and therefore we 
conclude that reduced branching morphogenesis in GATA6-1- chimeric lungs is the result 
of defective GATA6 mutant endoderm. Since we observed different areas with either 
blue, white or mixed white and blue endodermal cells and not lungs or lobes that were 
completely white or blue, it is likely that the lungs originate from a substantial number of 
cells from the foregut. Our observations are in contrast with data presented by another 
group, who demonstrated that GATA6-1- ES cells do not contribute to the bronchial 
epithelium in chimeric lungs, and concluded that GATA6 is required for establishment of 
the endodermally derived bronchial epithelium (Morrisey et al., 1998). The contradiction 
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in observations can be explained by the different approach that we used in order to obtain 
animals that were highly chimeric. Whereas regular protocols suggest the injection of nine 
to 12 ES cells into blastocysts to generate chimeric embryos (Hogan et aI., 1994), we used 
double the number of ES cells to obtain highly chimeric embryos. GPI electrophoresis 
revealed that most chimeric embryos were derived from at least 50% GATA6-/- ES cells 
and only chimeric embryos that were derived from more than 50% GATA6-/- ES cells 
were used in our experiments. If we assume that selection by competition between wild-
type and mutant cells occurs during the earliest stages of lung development in favor of 
wild-type cells then the regular amount of GA TA 6-/- ES cells (as used by Morrisey et al.) 
may not have progeny in pulmonary endoderm. However, by using more GATA6-/- ES 
cells, mutant cells were able to survive competition and to contribute to pulmonary 
endoderm. To overcome any interference that resulted from the percentage of wild-type 
cells present during early pulmonary specification of these chimeric lungs, it will be of 
interest to generate embryos exclusively derived from GATA6-/- ES cells. However, in all 
our experiments we never found embryos that were close to 100% chimeric (based on 
GPI electrophoresis), although a number of implantation sites with resorbed embryos 
were present. Based on the fact that GATA6 is not only expressed in extra-embryonic 
tissues, but also in embryonic tissues (Koutsourakis et aI., 1999; Morrisey et aI., 1996; 
Morrisey et aI., 1998) it is likely that embryos exclusively derived from GATA6-/- ES 
cells do not survive to later stages of gestation. Hence, it is unlikely that the use of 
methods such as the generation of tetraploid embryo chimeras would answer this 
question. It will probably require the generation of conditional knockout mice. 
Role for GATA6 in epithelial-mesenchymal interactions 
Since branching morphogenesis is highly dependent on epithelial-mesenchymal 
interactions (Hogan and Yingling, 1998), it is tempting to speculate which tissue layer 
causes the defect that reduces branching morphogenesis. Since the spatial-temporal 
distribution of GATA6 mRNA was predominantly observed in developing lung 
endoderm, it is most logical to postulate defective endoderm as the site where the primary 
defect is localized. Defective mutant GATA6-/- endoderm appears unable to undergo 
normal branching morphogenesis and late epithelial cell differentiation resulting in the 
observed phenotype in the chimeric lungs. This would lead to the conclusion that the 
observed phenotype is based on a cell-autonomous defect in GATA6-/- endodermal cells. 
However, there is an alternative explanation. Specification of pulmonary endoderm and 
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primary branching morphogenesis occurs normally in a GATA6-/- environment, but at the 
initiation of subsequent branching morphogenesis, as yet unidentified signals produced by 
the endoderm are not processed normally by the mesenchyme, which in turn sends 
abnormal or no signals to the (up till that moment normal) endoderm. From then on, the 
endoderm would be instructed incorrectly by the mesenchyme, and would not undergo 
normal branching morphogenesis, resulting in big airspaces and attenuated epithelial cell 
differentiation. As a consequence, the observed phenotype is based on a cell-
nonautonomous defect. Whichever scenario proves right, further investigation is 
warranted, and studies using transgenic and conditional knockout mice would be 
invaluable. Another important question not addressed in this study is what the early target 
genes for GATA6 in pulmonary development are. It is of interest whether known 
"master" genes of branching morphogenesis such as EMP 4 (Bellusci et aI., 1996), SHH 
(Litingtung et aI., 1998) and members of the fibroblast growth factor family (Post et aI., 
1996; Sekine et aI., 1999) are also transcriptionally regulated by GATA6. Future studies 
using immunoprecipitation, yeast two-hybrid screens and DNA microarray techniques, as 
well as detailed promoter analysis, should bring more insight. 
GATA6 fnnction during pulmonary development: a hierarchical model 
Based on the results of our experiments, a reconsideration of the position of GATA6 in 
the hierarchy of factors involved in pulmonary development is warranted. To date GATA6 
was considered to be one of the master genes in lung development (Whitsett and 
Tichelaar, 1999). Together with HNF 313 (Ang and Rossant, 1994) and TTF I (Kimura et 
al., 1996), GATA6 was positioned high up in the hierarchy because all three factors were 
thought to be essential for the specification of foregut endoderm into pulmonary 
endoderm. However, in this study, we provide evidence that GATA6 is not essential for 
pulmonary endoderm specification, but plays an important role in branching 
morphogenesis and late epithelial cell differentiation. Therefore, we postulate that 
GATA6 functions (in concert with TTF I) in the process of branching morphogenesis and 
late epithelial cell differentiation. 
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Chapter 4 
4.1 Abstract 
The transcription factor GATA-6 is expressed in the fetal pulmonary epithelium of the 
developing mouse lung and loss of function studies strongly suggested that it is required 
for proper branching morphogenesis and epithelial differentiation. We have further 
investigated the role of GATA-6 in this process by utilizing a pulmonary epithelium 
specific promoter to maintain high levels of GATA-6 protein during fetal lung 
development. Transgenic mice expressing a myc-tagged GATA-6 cDNA under the control 
of the human Surfactant Protein-C (SP-C) promoter were generated and their lungs were 
analyzed during fetal stages. Transgenic lungs exhibit branching defects as early as 
embryonic day (E) 14.5 and molecular analysis just before birth (EI8.5) shows a lack of 
distal epithelium differentiation whereas proximal epithelium is unaffected. Electron 
microscopic analysis and glycogen staining confirm the lack of differentiation to mature 
Type II cells. Thus, elevated levels ofGATA-6 protein affect early lung development and 
in analogy to other GATA factors in other tissues, GATA-6 also plays a crucial role in the 
terminal differentiation in this case of the distal pulmonary epithelium. 
4.2 Introdnction 
The complexity of the lung tissue with respect to morphogenesis and cell type constitution 
reflects the complexity in the control of its development. Early specification (around 
embryonic day 9.5 in the mouse) is far from understood and a molecule like HNF-3~ that is 
thought to be involved, has a more general role in foregut and midgut formation (Ang and 
Rossant, 1994; Dufort et al., 1998). For the initial lung bud outgrowth mesenchymal-
epithelial interactions are crucial since genetic studies have shown that molecules like FGF-
10, Gli-2 and Gli-3, all expressed in the lung mesenchyme, are key factors (Min et al., 1998; 
Motoyama et al., 1998). Mesenchymal-epithelial interactions are also important throughout 
branching morphogenesis and in the current concept of lung budding, localized high 
expression of FGF-JO induces the endodenn to bud (Hogan, 1999; Weaver et al., 2000). 
This pre-programmed process is reiterated and leads to the establishment of an extensive 
respiratory tree which, by the end of the pseudoglandular stage oflung development (E16.5), 
consists of proximal and distal airways. At this stage, epithelial cells undergo extensive 
differentiation to give rise to a number of distinct cell types (ciliated, nonciliated secretory, 
goblet, basal, alveolar Type I and Type II cells), which will establish a functional lung. 
Although some studies describe these different cell types morphologically and in terms of 
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surfactant protein expression (Ten Have-Opbroek, 1991; Ten Have-Opbroek et al., 1988; 
Ten Have-Opbroek et al., 1990) their differentiation program remains obscure at the 
molecular level. 
BMP-4 expression in the endoderm is thought to contribute to the acquisition of cell 
fate with distal epithelium resulting from exposure to high growth factor concentration 
(Weaver et aI., 1999). A number of other molecules including FGFs, glucocorticoids and 
some transcription factors like TTF-l, HFH-4 and GATA-6 have been iroplicated in 
epithelial cell differentiation and surfactant protein production (perl and Whitsett, 1999; 
Warburton et al., 2000; Whitsett and Tichelaar, 1999). TTF-l was shown to positively 
influence BMP-4 levels and its absence results in a lack of distal structures and the lack of 
surfactant proteins expression (Minoo et al., 1999). The HNF3/forkhead homologue-4 
(HFH-4) has been associated with induction of proximal fate and specifically the appearance 
of ciliated cells (Tichelaar et al., 1999). GATA-6, a member of the GATA DNA binding 
family of zinc finger transcription factors, is expressed in the early branching endoderm and 
it was thought to be essential for bronchial endoderm specification (Morrisey et al., 1998). 
However, recent studies have shown that the protein is not required for early specification 
but for normal branching morphogenesis and epithelial differentiation. Lung endoderm 
depleted of GATA-6 fails to branch normally and to acquire either distal or proxiroal fate 
(Keijzer et al., 2001). Furthermore, GATA binding sites have been identified in the 
promoters of Nkx2.1, Clara cell marker-IO and Surfactant Protein-A and -C (Bruno et aI., 
2000; Shaw-White et al., 1999; Wert et aI., 1993). 
GAT A proteins have been shown to play key roles in the differentiation of a number 
of distinct cell lineages and their levels can influence cell choices between differentiation 
and proliferation (Molkentin, 2000). GATA-l functions in erythrocytes and alteration of its 
levels results in a block of differentiation (pevny et aI., 1991; Whyatt et al., 1997). 
Overexpression of GATA-2 blocks differentiation of early haematopoietic progenitors 
(Briegel et al., 1993) and overexpression ofGATA-3 is involved in the differentiation ofT-
cells (Hendriks et al., 1999; Zheng and Flavell, 1997). In vivo loss of function studies in 
mice have shown distinct roles for GATA-4, -5 and --{) during development and both 
GATA-4 and --{) primarily function in the extraembryonic visceral endoderm (Koutsourakis 
et al., 1999; Kuo et al., 1997; Molkentin et al., 1997; Morrisey et aI., 1998). In vitro studies 
have implicated GATA-6 in the differentiation program of vascular smooth muscle cells, 
VSMCs (Mano et al., 1999), and more recently in glomerular mesangial cells, GMCs 
(Nagata et aI., 2000). In Xenopus embryos, it has been demonstrated that decreasing GATA-
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6 expression is associated with differentiation of cardiac precnrsors. When GATA-6 levels 
were sustained high, the cardiac differentiation program was blocked (Gove et aI., 1997). 
In this study we utilized a previously characterized promoterienchancer from the 
human Swfactant Protein-C (SP-C) gene (Wert et aI., 1993) to keep GATA-6 expression 
levels elevated in the pulmonary epithelium. Transgenic embryos were generated and their 
lungs were analyzed morphologically at various stages. Just before birth molecular as well as 
Electron Microscopic analysis were perfonned to evaluate the status of differentiation of the 
lung epithelium. Our results parallel data from other GATA factors and show that elevated 
GATA-6 expression in the lung epithelium, in vivo, not only affects its nonnal branching 
pattern but also impairs the differentiation program in the distal airways. 
4.3 Materials and methods 
Construction of the GATA-6 transgene 
The full GATA-6 cDNA was constructed by joining the two EcoRI fragments which were 
isolated from a mouse EII.5 library (CLONETECH) (Brewer et al., 1999; Kontsonrakis et 
al., 1999). 3' UTR was eliminated by PCR from the unique Pst! site to the stop codon 
(l44bp) and a unique site was introduced in the 3' PCR primer in order to clone the last non-
coding exon, intron and polyA (PA) (2.8 kb) from the human ~gIobin gene (Drabek et aI., 
1997). PCR between the first ATG and the unique Not! (520bp) site was used to eliminate 5' 
sequences. In the 5' PCR primer the myc epitope (EQKLISEEDL) was introduced 
immediately after the ATG of GATA-6 (Elefanty et al., 1996). The sequence of all PCR 
generated clones was confirmed before further cloning. The complete (1.7 kb) myc-tagged 
GATA-6 cDNA was transfected in COS-I cells and the overexpressed protein was 
immunoreactive in situ with both the anti-myc (9EIO) and the anti-GATA-6 (SantaCruz) 
antibodies (data not shown). The human SP-C promoter (Wert et al., 1993) was cloned as a 
3.7 kb blunted NdeI-Sal! fragment in blunted Sal! of pBS and the myc-GATA-6-giobinPA as 
an XhoI fragment. The transgene was released with CIaI between the pBS polylinker and the 
CiaI that was present at the end of the PA. The 8.2 kb fragment was gel purified with 
CONCERT™ Matrix (GIBCO BRL) and passed through ELUTIP-D colnrun (Schleicher & 
Schuell). 
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Generation of transgenic embryos 
Transgenic mouse embryos were generated by pronuclear injection of FVBIN oocytes with 
transgene concentration 2-3 ng//-ll according to standard protocols (Hogan et al., 1994). Day 
of injection and transfer to pseudopregnant females was considered as day 0.5 for the 
subsequent staging of the dissected embryos and lungs. Part of the tail of the dissected 
embryos was used for southern blot genotyping using the human fJ-globin PA as a probe. 
In situ hybridization and immunohistochemistry 
Fetal or newborn lungs were dissected out and fixed in 4% PFA overnight at 4°C before 
processing for paraffin embedding according to routine protocols. S-7/-lffi thick sections were 
used for H&E staining, RNA in situ hybridization (Motoyama et al., 1998) and 
immunohistochemistry (Keijzer et al., 2000). Digoxigenin labeled RNA probes were made 
from cDNA fragments of l.Skb for GATA-6, 0.33 kb for SP-C and 0.315 kb for CC-IO 
according to the protocol supplied by Roche Diagnostics. For TTF-l, a monoclonal antibody 
(Neomarkers, CA, USA) was used in 1:100 dilution and the sections were microwave boiled 
in citrate buffer for 15 min. The same dilution was used for the monoclonal anti-myc 
antibody (9EIO) but for antigen retrieval, trypsin treatment (0.6mg/mJ for 5 min at RT) was 
used. 
Electron Microscopy 
The caudal lobes of E18.S fetal lungs were fixed in 2.5% glutaraldehyde in 0.15 M 
cacodylate buffer pH 7.3 at 4°C for a few days until the genotypes were known. One 
trangenic and one wild type littermate lobe were washed in 0.1 M cacodylate buffer and 
postfixed in 1% OS04 in 0.1 M cacodylate buffer and finally embedded in epon as has been 
previously described (De Bruijn and Den Beejen, 1975). Ultrathin sections were contrasted 
with Uranyl-acetate and Lead-citrate prior to Electron Microscopic analysis (Hanaichi et al., 
1986). 
PAS staining 
From the epon-embedded El8.S lungs, semithin (l/-lm) sections were used for periodic acid 
Shiffs staining as previously described (Nevalainen et al., 1972). 
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Figure 1 
Distribution of GATA-6 (A) and SP-C (B) mRl'lA in E15.5 lungs. Both genes, although at a different 
level, are expressed in cells lining the distal epithelium (blue is the detected mRNA and the tissue is 
counterstained with methyl-green). In C the transgene used to overexpress GATA-6 in the pulmonary 
epithelium is schematically depicted. A myc-tagged version of the complete mGATA-6 eDNA is 
under the control of the 3.7 kb human SP-C promoter and it is followed by the human j3-glohin last 
intron and polyadenylation signal. 
4.4 Results 
GATA-6 expression and over-expression in the pulmonary epithelium 
Expression of GATA-6 in the developing embryonic bronchial epithelium has been described 
previously (Morrisey et al., 1996). In a recent study (Keijzer et aL, 2001), a more extensive 
analysis of GATA-6 expression revealed that initially it is expressed at the tips of the 
growing buds (E105) and by E12.5 it is expressed in the entire endoderm lining the 
developing buds. By E155, GATA-6 mRNA is predominantly expressed in the endoderm 
lining the growing airways and to a lower extent in parts of the surrounding mesenchyme 
(Fig. IA). This expression pattem, although not at a comparable level, is quite reminiscent to 
that of SP-C at the same developmental stage (Fig. IB). This observation led us to employ 
the 3.7kb promoter/enhancer of the human SP-C gene (Wert et al., 1993) in order to sustain 
high GATA-6 expression levels in the developing epithelium in vivo. The complete mouse 
GATA-6 eDNA was cloned downstream of the SP-C promoter and was followed by the 
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human fJ-globin last exon, intron and polyA for mRNA stability. Sequences coding for the 
myc epitope were introduced in frame with the first ATG of the gene (Fig. 1 C). The SPC-
mycGATA-6 transgene was injected into fertilized eggs and lungs were isolated from 
embryos at different developmental stages, E14.5, E16.5 and El8.5. Embryos were 
genotyped by Southern blotting (data not shown) and transgenic lungs were identified. All 
the analysis was performed in F 0 transgenic founder embryos. Transgenic lungs were not 
significantly different in size from their wild type littermates (data not shown). Only after 
careful examination of the whole transgenic lungs, a difference in the texture was noticed, 
especially in the affected lungs at E18.5 (data not shown). At this stage, out of 5 transgenic 
founder, 3 were expressing the transgene and they all had a comparable phenotype (Fig. 2F 
and 4H). Sections from the sarne transgenic EI8.5 lung were used for both morphological 
(Fig. 2F) and transgene expression analysis (Fig. 3B&D). Expression analysis of molecular 
markers (Fig. 4) and EM (Fig. 5) were performed on sections from a different transgenic 
E18.51ung. 
Branching morphogenesis in the SP-C/GATA-6 transgenic fetal lungs 
Starting at E14.5, the transgenic lungs looked similar in size to the wild type but they had 
undergone less extensive branching judged by the fewer terminal buds (Fig. 2B). Two days 
later, at El6.5, the defect in branching morphogenesis was more pronounced because of the 
presence of grossly dilated terminal buds separated by excess of mesenchyme (Fig. 2D). Just 
before birth, at E18.5, the phenotype was comparable to that seen at E16.5 and the overall 
growth of the tissue was not severely affected (Fig. 2F). The mesenchyme appears to be 
thickened a1thougb it is at present not clear whether this is due to an actual increase in the 
number of mesenchymal cells or the lack of being intersected by branching endoderm. 
Postnatally, although the remains of a transgenic pup were found subsequent to its perinatal 
death, few transgenic pups were born alive and they were breathing normally. These 
transgenic pups were left to breathe for a few hours before they were sacrificed for 
genotyping and histologic analysis. In figure 2H a section of an abnonnal lung among the 
transgenic pups is shown with a phenotype similar to the clinical centro-acinar aeration 
pattern. The severity of the phenotype was less than that seen in EI8.5 lungs (Fig. 2F) most 
likely due to the lower expression levels of the transgene. Expression of the trans gene in the 
affected E18.5 lungs was confirmed by innnunostaining for the myc epitope (Fig. 3B) and 
GATA-6 mRNA, transgenic and endogenous, was detected by in situ hybridization (Fig. 3C 
and D). 
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Molecular analysis of di:IIerentiation in the GATA-6 over-expressing epithelium 
Since extensive differentiation and the initiation of surfactant production start at the saccular 
stage of lung development (E17.S), which extends even after birth (to PS), we decided to 
investigate epithelium differentiation in EI8.S transgenic lungs. Thyroid Transcription 
Factor-I (TTF-I or Nkx2.I) protein, a marker for specified pulmonary endoderm (Minoo et 
a!., 1999), was abundantly present in transgenic lungs (Fig. 4B and C). However, the 
staining in all cells lining the dilated terminal buds is more intense than the characteristic 
staining for this stage of development as seen in wild type E18.5 lungs (Fig. 4A). Clara Cell 
marker-IO mRNA (Ray et a!., 1996) was expressed in transgenic lungs at a normal level 
indicating the presence of non-ciliated sectretory cells in the proximal epithelium (Fig. 4D-
F). In the distal epithelium, topologically represented by the dilated buds, Surfactant 
Protein-C (Kalina et al., 1992) expressing cells could be detected among the cells lining the 
epithelium (Fig. 4H and I) although the number of cells and their distribution were very 
different from that observed in wild type lungs (Fig. 4G). SP-C is expressed in the Type II 
cells which function mainly in surfactant production and they can further differentiate into 
Type I pneumocytes, the functional cells for gas exchange. 
Morphological analysis of di:IIerentiation in the GATA-6 over-expressing epithelium 
From morphological studies (Ten Have-Opbroek, 1991; Ten Have-Opbroek et al., 1988) it 
was shown that before maturation, Type II cells have an excess of glycogen present in their 
cytoplasm and their nucleus is less round. We therefore stained the epithelium of the 
transgenic lungs (E18.5) for glycogen (Fig. 4J-L) and used Electron Microscopy to examine 
the ultrastructure of the cells lining the dilated buds (Fig. S). Periodic acid Shiff's staining 
(PAS) for glycogen revealed that a very high percentage of cells lining the distal epithelium 
of the transgenic lungs is positive for glycogen in their cytoplasm (Fig. 4K and L). Normally 
at this stage, due to advanced differentiation, glycogen positive cells are hardly detectable in 
the lining of the distal epithelium (Fig. 4J). The caudal lobe of a transgenic (Fig. 4) and a 
wild type littermate lung were processed for Electron Microscopy. In the epithelium of the 
wild type lung, normal Type II cells could be easily identified by the cuboidal shape, the 
almost round nuclei and the presence of several multilamellar bodies (Fig. SC). Squamous 
Type I cells were also observed surrounding capillaries (Fig. SE, arrows indicate capillaries). 
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transgenic 
A B 
Figure 2 
Histological analysis of SP-C/GATA-6 transgenic lungs during fetal lung development At E14.5, 
transgenic lungs (B) are smaller than wild type (A) and they have fewer tenninal buds. Two days 
later, at E16.5 the branching defect is more promioent with big dilated distal buds present in the 
transgenic lungs CD) while fine branching is already apparent in wild type littermates (C). This 
phenotype is more dramatic just before birth, at E18.5, with the presence of abnormally shaped and 
sized distal alveoli (F) in contrast to normal alveolization that can be seen in wild type lungs (E). A 
few transgenic pups were born alive and the most severely affected one (H) had a milder branching 
phenotype when compared to most of the E18.5 transgenic lungs (F). This phenotype is similar to 
the clinical central-acinar aeration pattern. All pups were sacrificed few hours after birth. 
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Figure 3 
wild type 
~-~>. ... <.r' '. ~::~:<~~, ;-:"')~~ .. .1:)1 
.'-" '~ 
transgenic 
c;r:-,----
Expression of the SP-C/GATA-6 transgene in E18.5 lungs. The anti-myc antibody was used to detect 
chimeric protein in transgenic lungs (B). Intense staining can be seen in the epitheliUDl lining the 
abnormally dilated alveoli (brown). Wild type lungs show no staining (A). GATA-6 mR.t'lA was 
detected in both wild type and transgenic lungs by in situ hybridi7.ation. In C. normal GATA-6 
expression in parts of the epitheliUDl and in the surrounding mesenchyme can be seen in wild type 
E18.5 lungs (blue). In transgenic lungs (D) the signal for RNA expression (blue) is very intense in 
the lining of the epithelium as seen with the anti-myc antibody staining (B). For this analysis, 
sections from the lung that is shown on Figure 2F were used. 
Both Type IT and I cells were represented in every alveoli that was examined. In contrast, 
examining the epithelial lining in the dilated alveoli in the transgenic lung we were not able 
to find any typical Type IT or I cells. Instead, a number of ceIls with more irregular nuclei 
and numerous glycogen fields in their cytoplasm were found (Fig. 5D, glycogen fields are 
indicated by arrowheads). Although formation and localization of capiIlaries appeared 
normal, the squamous ceIls present around them had different morphology than that of a 
typical Type I cell and some even had glycogen in their cytoplasm (Fig. 5F, arrow indicates 
capiIlary and arrowhead glycogen). Proximal epithelium appeared nonual and ciliated ceIls 
were observed as in the wild type epithelium (data not shown). 
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Figure 4 
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Molecular analysis of differentiation in the transgenic epithelium at EI8.5. TTF-l protein 
localization in wild type (A) and transgenic (B and C) epithelium shows the abnormally, for this 
stage, TTF-l positive epithelium which lines the complete transgenic alveoli (brown). In D and E, F 
the nonnal expression of CC-JO mRNA, a marker for proximal non-ciliated cells, is shown in both 
wild type and transgenic lungs, respectively (blue). In the distal epithelium, expression of 
endogenous SP-C, a marker for Type II cells, can be seen in a wild type lung (G) and the decreased 
levels with the different distribution in the transgenic lung (H and I) (blue). Periodic Acid Shiffs 
staining for glycogen (purple) revealing that in contrast to the wild type lung (J), the transgenic lung 
has an alveolar epithelium which is lined almost exclusively by glycogen positive cells (K and L). 
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Figure 5 
Electron Microscopic analysis of the distal epithelium at EIS.5. A low power overview of a wild 
type and a transgenic lung is shown in A and B, respectively. In the distal epithelium of a mId type 
lung both typical Type II cells, with multilamellar bodies in their cytoplasm (C) and flat Type I 
pneumonocytes, around capillaries, can be detected (E). In the transgenic lung atypical cells lining 
the alveoli are detected and the presence of glycogen in their cytoplasm is a common feature (D). 
Flat cells are present around the capillaries (F) although they look distinct from wild type Type I 
cells and some of them still have glycogen in their cytoplasm (arrowheads point to glycogen fields 
and arrows indicate capillaries; magnifications: A and B X620, C-F X5S00). 
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4.5 Discussion 
Depletion of GATA-6 expression io the pulmonary endodenn, both in vitro and in vivo, 
resulted io lack of branching morphogenesis and failure of the epithelium to differentiate 
(Keijzer et a!., 2001). To better understand the role of this transcription factor io lung 
development we used the SP-C promoter to artificially maiotaio high levels of GATA-6 
expression io the fetal pulmonary epithelium in vivo. This alteration also resulted io 
defective branching morphogenesis and epithelial differentiation. However, the branching 
phenotype was manifested later duriog development and io a less severe fonn probably due 
to the late onset of the transgene expression (Wert et a!., 1993). The promoter is active after 
pulmonary endodenn specification, initial buddiog and lobe detennination but before the 
differentiation program starts at the pseudoglandular stage (E14.5) of lung development 
(perl and Whitsett, 1999; Warburton et al., 2000). Hence, GATA-6 expression io the SP-
C/GATA-6 lungs is already elevated io the primordial epithelium before any proximal or 
distal fate had been acquired. Nevertheless, this overexpression affected only distal 
epithelium where the gene is nonnally expressed. Thus, this study shows that GATA-6 has a 
specific regulatory role io the differentiation program of the distal epithelium and also 
confinns that GAT A -6 proteio levels are crucial duriog both lung morphogenesis and cell 
type specification (Keijzer et a!., 2001) 
Branchiog morphogenesis io the SP-C/GATA-6 transgenic lungs 
The ioteraction between epithelium and mesenchyme is a detennining factor io lung 
development startiog from the initial budding and continuiog duriog branching 
morphogenesis iovolviog well-studied molecules like FGF-IO, BMP-4 and SHH (Hogan, 
1999; Weaver et a!., 2000). The localized high expression of FGF-IO io the mesenchyme 
promotes the endodenn to bud and to express high levels of BMP-4. Subsequently, BMP-4 
together with SHH downregulates FGF-IO to prevent new budding at the same position 
while allowiog the newly fonned bud to grow. When a certain distance has been reached, the 
high expression domaios of FGF-IO present on either side or both sides of the growiog bud 
induce new buddiog resulting io lateral or dichotomous branchiog, respectively. GATA-6 
expression io the endodenn coiocides with branching morphogenesis but unlike BMP-4 
expression (Weaver et al., 2000), there are no detailed GATA-6 expression data duriog the 
ioduction and growth of a bud. In EIO.5 lungs GATA-6 mRNA has been localized to the 
growiog tips of the initial buds (Keijzer et al., 2001). At that stage, the SP-C promoter 
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becomes active resulting in higb expression of GATA-6 in all SP-C expressing cells 
througbout the transgenic endoderm. This alteration of GATA-6 expression results in the 
branching defects in the transgenic lungs which could be explained in two ways. Either by 
distorting a molecular pathway intrinsic to the branching endoderm or by interrupting a 
pathway involved in processing an inductive signal from the mesenchyme. 
In cardiac development, FGFs and BMPs have been placed upstream of GATAs 
(Schultheiss et al., 1997). Cardiac induction involves GATA-4 and its co-factor Nkx 2.5 and 
they are both necessary to establish a cardiac phenotype (Durocher et al., 1997). An 
analogous regulatory pathway appears to operate in the lung endoderm. TTF-I (orNkx 2.1), 
a gene from the same Nkx homeobox family and GATA-6 are expressed in the lung 
endoderm from early pulmonary specification and both are required for branching 
morphogenesis (Lazzaro et al., 1991). It has been suggested that TTF-1 expression may be 
downstream and depends on GATA-6 expression (Shaw-White et aI., 1999), however, TTF-
I expression is normal in GATA-6 -/- endoderm showing that TTF-1 expression is 
independent of GATA-6 (Keijzer et aI., 2001). Unfortunately it is not known whether 
GATA-6 is still expressed in TTF-I -/- embryos (Minoo et aI., 1999) 
GATA-61evels and pnlmonary epithelium differentiation 
Expression of GATA-6 starts in the primordial epithelium and it is restricted to the distal 
epithelium by E15.5. The levels of its expression are difficult to quantitate by in situ 
hybridization. By expressing GATA-6 under the control of SP-C, a constant higb level of the 
protein was present from the onset of differentiation resulting in a distal epithelium 
attenuated of any terminal differentiation. Unlike overexpression of TGF-f31 (Zhou et al., 
1996) and HNF-3f3 (Zhou et aI., 1997) that resulted in endodermal arrest at the primordial or 
pseudoglandular stages, GATA-6 overexpression did not affect initiation of the 
differentiation program. The pathway of proximal epithelium differentiation was unaffected 
since both ciliated cells, seen in the EM analysis, and non-ciliated secretory cells, visualized 
by CC-IO expression, were detected as normal. Along the distal epithelium no mature Type 
II cells were present and all the cells were still expressing TTF-I. Normally the presence of 
numerous glycogen fields in the cells lining the distal airways is indicative of their 
differentiating status (Soroldn, 1965). This has been described in detail in an extensive 
morphological study of the features of Type II alveolar epithelial cells by Ten Have-
Opbroek (1988). Later during lung development, before birth, a multi-step formation of 
multilamellar bodies (MLB) is thought to compartmentalize glycogen (Ten Have-Opbroek 
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et al., 1990). Our data show a continued presence of glycogen in the distal epithelial cells 
suggesting that GATA-6 is involved in a particular stage of this maturation process. When 
the levels are elevated, the cells do not initiate the final differentiation step which is 
characterized by multilamellar bodies fonnation. Instead, most of the cells lining the alveolar 
epithelium have glycogen in their cytoplasm, as visualized by periodic acid Shiff's staining 
(Fig. 4K and L), indicating a block in the Type II differentiation pathway. The flat Type I 
cells which function in gas exchange, are thought to originate from further differentiation of 
Type II cells although it is not clear whether they are derived from a mature Type II cell or 
from one of the intennediate stages during their maturation. In the GATA-6 overexpressing 
lungs, flat epithelial cells surrounding the capillaries were observed and their shape and 
localization suggest that they are Type I cells. However, some of them still had glycogen 
fields, they were not as flat as nonnal Type I cells and their nucleus had an irregular shape. 
At this final step, differentiation is thought to be driven by growth and particularly by the 
intercalation of the forming capillaries with the epithelium (Ten Have-Opbroek et aI., 1988). 
Thus, the apparent Type I-like cells we see, could be the same precursors of Type II cells as 
discussed above, except that they are in close proximity with the capillaries and have less 
glycogen fields. This would suggest that elevated levels of GATA-6 would prevent the 
fonnation of fully differentiated Type I cells even when in contact with capillaries. In 
conclusion, our data demonstrate that GATA-6 plays an important role in lung 
organogenesis and especially during the multi-step process of maturation of Type II cells. 
Elevated GATA-6 protein levels result in a block oftenninal differentiation to mature Type 
II and Type I pneumocytes. 
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5.1 Abstract 
It is well established that lung morphogenesis is dependent on epithelial-mesenchymal 
interactions, however, the exact molecular mechanisms guiding lung organogenesis have 
yet to be determined. Cell proliferation has been recognized to be a crucial modulator of 
lung development. Recently, it has been suggested that programmed cell death, apoptosis, 
is another important mechanism involved in remodeling of both the prenatal and postnatal 
lung. Utilizing an in vitro cell recombinant model, we investigated cell proliferation and 
apoptosis during lung morphogenesis in vitro and the influences of epithelial-
mesenchymal interactions on these processes. Embryonic day (E) 13 and El9 
mesenchymal and endodermal pulmonary cells were isolated from fetal rat lungs using 
standard primary culture techniques. The cells were then recombined in various 
combinations and cultured in a semi-dry system. In these recombinants, proliferating cells 
were identified using a proliferating cell marker and apoptosis was determined by 
TUNEL assay. We observed more proliferating cells in homotypic E13 recombinants than 
in El9 recombinants. The proliferation characteristics of the different tissues appeared to 
be intrinsic. Massive apoptosis was observed in fibroblasts of El9 homotypic 
recombinants. Surprisingly, the apoptosis of El9 fibroblasts was diminished after 
heterotypic recombination with El3 epithelial cells. The massive apoptosis appeared to be 
due to a loss of inhibition by El9 epithelial cells. In conclusion, both proliferation and 
apoptosis are developmentally regulated during morphogenesis in vitro. In addition, the 
apoptosis of late gestation fibroblasts appears to be regulated by a loss of inhibition of the 
neighboring epithelial cells. 
5.2 Introduction 
Organogenesis of the lung is, like organogenesis of other glandular-like organs, highly 
dependent on epithelial-mesenchymal interactions as well as cell-matrix interactions [for 
review see (Hogan, 1999)]. Several tissue recombination studies have demonstrated that 
for nonnal branching morphogenesis of the lung to occur, interaction betvveen lung 
epithelium and lung mesenchyme is absolutely required (Masters, 1976; Shannon et aI., 
1998; Spooner and Wessells, 1970). It has long been recognized that branching 
morphogenesis of lung epithelium is guided by "instructions" coming from the 
surrounding mesenchyme. Interestingly, proximal tracheal epithelium, which is normally 
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not able to branch, can in this manner be forced to undergo branching morphogenesis 
when it is recombined with distal lung mesenchyme (Alescio and Cassini, 1962). In 
contrast, distal lung epithelium, which is normally undergoing extensive branching 
morphogenesis during pulmonary development, can be inhibited by recombining it with 
proximal tracheal lung mesenchyme (Wessells, 1970). Additional experiments 
demonstrated that epithelial differentiation is dependent on the type of mesenchyme used 
for recombination (Shannon et al., 1998). These epithelial-mesenchymal interactions are 
modulated by a well orchestrated interplay between hormones, grO\\!lh factors and 
extracellular matrix proteins [for review see (Keijzer and Post, 1999)]. The factors 
involved have just recently been revealed as was shown by experiments with isolated 
mesenchyme-free pulmonary epithelium. In this system isolated epithelium could be 
stimulated to undergo branching morphogenesis when it was cultured in the presence of a 
specified mix of certain gro\\!lh factors and extracellular matrix proteins (Shannon et aI., 
1999). All these experiments have demonstrated an important role for the mesenchyme in 
instructing the developing epithelium. However, the influence of epithelium on 
development of the mesenchyme is less well understood and has not been studied 
extensively thus far. 
Cell proliferation has been recognized as a crucial modulator not only for lung 
gro\\!lh, but also branching morphogenesis (Goldin and Wessells, 1979; Mollard and 
Dziadek, 1998). Outgrowth of terminal lung buds is associated with higher numbers of 
proliferating cells. Recently, it has been suggested that progranuned cell death, apoptosis, 
is another important mechanism involved in remodeling of both the prenatal and postnatal 
lung (Kresch et aI., 1998; Scavo et aI., 1998). Apoptosis was demonstrated to occur 
predominantly in interstitial cells, in particular during the perinatal period (Kresch et aI., 
1998; Scavo et aI., 1998). This is the period when a huge thinning of the pulmonary 
mesenchyme has to occur in order to enable gas exchange over the pulmonary epithelium. 
During this process, apoptosis is known to playa significant role (Kresch et al., 1998; 
Scavo et aI., 1998). Taken together, a balanced interplay between cell proliferation on the 
one hand and apoptosis on the other is required to help a primary lung bud early in 
embryonic development to become the postnatal gas exchanging organ which has 
undergone a huge surface expansion. 
The aim of this study was to investigate cell proliferation and apoptosis into more 
detail in a cell recombinant model. Isolated fetal rat lung embryonic day (E) 13 
mesenchymal cells or EI9 fibroblasts were recombined with EI3 endodermal cells or EI9 
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epithelial cells. The cells were recombined in various combinations (Figure I) and the cell 
mixtures were cultured for 5 days. Subsequently, cell proliferation and apoptosis were 
investigated in the recombinants using immunohistochemistry with an antibody for 
Proliferating Cell Nuclear Antigen (PCNA) and Terminal deoxyribonucleotidyl 
transferase dUTP Nick End-Labeling (TUNEL) assay, respectively. The cell recombinant 
model enabled us to dissect out the developmental and tissue-specific influences that the 
various recombinations of cells have on cell proliferation and apoptosis. Our results 
indicate that both proliferation and apoptosis are developmentally regulated during 
morphogenesis oflung epithelial cells and fibroblasts in vitro. In addition, epithelial cells 
appear to be less susceptible to apoptosis than fibroblasts in this tissue cell recombinant 
model, which corroborates with previously published in vivo studies (Kresch et a!., 1998; 
Scavo et al., 1998). Finally, we demonstrate that apoptosis of fibroblasts which occurs 
during thinning of the mesenchymal tissue mass late in gestation can be inhibited by 
endodermal cells of early gestation, but cannot be induced by epithelial cells of late 
gestation. 
53 Materials and methods 
Animals 
Female (200-250 g) and male (250-300 g) Wistar rats were obtained from Charles River 
(St. Constant, Quebec, Canada). The animals were kept in a controlled light-dark cycle 
and food and water were supplied ad libitum. Rats were mated overnight and the finding 
of a sperm-positive vaginal smear was designated day 0 of gestation. At embryonic day 
(E) 13 and EI9 (term = E22) timed-pregnant rats were killed by exposure to an overdose 
of diethyl ether. The fetuses were delivered by Caesarian section using aseptical surgical 
techniques. 
Cell preparations and recombinations 
Using microsurgical techniques, lungs were dissected from embryos at EI3 and 
transferred to Hanks Balanced Salt Solution (-) (HBBS(-)) from Gibco (Grand Islands, 
NY). Subsequently, the lungs were treated with 20% (v/v) Dispase and 100 f.lg.mr1 
DNAse for 45 minutes at 37°C in order to "loosen" the tissue layers. Following 
neutralization of enzyme activity with fetal calf serum (FCS), the endodermal and 
mesenchymal components were separated under a dissection microscope, using 
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microsurgical techniques. The separated rudiment layers were broken up in single cells by 
gentle mechanical agitation. 
At E19, epithelial cells and fibroblasts were separated using standard primary 
culture techniques, which were previously described (Caniggia et aI., 1991). After 
separation of epithelial cells and fibroblasts, E19 epithelial cells were recombined with 
either EI9 fibroblasts or EI3 mesenchymal cells. EI9 fibroblasts were also recombined 
with EI3 endodermal cells (see figure 1). In order to recombine the cells, individual cell 
populations oflate gestation (i.e. E19) were first trypsinized from tissue culture flasks and 
counted by a Coulter counter. Approximately 3 x 106 endodermal or epithelial cells were 
mixed with 3 x 106 mesenchymal cells or fibroblasts and the cell mixtures were then 
centrifuged at 420 x g for 5 minutes. Subsequently, excess medium was removed and the 
cell aggregates were incubated at 37°, in air with 5% CO2 for 1 hour. Aggregates were 
then gently loosened by stirring with the tip of a micro-pipette and transferred to porous 
membrane inserts (4 fUll pore size) from Millipore (Bedford, MA) in 24-well tissue 
culture plates from Nunc (Intermed, Denmark). Membranes were presoaked in MEM 
(Gibco, Grand Islands, NY) for 1 hour before addition of the cells. 200 J.lI Dulbecco's 
Modified Eagle Medium (DMEM) (Gibco, Grand Islands, NY) + 5% (v/v) FCS was 
added to each well so that the medium just moistened the surface of the cells, but the 
aggregates were not submerged (i.e. a semi-dry culture). The cell recombinants were 
cultured at 37°C in an atmosphere of 5% CO2 in air for 5 days. 
Tissue preparation 
All recombinants were fixed in 4% (v/v) paraformaldehyde in phosphate buffered saline 
(PBS) for 16-18 hours at 4°C, dehydrated in a graded series of ethanol, cleared in xylene 
and embedded in paraplast (Oxford, Labware, St. Louis, MO). Sections of 5 J.lm were cut 
and mounted on Superfrost slides (Fisher Scientific, Unionville, ON). After de-waxing, 
the tissue sections were rehydrated in a graded series of ethanol. 
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Figure 1 
Schematic representation of the various combinations that were used in the recombination 
experiments. Following separation of lung tissues, El3 mesenchymal cells (black) were 
recombined with E13 endodermal cells (black) in homotypic recombinants. The same procedure 
was used in making the homotypic recombinants of EI9 fibroblasts (grey) and EI9 epithelial 
cells (grey). In heterotypic recombinants, E 13 endodermal cells (black) were recombined with 
EI9 fibroblasts (grey) or EI9 epithelial cells (grey) were recombined with E13 mesenchymal 
cells (black). 
Immunohistochemistry 
Immunohistochemistry was essentially carried out as described before (Keijzer et aI., 2000). 
Following pretreatments, sections of the recombinants were incubated for 16-18 hours at 
4°C with 1:5 diluted primary monoclonal antibody to cytokeratin (Boehringer Mannheim, 
Laval, Qc), or undiluted primary monoclonal antibody to vimentin (Serotec, Missisauga, 
ON) or I: 1000 diluted primary monoclonal antibody to proliferating cell nuclear antigen 
(PCNA; Santa Cruz Biotechnology, Santa Cruz, CAl. Terminal Deoxyribonucleotidyl 
Transferase dUTP Nick-End labeling (TUNEL) Assay was carried out exactly as described 
before (Keijzer et aI., 2000). 
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Cytokeratin Vimentin 
Figure 2 
Morphogenesis occurred spontaneously in the recombinants during the culture period. Antibodies 
against cytokeratin (A,C) and vimentin (B,D) were used to distinguish between endodennal and 
mesenchymal cells, respectively. In the E13 homotypic recombinants large airspaces developed 
with a lining of cuboidal endodenna! cells (cytokeratin positive) surrounded by mesenchymal 
cells (vimentin positive) (A,B). In the El9 homotypic recombinants, alveolar-like structures 
fonned consisting of a nice circle lining of epithelial cells (cytokeratin positive) and a thin 
interstitial layer of fibroblasts (vimentin positive) (C,D). 
5.4 Results 
Morphogenesis in the recombinants 
Approximately 72 hours after putting the recombined cell mixtures into culture, 
morphogenesis started to occur in the till then unorganized clump of cells (results not 
shown). In the El3 homotypic recombinants large airspaces developed with a lining of 
cuboidal endodermal cells surrounded by mesenchyma! cells (Figure 2A,B). We used the 
131 
Chapter 5 
molecular markers cytokeratin (Figure 2A,C) and vimentin (Figure 2B,D) to distinguish 
between endodennal and mesenchymal cells, respectively. In the E19 homotypic 
recombinants, alveolar-like structures fonned consisting of a nice circle lining of 
epithelial cells and a thin interstitial layer of fibroblasts (Figure 2C,D). In the recombinant 
of E13 endodennal cells and E19 fibroblasts, large airspaces with a thick lining of 
cuboidal endodennal cells were fonned (Figure 3C). Mesenchymal cells surrounded the 
endodennallining. The structure of this recombinant resembled the structure of the E13 
recombinant (Figure 2A,B). In the recombinant of EI9 epithelial cells and E13 
mesenchymal cells more alveolar-like structures were observed (Figure 3D), albeit 
smaller than in the E19 homotypic recombinant (Figure 2C). 
Proliferation in the recombinants 
Using an antibody against proliferating cell nuclear antigen (PCNA), a cell cycle 
associated protein, patterns of proliferation were investigated in the different 
recombinants. Massive cell proliferation, between mesenchymal and endodennal cells, 
was observed in E 13 homotypic recombinants (Figure 3A). In contrast, proliferating cells 
were mainly observed in the epithelial lining of cells in the E 19 homotypic recombinants 
(Figure 3B) and much less in fibroblasts. In the heterotypic recombinants, a comparable 
pattern of proliferation was observed. In the recombinant of EI3 endodennal cells and 
El9 fibroblasts, proliferating cells were predominantly localized in the endodennal cells, 
whereas proliferation appeared to be attenuated in the fibroblasts when compared to the 
E13 homotypic recombinants (Figure 3C). In the recombinant ofE19 epithelial cells and 
E13 mesenchymal cells, proliferation appeared to be less pronounced, but evenly 
distributed between epithelial cells and mesenchymal cells (Figure 3D). (For a summary 
of results see also table 1) 
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E13endolE13mes E 1gepiJE 19fib 
E13endolE19fib E 1gepiJE 13 mes 
Figure 3 
An antibody against PCNA was used to investigate cell proliferation in the recombinants. Highest 
numbers of proliferating cells, mesenchymal and endodermaI cells, were observed in E13 
homotypic recombinants CAl. In E19 homotypic recombinants (B) proliferating cells were mainly 
observed between epithelial cells and much less between fibroblasts. In the recombinants ofE13 
endodermal cells and EI9 fibroblasts, proliferating cells were predominantly localized in the 
endodermal cell lining Cc). In the recombinant of EI9 epithelial cells and E13 mesenchymal 
cells, proliferation was less pronounced, but evenly distributed over both cell layers CD). 
Apoptosis in the recombinants 
Using the TUNEL assay, apoptosis was investigated in all recombinants. Apoptotic cells 
were only observed in the mesenchymal cells or fibroblasts. In the E13 homotypic 
recombinant, TUNEL positive cells were sporadically observed in the mesenchymal cells 
(Figure 4A). In sharp contrast with this observation, almost every fibroblast was TUNEL 
positive lD the EI9 homotypic recombinant (Figure 4C). In both heterotypic 
recombinants, a similar picture as in the E13 homotypic recombinant was observed: 
hardly any mesenchymal cell or fibroblast was TUNEL positive, whereas no TUNEL-
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positive endodennal or epithelial cells were observed (Figure 4E,G). All nuclei were 
stained with DAPI to visualize the tissue structure of the recombinants (Figure 4B,D,F,H). 
(For a summary of results see also table I) 
Table 1 
Summary of proliferation and apoptosis results in the recombinants. 
Proliferation Apoptosis 
Recombinant Endodennall Mesenchymal Endodennall 
Epithelial cells cellslFibroblasts Epithelial 
cells 
EI3 endolE13 mes ++ + 
EI9 epilEI9 fib + +/-
El3 endolE19 fib ++ +/-
EI9 epilEl3 mes + + 
Mesenchymal 
cellslFibroblasts 
+/-
++ 
+/-
+/-
~ indicates high number of cells; + indicates medium number of cells; +/- indicates low number 
of cells; - indicates no cells. 
E indicates Embryonic day; endo indicates endodennal cells; mes indicates mesenchymal cells; 
epi indicates epithelial cells; fib indicates fibroblasts 
5.5 Discussiou 
Morphogenesis of the lung has long been recognized to be highly dependent on epithelial-
mesenchymal interactions (Hogan and Yingling, 1998). Most studies have focused on 
branching morphogenesis and demonstrated that these epithelial-mesenchymal 
interactions occur mainly into one direction, considering a pivotal role of the mesenchyme 
over the epithelium. The regulation of pulmonary endodenn branching morphogenesis is 
thereby modulated by factors produced by the surrounding mesenchyme (Keijzer and 
Post, 1999; Warburton et aI., 2000). Using a cell recombinant model of fetal rat lung we 
provide here evidence for regulation of mesenchymal morphogenesis by its surrounding 
epithelium. Our results indicate that proliferation in both pulmonary fibroblasts and 
epithelial cells occurs cell-autonomously during pulmonary development. Highest 
numbers of proliferating cells were observed between El3 endodennal and mesenchymal 
cells. Recombining these cells with EI9 epithelial cells or fibroblasts did not alter the 
distribution and number of proliferating cells. 
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TUNEL DAPI 
Figure 4 
Programmed cell death, apoptosis, was determined in the recombinants using TUNEL assay 
(A,C,E,G). All nuclei were stained with DAPI to visualize the tissue structure of the 
recombinants (B,D,F,R). In the E13 homotypic recombinant only a few TUNEL positive cells 
were observed in the mesenchymal cells (A). The same holds true for both the heterotypic 
recombinant ofEl3 endodermal cells and El9 fibroblasts (E) and the heterotypic recombinant of 
El9 epithelial cells and E13 mesenchymal cells (G). In contrast, massive apoptosis was observed 
between the El9 fibroblasts in the El9 homotypic recombinant (C). 
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In contrast to these observations, apoptosis ofEl9 fibroblasts was demonstrated to 
be developmentally regulated by epithelial cells. Massive apoptosis of El9 fibroblasts 
occurs when they are recombined with El9 epithelial cells, but this can be inhibited when 
El9 fibroblasts are recombined with El3 endodermal cells. On the other hand, E13 
mesenchymal cells could not be forced to undergo apoptosis by recombining them with 
El9 epithelial cells, indicating, that E13 endodermal cells inhibit apoptosis of El9 
fibroblasts in contrast to induction of apoptosis of El9 fibroblasts by El9 epithelial cells. 
Thus, we conclude from these results that thinning of pulmonary interstitial tissue through 
apoptosis occurs because of a loss of inhibition by the surrounding epithelial cells. This is 
in accordance with the distribution of apoptotic cells in vivo during rat pulmonary 
development. Apoptotic cells were only observed in the mesenchyme and predominantly 
during the later stages of pulmonary development (Kresch et aI., 1998; Scavo et al., 
1998). 
Our studies indicate that proliferation is a cell intrinsic feature of both fibroblasts 
and epithelial cells when they are cultured in close contact to each other. E13 endodermal 
cells remained in a high proliferative state when recombined with El9 fibroblasts that 
proliferate much less. On the other hand, the El9 fibroblasts could not be induced to 
proliferate more when recombined with the El3 endodermal cells. Proliferation 
characteristics of heterotypic recombinants ofEl9 epithelial cells and El3 mesenchymal 
cells also did not change when compared to their homotypic counterparts. Thus, E13 
mesenchymal cells, El9 fibroblasts, E13 endodermal cells and El9 epithelial cells all 
displayed intrinsic proliferation characteristics, which were not influenced by 
recombination with cells from a heterotypic tissue. This result is in contrast to results 
obtained with studies using conditioned medium from epithelial cells which were 
demonstrated to elaborate a hydrophobic polypeptide that inhibits fetal lung fibroblast 
proliferation in vitro (Caniggia et aI., 1995). However, in this study the fibroblasts were 
not in close contact to the epithelial cells, and this might be an essential condition for 
normal proliferation to occur. 
The situation was somewhat different in case of apoptosis characteristics. We 
observed massive apoptosis in El9 fibroblasts in homotypic El9 recombinants. This is 
possibly a physiological phenomena which is required for normal thinning of 
mesenchymal tissue in late pulmonary development. The fact that we and others observed 
much less apoptosis in vivo than in vitro during late gestation can be explained by the fact 
that we recombined equal amounts of fibroblasts and epithelial cells whereas in vivo there 
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are already much less fibroblasts than epithelial cells at the investigated stage of 
pulmonary development. Apoptosis characteristics appeared to be non cell-autonomous, 
since they changed depending on the recombination that was used. Massive apoptosis was 
observed in El9 homotypic recombinants. This could be the result of either cell intrinsic 
apoptosis of E19 fibroblasts, induction of E19 fibroblast apoptosis by epithelial cells or 
loss of inhibition of apoptosis of El9 fibroblast by epithelial cells. The latter situation 
seems to be the case in our studies, because El9 fibroblasts did not undergo apoptosis 
when recombined with E13 epithelial cells ruling out the first possibility. Moreover, E13 
fibroblasts were not induced to undergo apoptosis when recombined with El9 epithelial 
cells ruling out the second possibility. This leaves loss of inhibition of E 19 fibroblast 
apoptosis by El9 epithelial cells as the only explanation for our observations. One could 
argue that El3 mesenchymal cells cannot yet be induced to apoptosis by E19 epithelial 
cells, because they are not sensitive yet for the inductive signals coming from the 
epithelial cells. However, in E13 homotypic recombinants we demonstrate that El3 
mesenchymal are indeed able to undergo apoptosis. 
Taken together, our results indicate that thinning of mesenchymal tissue late in 
pulmonary development is possibly due to a loss of inhibition of apoptosis by epithelial 
cells. This is one of the first studies providing direct evidence of modulation of 
mesenchymal morphogenesis (through apoptosis) by its surrounding epithelium. This 
adds to the already extensively studied influence of mesenchyme on branching 
morphogenesis of the endoderm (Alescio and Cassini, 1962; Hogan and Yingling, 1998; 
Masters, 1976; Shannon et aI., 1998; Spooner and Wessells, 1970; Wessells, 1970). In 
addition, our study demonstrates again the essential role of epithelial-mesenchymal 
interactions in lung morphogenesis through a balanced interplay between cell 
proliferation and mesenchymal apoptosis. Future studies revealing the factors involved in 
these epithelial-mesenchymal interactions, and in particular in modulating mesenchymal 
apoptosis through loss of epithelial inhibition are warranted. 
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Developmental changes in the expression of the thyroid hormone receptors 
alpha and beta in rat tissues, evidence for extensive post-transcriptional 
regulation. 
Based on: 
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D., and Lamers, W.H. Developmental changes in the expression of the thyroid honnone 
receptors alpha and beta in rat tissues, evidence for extensive post-transcriptional regulation. 
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6.1 Abstract 
The significance of thyroid hormone for normal development is undisputed. yet the signal-
transduction pathways that mediate its effects have remained elusive. Although the 
involvement of thyroid-hormone receptors as ligand-dependent transcription factors seems 
likely, the respective roles of the TRa and TRj3 isoforms are far from clear. Using in situ 
hybridization and immunohistochemistry as visualization techniques, and RT-PCR and 
Western blotting as quantification techniques, the TRa isoform was found to be expressed in 
the mesenchymal tissues and the TRj3 isoform in the epithelial tissues of liv.er, lung, bone, 
and kidney. Furthermore, we observed extensive posttranscriptional control. A TRj3z-like 
protein of 47 kD, i.e. I I kD less than that predicted by the reported open reading frame, was 
abundantly expressed in many tissues, but the corresponding mRNA concentration was 
vanishingly low. Tissue TRa2, TRj31 and TRj32 protein levels reached the adult level at 5 
days before birth, whereas TRal protein reached its highest level only after birth. The 
distinct time-course of TRal and TRj3 suggests an initiating, TRj3-mediated signaling from 
the epithelium, followed by a TRa-mediated response of the mesenchyme. Extensive co-
expression of TRa and TRj3 was observed in the developing brain and intestinal epithelium. 
These organs were characterized by a very low TRa (brain, intestine) and TRj3 (intestinal 
epithelium only) proteinlmRNA ratio, implying a low translational efficiency of the TR 
mRNA or a high turnover of TR protein. Furthermore, the TRj32 protein levels in brain and 
intestine were the highest measured. These data indicate that the TR -dependent regulatory 
cascades function differently in organs with a complementary expression pattern and those 
with co-expression of the TRa and TRj3 genes. The developmental delay in the expression 
of TRj32 protein in the pituitary may serve to accommodate the perinatal rise in circulating 
thyroid hormones in rodents. 
6.2 Introduction 
It is generally accepted that thyroid hormones play a crucial role in controlling growth, 
development, differentiation and metabolism of virtually all tissues of vertebrates. In 
particular, studies in amphibians have shown that thyroid hormones are involved in 
metamorphosis and remodeling certain tissues and organs [for review see (Tata, 1993)]. The 
effects of thyroid hormones on gene expression are mediated via (nuclear) thyroid-hormone 
receptors (TRs), which are members of the steroid/thyroid-hormone receptor superfamily of 
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ligand-dependent transcription factors (Tsai and O'Malley, 1994; Zhang and Lazar, 2000). 
There are two thyroid hormone-receptor genes, TRa and TR~, which are located in humans 
on chromosomes 17 and 3, respectively (Dayton et al., 1984; Weinberger et aI., 1986). Due 
to altemative splicing, three different thyroid hormone-binding receptors are generated, 
namely TRa" TR~I and TR~2' of which the latter is thought to have the most limited 
distribution. In addition, three proteins that do not bind thyroid hormone are formed: TRa2 
and TMal and TMa2. These proteins are thought to function as antagonists of thyroid 
hormone-mediated gene expression (Koenig et al., 1989; Lazar et al., 1989a; Lazar et aI., 
1989b; Weinberger et aI., 1986). In the liganded condition, TRs bind to DNA as 
homodimers, or as heterodimers in combination with another member of the superfamily, 
preferentially the 9-cis retinoic-acid receptor (RXR) (Wahlstrom et aI., 1992; Yen et aI., 
1994; Yen et aI., 1992). Binding to thyroid-hormone-response elements (TREs) in 
regulatory DNA regions leads to activation or inhibition of gene transcription. The validity 
of this model of thyroid hormone-mediated gene transcription has been confirmed both at 
the structural and the functional level (Brent, 1994; Rastinejad et aI., 1995). 
Despite the detailed insights into the molecular action of thyroid hormones, such 
elaborate insight is not yet available for the developmental effects of these hormones. A 
prototypical example of the developmental significance of thyroid hormones, the induction 
of amphibian metamorphosis, is known for 90 years now (Gudematsch, 1912; Etkin, 1968). 
The beneficial effects of thyroid hormones on perinatal development and maturation, 
especially true for brain, have also been established (DeLong, 1989; Legrand, 1986; van 
Wassenaer et al., 1997). In addition, it is now firmly established that thyroid hormones can 
pass the placenta of rodents and do accumulate in embryonic cells to a functionally relevant 
concentration well before the embryonic thyroid starts to function on its own (Feldman et aI., 
1961; Morreale de Escobar et al., 1990; Obregon et al., 1984; Porterfield and Hendrich, 
1992; Vulsma et aI., 1989). However, a specific hypothesis for the mechanism of action of 
thyroid hormones on prenatal organ development is not yet available. 
In chickens, the TRa gene is ubiquitously expressed, that is, in brain, lung, kidney, 
heart, liver, eye, intestine, spleen and muscle tissue, from early developmental stages onward 
(Forrest et al., 1990). In rat, the TR mRNA was demonstrated by Northern blot analysis to 
be expressed in liver, brain, kidney, heart and spleen tissue from 18 days of development 
onward (Strait et al., 1990). In chicken, expression of the TR~ gene is more restricted and 
confined to brain, eye, lung and kidney, whereas in developing manunals, TR~ mRNA is 
found in the same organs that also express TRa. However, TR~ expression starts late in 
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embryonic development and increases to highest levels just after birth, thereby marking the 
onset of the so-called hormone-sensitive period, suggesting that TR~ equates with perinatal 
hormonal responsiveness (Forrest et al., 1990). Bradley et al. (Bradley et al., 1992) reported 
a specific spatial and temporal expression of the TRa and TR~ mRNAs in the developing rat 
nervous system. The TRa gene is widely expressed, but highest levels were found in the 
fetal neocortical plate, that is, the site of cortical neuronal differentiation. Expression of the 
TR~ gene is restricted to zones of neuroblast proliferation such as the germinal trigone and 
the cortical ventricular layer. 
In order to obtain a better insight into the role of thyroid hormones on organogenesis, 
the spatial and temporal distribution of the mRNAs and proteins encoding the TRs was 
investigated by in situ hybridization and inununohistochemistry. Since our in situ probes did 
not differentiate between the two isoforms, quantitative polymerase chain reaction (PCR) 
techniques were used to determine the tissue levels of TRaj and TRa2. Similarly, tissue 
levels of TR~j and TR~2 mRNA were determined, even though it is assumed that in the 
adult, TR~2 is only expressed in the pituitary gland (Weinberger et al., 1986). Since there are 
good indications that there may not be a simple direct relationship between TR mRNA level 
and nuclear thyroid hormone-binding capacity (i.e. functional TR protein) in some tissues 
(Strait et al., 1990), we also investigated tissue TR protein level by Western-blot analysis 
and inununohistochemistry. We report a highly specific, but heterogeneous spatial and 
temporal expression pattern of the TRa and TR~ mRNAs, as well as extensive 
posttranscriptional regulation in the developing rodent fetus and neonate. 
63 Materials and methods 
Animals 
Adult Wistar rats were obtained from the Broekman Institute B.V. in Someren, The 
Netherlands. The animals were kept in a controlled lighVdark cycle and food and water were 
supplied ad libitum. Females in heat were selected and mated at the end of the morning. The 
next day was designated day I of gestation or embryonic day I (EDI). Fetuses were 
delivered by Caesarian section at ED 13, 14, 15, 16, 17, 18, 19 and 20, or were born naturally 
and sacrificed I day after birth (ND I), ND4, or as an adult. 
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Tissue isolation and preparation 
ED13-17 fetuses were fixed in toto. Older fetuses were decapitated, fueir skin was removed 
and fueir body cavities were opened for optimal penetration of fue fIxative. From ED20 
onward, fue head and lower part offue body were removed. From all newborns, organs were 
isolated and fixed separately. All tissues were fixed at 4°C for 16-IS hours in phosphate-
buffered 4% formaldehyde for in situ hybridization and in mefuanol:acetone:water [2:2: I 
(v/v)] for immunohistochemistry, dehydrated in a graded series of efuanol, cleared wifu 
isobutanol and embedded in Paraplast Plus (Monoject, Kildare, Ireland). 7 f!m serial frontal 
sections were cut and mounted onto RNAse-free 3-aminopropyltriefuoxysilane- (Sigma 
A3 64S) coated slides. 
In situ hybridization 
As probes for fue TRa and TR~ mRNA detection, EcoRI-HindIII cDNA fragments of fue 
clones rc-erbA-a (nucleotide -29 to nucleotide +1S21) and rc-erbA-~ (nucleotide -37 to 
nucleotide +2165) were used, respectively. The fragments contain fue coding region of fue 
respective genes and recognize bofu fue TRal and TRa2 and TR~l and TR~2 isoforms. Bofu 
cDNA fragments were obtained from H.C. Towle (Bradley et aI., 1992). The [a_35S]UTP 
labeled antisense probes for bofu fue TRa and TR~ were generated wifu Sp6 RNA 
polymerase, after linearization of fue plasmids wifu HindlII, while fue sense probes were 
generated wifu T7 RNA polymerase after linearization wifu EcoRI. All plasmids were 
linearized by enzyme digestion using enzymes of GibcolBRI. (Life Technologies B.Y., The 
NefuerJands). Radioactively labeled RNA transcripts were obtained using eifuer T3, T7 
(GibcoIBRI.) or SP6 (HT Biotechnology Ltd., Cambridge, England) RNA polymerase in fue 
presence of 50 f!Ci [a-35S]UTP (Amersham, United Kingdom). After degradation of fue 
full-Iengfu transcripts by alkaline hydrolysis, fue fragments were purifIed by phenol-
chloroform extraction and efuanol precipitation. In situ hybridization was carried out exactly 
as described (Moorman et aI., 2000). 
Quantitative peR 
At EDI5, EDIS, NDI, and at adult age, mRNA concentrations ofTRaJ, TRa2, TR~l and 
TR~2 were determined in brain, lung, liver, kidney, and intestines, using quantitative PCR. 
For each stage, minimally 3 rats were assayed. PolyA+ RNA was isolated from 50-250 mg 
tissue with fue PolyATtract" System 100 (Promega Corporation, Madison, WI, USA). 
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Absorbance at 260nrn was used as a measure for the amount ofpolyA+ RNA and the ratio 
between the absorbance at 260nrn and 280nrn as a measure for purity. 
TRu mRNA was estimated by competitive RT-PCR. The sense primer was chosen 
in the common part of the TRul and TRuz mRNA sequence, whereas the antisense 
primers were located in the specific part of the sequences. For TRuj, a 343bp fragment 
was formed (nt 1219-1562 of the mRNA) and for TRuz a 242bp fragment (nt 1411-1653) 
(primers: GibcoIBRL). Messenger RNA (0.5 Ilg) was reverse transcribed with 100 units 
SuperscriptT" II (GibcoIBRL) for 60 min at 42DC in the presence of 0.5 Ilg oligo (dT)IZ.lS 
primer (GibcoIBRL) and 25 Ilg BSA in 75 mM TrislHCI (PH 9.0), 20 mM (NH.,),S04, 
1.25 mM MgClz, 0.01% Tween 20, I mM DTT and 100 IlM dNTPs. As a control for 
DNA contamination, the reaction was also carried out without the addition of Superscript 
II. One tenth of the R T -reaction was used for the PCR. After an initial denaturation of 2 
min at 94 DC, the cDNA was amplified with 0.25 units Taq polymerase (Goldstar; 
Eurogentec, Seraing, Belgium), 0.8 IlM primers, 3 mM MgCl, (buffer and dNTP 
concentration are the same as for the RT-reaction) for a total of 35 cycles according to a 
'touch-down' protocol in which the mixture was denatured for 30 s at 94 DC at the 
beginning of each cycle, annealed for 30 s at 62°C (this temperature was lowered 0.5 °c 
each cycle during the initial 20 cycles), and extended for I min at 68°C. The 
concentration ofTRul mRNA in 50 ng total RNA was estimated by titrating 8-5,000.10-4 
amol of the TRul PCR fragment without a 82 bp Hinc II fragment. The concentration of 
TRuz in 50 ng total RNA was estimated by titrating 4-2,500.10.3 amol of the TRuz PCR 
fragment missing the same 82 bp Hinc II fragment as TRu1. The competimer or mimic 
fragments were quantified by including a known amount of [35 S]dATPuS during the 
large-scale PCR amplification of these fragments. Fragments were separated on 1.5% 
pronarose MS-8 (Hispanagar, Burgos, Spain) in 0.5x TBE buffer (0.09 M Tris, 0.89 M 
H3B03, 0.02 M EDTA, pH 8.0) and quantified with the Eagle Eye II system (Stratagene, 
La Jolla, CA, USA). TRu mRNA concentration in the sample was calculated by plotting 
the logarithm of the TRaicompetimer ratio as a function of the logarithm of the 
competimer concentration (Moller et aI, 1997). 
TR~ mRNA levels were measured by real-time RT -PCR. The antisense primer was 
chosen in the common part of the TR~1 and TR~z sequences, whereas the sense primers 
were in the specific part. For TR~j, a 185bp fragment was formed (nt 437-622 of the 
mRNA) and for TR~z, a 244bp fragment (nt 343-587 of the mRNA). For the RT-reaction 
146 
Expression ofthe thyroid hormone receptors alpha and beta in rat tissues. 
the same protocol was used as for the TRas. Real-time PCR was performed using one 
twentieth of the RT-reaction (25 ng mRNA) for both the TR~l and the TR~z with the 
LightCycler™ DNA Master SYBR Green I kit in the LightCyclerTM (Roche Molecular 
Biochemicals, Mannheim, Germany), as prescribed by the manufacturer. The final 
concentrations in the reaction mixture were Ix DNA Master SYBR Green I, 3 mM 
MgClz, 0.5 J.tM primers and 10 Pg/ill !RNA in a final reaction volume of 20 Ill. After an 
initial denaturation step at 95°C for 30 s, amplification was performed using 50 cycles of 
denaturation (95°C for 0 s), annealing (52°C for 5 s) and extension (72 °c for 10 s) and a 
transition rate of 20 °C/s for all steps. Fluorescence (530 nm) was measured at the end of 
each extension step to monitor amplification. After amplification was complete, a melting 
curve analysis was done. For the measurement of the concentration of TR~ mRNA 5-
50,000.10-4 amol of a DNA fragment was used to generate a standard curve. The standard 
curve is created by plotting the cycle numbers at which the fluorescent signals enter the 
log phase versus the log of the concentrations of the standard. The mimic fragments were 
made by PCR with the TR~l and TR~z-specific sense primers and an antisense 
megaprimer internally missing 33bp of the mRNA sequence, and were quantified by 
including a known amount of [a-,ZPjdATP during the large-scale PCR amplification of 
the fragment. TR~z mRNA levels are also measured with the LightCycle?M DNA Master 
Hybridization Probes (Roche Molecular Biochemicals). Amplification primers and 
hybridization probes were designed and synthesized by Tip MolEiol (Berlin, Germany). 
With the amplification primers a 316bp fragment was formed (nt 241-556 of the TR~2 
mRNA). The LightCycler Red640-labeled probe was located at nt 264-290 and the 
fluorescein-labeled probe at nt 292-316. The final concentrations in the reaction mixture 
were Ix DNA Master Hybridization Probes, 4 mM MgClz, 0.25 J.tM amplification primers 
and 0.2 IlM hybridization probes in a final reaction volume of 20 Ill. After an initial 
denaturation at 95°C for 30 s, amplification was performed using 45 cycles of 
denaturation (95°C for 0 s), annealing (55°C for 10 s) and extension (72 °c for 13 s). 
Fluorescence (530 and 640 nm) was measured after each annealing step. For the 
measurement of the TR~2 mRNA concentration, dilutions of pituitary gland mRNA with a 
known TR~z mRNA concentration were used to generate a standard curve. 
The efficiency of the reverse-transcription step was measured using the TR~ mimic 
DNAs. Large-scale mRNA synthesis was performed with the MEGAshorlscript™ T7 Kit 
(Ambion, Austin, Texas, USA) and a known amount of [a_35SjCTP. In addition, different 
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amounts of the TR~I and TR~2 RNA transcripts were used. The transcription efficiency 
was calculated by plotting the mRNA input concentration against the DNA oujput 
concentration and amounted to approximately 80% for the TRi31 and 100% for the TRi32 
mRNA. 
Western blotting and immunohistochemistry 
At EDI7, ND4 and in the adult, extracts of brain, liver, trachea, lung, heart, kidneys, 
adrenals, intestines, spleen, muscle, pituitary gland, bladder, thyroid, epididymal fat pad and 
testis were analyzed by Western blotting, using antisera that discriminate between the TRa 
isoforms TRal and TRa2 and the TR~ isoforms TR~I and TRi32. These antisera were raised 
in rabbits against oligopeptides, coupled to thyroglobulin or keyhole-limpet hemocyanin. 
The antibodies recognized proteins of 47 kDa (TRal), 55 kDa (TRa2), 57 kDa (TR~I)' and 
47 kDa (TR~2)' The extracts were prepared in 0.25 M sucrose, to which DTT, SDS, EDTA, 
TrisHCI, and glycerol were added to 40 mM, 2%, I mM, 62.5 mM, and 10%, respectively. 
The proteins in the extracts were separated on 10% (w/v) polyacrylamide gels in the 
presence of SDS and subsequently blotted on a 0.45 J.lm polyvinylidene fluoride 
membrane (Immobilon-P, Millipore Corporation, Bedford, MA) in 25 mM 
ethanolamine/glycine buffer (PH 9.5), 20% methanol. After staining with amidoblack to 
assure similar protein loading, the membrane was stained for the presence of TR protein 
by incubation for 6 hrs in 10 mM Tris.HCI (PH 8.0), 150 mM NaCI, 0.5% Tween20, and 
5% non-fat dried milk powder (Natrinon, Nutricia, Zoetermeer, The Netherlands), 
followed by an overnight incubation in a 1:1,000 dilution of the rabbit antisera. Antibody 
binding was quantified using a chemiluminescent substrate based on dioxetane/alkaline 
phosphatase (AP) (CDP-Star™ Roche), in combination with a LUMI-imager™ FI 
(Roche) (Bakker, 1998). 
Immunoperoxidase staining was performed on dewaxed tissue sections. Antibody 
binding on sections was visualized by the indirect unlabelled antibody peroxidase 
anti-peroxidase (PAP) method (Sternberger et aI., 1970) with 0.05% (w/v) 
3,3'-diaminobenzidine tetrahydrochloride (Sigma) as chromogen and om % (v/v) H20 2 as 
peroxidase substrate. Color was developed for 5-7 minutes in 25 mM imidazole, I mM 
EDTA, pH 7.0. PAP immunocomplexes were purchased from Nordic (Nordic, Tilburg, 
The Netherlands). 
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Image recording 
Digital optical density images were recorded using a Photometrics (Tucson, AZ, USA) 
cooled CCD camera attached to an Axioplan microscope (Carl Zeiss, Oberkochen, 
Germany), a stabilized power supply and an infrared blocking filter. mRNA distribution 
patterns were recorded using white light, whereas protein distribution patterns were recorded 
using blue light. The obtained images were corrected for inhomogeneity of illumination. 
6.4 Results 
Specificity of the antisense &'''IA probes and antisera 
The specificity of the hybridization-signal of the TRa and TR~ antisense RNA probes was 
shown by the absence of a hybridization signal with TRa and TR~ sense RNA probes in 
sections of an EDl8 fetus (results not shown). Furthermore, the respective radioactively 
labeled antisense RNA probes produced highly characteristic and often mutually 
complementary hybridization signals, which constitute important tissue-intrinsic specificity. 
Western-blot analysis of extracts of organs at different gestational ages was carried 
out to test the specificity of the respective rabbit antisera For all antibodies, specific bands 
were detected at the anticipated M, of the corresponding receptors, with the exception of the 
antiserum against the TR~2 protein, where a band of 47 kD instead of 58 kD was detected. 
However, inspection of the TR~2 cDNA sequence (Rodin et aI., 1989) indicated that the 117 
aa downstream ATG codon that produces the 47 kD protein, is in a much more favourable 
Kozak context than the one giving rise to the 58 kD form. In liver and kidney extracts, extra 
bands at both higher and lower M, than found in other organs were observed for TRa, and 
TR~" These patterns were also found if only these organs were isolated and analyzed 
immediately. The lower bands were probably due to protein degradation. It is unlikely that 
the higher bands represent aggregates, as the protein extracts were denatuted in the presence 
of40mMDTT. 
Distribution of the TRa and TR/l 
Although the focus of this study is on non-neural tissue, we include a brief description of 
some prominent structures in the central nervous system to make this study comparable to 
earlier ones, which have focused on that organ (Bradley et al., 1992). For the same reason, 
we include a brief description of our findings in the pituitary gland. 
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Figure 1 
Thyroid-honnone-receptor-rnRNA expression in fetal central nervous system. TRa. rnRNA was 
observed in the basal plate of the EDl5 neural tube (A), whereas no TR~ mRNA was present at 
this stage (B), In the EDl6 brain, high TRa expression was observed in the cortical plate (e). At 
this stage TRJ3 expression was also present in the cortical plate, albeit at a much lower cellular 
concentration (D). In contrast, a very intense TRJ3 signal was observed in the cochlear sensory 
epithelium (F), whereas TRa could only weakly be detected in the cochlear nerve (E). (Scalebar 
represents magnification level) 
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Central nervous system 
In the early fetus (ED IS), a high TRa mRNA expression was observed in the basal plate of 
the neural tube (Fig. IA), whereas TR~ mRNA was not yet expressed (Fig. IB). Similarly, a 
high TRa expression in the cortical plate of the brain was observed at EDI6. TR~ mRNA 
expression in the telencephalon coincided with that of TRa, but its cellular concentration 
was much lower (Fig. I C,D). In accordance with earlier observations (Bradley et al., 1992), 
quantitative PCR demonstrated that the TRa2 isoform concentration exceeded that of TRa 1 
more than 20-fold and, hence, is responsible for the observed TRa expression pattern (Fig. 
2). The expression of both isoforms was highest at NDI (Fig. 2). TR~l expression followed 
a similar temporal pattern as TRa2, except that the observed mRNA levels were 
approximately twenty times lower (Fig. 2). TR~2 mRNA levels in whole brain extracts were 
below the limit of detection (results not shown). Whereas co-expression of TRa and TR~ 
was observed at many sites in central nervous tissue, this was not the case in the sensory 
epithelium of the inner ear: at ED 16, we observed a strong and very specific expression of 
TR~ mRNA in the cochlear sensory epithelium and only a very weak signal in the cochlear 
nerve, whereas the staining pattern ofTRa mRNA was just opposite (Fig. IE,F). 
Both before and shortly after birth, the TRal and TRa2 protein concentration in the 
brain was very low compared to that in the other organs investigated (Fig. 3A,B). In 
contrast, TR~l protein was already present in fetal brain (EDI7) and increased to a higher 
level at four days after birth (Fig. 3C). Similarly, the TR~2 protein was already present at a 
reasonable level around the ventricles before birth (Fig. 3D, 4D) and at a higher level shortly 
after birth (Fig. 3D), when it accumulates mainly in the choroid plexus (Fig. 4H). 
Comparing mRNA and protein levels, we observed a very low proteinlmRNA ratio 
for TRal and, in particular TRa2, whereas this ratio was much higher for TR~l and, in 
particular, for TRh 
Pituitary gland 
Protein for all four receptors was observed in extracts of adult pituitary glands (Fig. 3A-D). 
The TR~ isoforms were more highly expressed than the TRa isoforms. Interestingly, TR~l 
protein was present in the EDI8 pituitary, but TR~2 protein not yet (Fig. SC,D). In ND4 
pituitaries, TR~l and TR~2 protein were both present (Fig. S E,F), whereas the proteins of 
both TRa isoform could not be detected (Fig. SG,H). 
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Figure 2 
Thyroid-honnone-receptor-mRNA levels during brain development. TRul and TRu, and TRj31 
mRNA levels during brain development of the rat. TRa2 levels exceed TRa} levels more than 20-
fold. All three isofonns reach maximum levels atND1. 
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Lung 
The lung primordium, an outgrowth of foregut endoderm that appears at ED 1 0-11 in the rat, 
develops by dichotomous branching. The endoderrnally derived puhnonary epithelium is 
initially surrounded by a conspicuous mass of mesenchyme. Expression ofTRu mRNA was 
observed in the mesenchyme surrounding the developing lung buds from ED 13 onwards 
(EDI5 shown in Fig. 6A), whereas only a faint expression of the TRf3 mRNA was detected 
in the puhnonary epithelium up to ED15 (Fig. 6B). During the canalicular stage of 
pulmonary development (EDI6-1S in the rat), the expression of TRf3 mRNA became 
increasingly strong in the epithelium (Fig. 6D), whereas expression of TRu mRNA 
remained confined to the mesenchyme (Fig. 6C). During the alveolar stage of lung 
development (>EDI9), the prominence of the interstitial tissue decreases. In this period, 
TRf3 mRNA disappeared from the puhnonary epithelium (Fig. 6F), but TRu mRNA 
remained present in the puhnonary mesenchyme (Fig. 6E). Because of attenuation of the 
walls of the airways due to expansion of the gas-exchange surface, the complementary 
distribution was more difficult to discern. TRf3 mRNA was also present in pulmonary 
arteries at all time points (Fig. 6D), whereas expression of the TRu mRNA was continuously 
observed in the myocardium of the pulmonary veins (Fig. 6C). Quantitative PCR 
demonstrated that TRu, mRNA levels were approx. lO-fold higher than TRul mRNA levels 
(Fig. 7). TRu, mRNA levels increased from ED15 to peak at EDlS and NDI (Fig. 7). These 
data indicate that the TRu mRNA observed in the in situ hybridization experiments actually 
represented TRu, mRNA. The TRf3 signal in the in situ hybridization experiments 
represented TRf3j, because no TRf3, mRNA could be detected upon PCR amplification 
(results not shown). TRf31 mRNA levels were approximately 3-fold lower than TRu, mRNA 
levels and peaked at EDlS (Fig. 7). 
Westem blot analysis revealed a band of the expected size of TRul in extracts at 
EDI7, which had markedly increased in intensity atND4 (Fig. 3A). At the same time points, 
the intensity of the TRu,-protein band was relatively weak and even appeared to decrease 
with development (Fig. 3B). TRf31 protein levels were similar at ED 17 and ND4 (Fig. 3C). 
TRf3, protein levels were very modest both pre- and postnatally (Fig. 3D). Despite the 
positive Western blots, we were not able to demonstrate TRul or TRu, protein by 
immunohistochemistry, indicating that the proteins were present at low levels in many cells 
(Fig. SA,B,E,F). TRf31 protein was predominantly and TRf3, protein was exclusively 
expressed in lung epithelium (Fig. SC,D,G,H). 
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Thyroid-hoITIlone-receptor-protein levels in various organs during development. Western blotting 
experiments for all four TR isoforms in organs of EDl7 (muscle, heart, lung, brain, intestines, 
kidneys. liver), ND4 (trachea, lung, liver, kidneys, adrenals, muscle, heart, spleen, brain, testis, 
thyroid, fat pad, jejunwn, ileum and bladder) and adult animals (liver, pituitary gland). See text for 
details. 
M= muscle; He=heart; Lu=lung; B=brain; In=intestine; K=kidneys; Li=liver; Pg=pituitary gland; 
Tr=trachea; A=adrenal gland; Sp=spleen; Te=testis; Th=thyroid gland; Fp=fat pad; J<rjejunum; 
Il=ileum; Bl=bladder 
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Figure 3 continued 
D 
Thyroid-honnone-receptor-protein levels in various organs during development. Western blotting 
experiments for all four TR isoforms in organs of ED17 (muscle, heart, lung, brain, intestines, 
kidneys, liver), ND4 (trachea, lung, liver, kidneys, adrenals, muscle, heart, spleen, brain, testis, 
thyroid, fat pad, jejunum, ileum and bladder) and adult animals (liver, pituitary gland). See text for 
details. 
M= muscle; He=heart; Lu=lung; B=brain; In=intestine; K=kidneys; Li=liver; Pg=pituitary gland; 
Tr=trachea; A~adrenal gland; SFspleen; Tegestis; Th=thyroid gland; FFfat pad; Je=jejunum; 
n~leum; Bl~bladder 
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Figure 4 
Thyroid-honnone-receptor-protein distribution during brain development. At EDl8 and ND4, 
protein expression of both TRa isoforms is very low (A,B,E,F). In contrast, TRBI protein is highly 
expressed in various structures of the brain (C,G), whereas TRB2 protein is confined to the choroid 
plexus (D,H). (ScaIebar represents magnification level) 
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Thyroid-hormone-receptor-protein distribution during pitui1:aty gland development. TR~, is the only 
isoform of which protein is expressed at ED18 (C), whereas the other isoforms do not express any 
protein at this stage (A,B,D). At ND4, both TRa isoforms do not express any protein (E,P), whereas 
both TR~, and TR~2 protein are observed at this stage in the pitui1:aty gland. (Scalebar represents 
magnification level) 
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Figure 6 
Thyroid-honnone-receptor-mRNA expression during feta! lung development. TRa mRNA is 
observed in the mesenchyme of the developing lung from EDl5 onwards (A,C,E). TRB mRNA is 
only faintly expressed in the pulmonary epithelium at EDl5 (B), but the expression is more 
pronounced at EDl8 (0). Expression of TRB mRNA in the epithelium decreases near tenn (F). 
(Scalebar represents magnification level) 
The proteinlmRNA ratio increased for TRu" and remained more or less constant for 
TRu, and TRJ31 in development. Since TRJ32 mRNA concentration was undetectably low, 
this ratio could not be determined. 
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Figure 7 
Thyroid-hormone-receptor-mRNA levels during pulmonary development. TRa2 mRNA levels are 
approximately 100fold higher than TRu, mRNA levels. TRu, mRNA levels peak at EDl8 and NDl, 
whereas TR~, mRNA levels peak at ED18 and are approximately 3-fold lower than TRu, mRNA 
levels. 
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Figure 8 
Thyroid-honnone-receptor-protein distribution during pulmonary development Despite posrhve 
Western blots for both TRa isoforms, no protein is seen in the developing lung (A,B,E,F), In 
contrast, TR~ protein is easily detectable, with TR~I being predominantly and TR~2 exclusively 
expressed in lung epithelium at EDl8 (C,D), and ND4 (G,H), (Scalebar represents magnification 
level) 
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Liver 
The liver, like the lungs, is a ventral outgrowth of the caudal foregut. Expression of TRu 
mRNA was first observed in the liver at EDIS (Fig. 9A). From 17 days of gestation 
onwards, this expression could be located in the stromal tissue of the liver, including the wall 
of the veins (Fig. 9C,E). Expression of TR~ mRNA was observed from EDIS, declined 
during the next 2 days to undetectable levels, and reappeared in the parenchymal tissue only 
at EDI9 (Fig. 9B,D,F). At ED20, the reciprocal expression ofTRu in the stromal tissue and 
of TRj3 in the parenchymal tissue became very striking (Fig. 9E,F). The identity of portal 
and central veins was verified by the expression pattern of carbamoylphosphate synthetase 
and glutamine synthetase in the surrounding hepatocytes, respectively (Christoffels et aI., 
1999)(results not shown). The concentration ofTRu, and, in particular, TRu2mRNA, was 
very low in comparison to other tissues during all investigated stages (Fig. 10). As a result, 
the TRu,iTRU2 ratio was the highest observed in any of the tissues investigated and was 
more than 5 times as high as in the brain. TR~, mRNA levels were higher than those of 
TRu2 and peaked at ED 18 (Fig. 10). TRj32 mRNA levels were below the limit of detection 
(results not shown). 
The TRu, antibody detected a band at the expected size in extracts of liver, but in 
addition, bands at higher and lower M,s. TRu, levels increased between ED 17 and ND4, 
when levels were comparable to those obtained in the adult (Fig. 3A). TRu2 protein did not 
change in development (Fig. 3B). TRj3, levels were similar at 5 days before and 4 days after 
birth, but appeared to be higher in the adult, with a prominent band at 30 kD (Fig. 3C). No 
band was detected prenatally with the TR~2 antibody, but very intense bands appeared in 
postnatal liver (Fig. 3D). Immunohistochemical staining revealed weak staining of TRu, 
protein in parenchymal cells surrounding the central veins, but after birth only, whereas 
TRu2 protein had then become detectable in isolated liver cells in a wide region surrounding 
the portal veins (Fig. IIA,B,E,F). In fetal rat liver, TRj3, protein was observed faintly in the 
parenchyma of the liver (Fig. II C). After birth, expression had become much stronger, but 
only in hepatocytes surrounding the central veins (Fig. 110). In contrast, TR~2 protein was 
difficult to localize (Fig. 11D,HJ. 
The proteinlmRNA ratios for TRu" TRu2 and TRj3, did not change appreciably with 
development. 
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Figure 9 
Thyroid-hormone-receptor-mRNA expression during fetal liver development. TRa mRNA is 
expressed in the liver at EDl5 (A). At EDl7 the TRa mRNA is located in the stromal tissue. 
including the walls of the veins (C). TR~ mRNA was observed from EDl5 (B), has disappeared at 
EDl7 (D), but reappears at EDI9. At ED20, TRa mRNA is expressed in the stromal tissue (E), and 
TR~ mRNA in the parenchymal tissue (F). (Scalebar represents magnification level) 
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Figure 10 
Thyroid-honnone-receptor-mRNA levels during liver development. Both TRa, and TRa2 mRNA 
levels are very low during liver development, when compared to other tissues. In liver, TR~1 niR.t~A 
levels are higher than those ofTRa2 and peak at EDI8. 
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Figure 11 
Thyroid-honnone-receptor-protein distribution during liver development TRa.] protein can be 
detected only after birth in parenchymal cells surrounding central veins (E). At that stage TRa, 
protein is observed in isolated liver cells in a wide region surrounding the portal veins (F). No TRa. 
isoform protein is observed before birth (A,B). In contrast, TR~l protein is observed in the 
parenchyma of the liver before birth (C), but very strong protein expression is observed after birth in 
hepatocytes surrounding the central veins (G).TR~2 protein is difficult to localize (D,H). (Scalebar 
represents magnification level) 
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Kidney 
The definitive kidney (metanephros) starts to develop when the ureteric bud penetrates the 
metanephric mass. From EDl6 onwards, metanephric tubules fuse with collecting tubules 
(originating from the ureteric bud) to form the nephrons. TR~ mRNA was found to be 
expressed in the deVeloping nephrons from EDl6 onwards (Fig. 12B,D,F), whereas TRu 
mRNA then became expressed in the ureteric bud and surrounding mesenchyme (Fig. 
12A,C,E). PCR analysis showed that TRu, mRNA levels were more than ten times higher 
than TRul levels (Fig. 13). Both TRul and TRu, mRNA concentrations peaked perinatally 
and were lower in adulthood (Fig. 13). TR~1 mRNA peaked just after birth with a level that 
was almost 3 times higher than that of TRu, (Fig. 13). TR~, mRNA concentration was 
below the limit of detection of our assay. 
TRul protein levels increased perinatally, with a band at approximately 30 kD that is 
also present in liver extracts, becoming more pronounced (Fig. 3A). In adult kidney, this 
band has become even stronger than the 47 kD species (Fig. 3A). At EDlS, TRul protein 
was weakly present in the collecting tubules (Fig. 14A), but had disappeared at ND4 (Fig. 
14E). TRu, protein was not detectable in any cell type in the kidney (Fig. 14B,F). TR~1 
protein was detected in the glomeruli and the tubules at ED IS, with particularly high levels 
in the collecting tubules (Fig. 14C). However, after birth, the glomeruli were no longer 
positive, but the tubules still stained homogeneously. TR~, protein expression was limited to 
the collecting tubules before birth (Fig. 14D), but present in all tubules after birth (Fig. 14H). 
If the 30 kD species is a proper TRUI product, the proteinlmRNA ratio for TRul 
increases with development. The proteinlmRNA ratio for TRu, did not change appreciably 
in development. The proteinlmRNA ratio for TR~1 declined when comparing prenatal with 
postnatal stages, but in the adult, a 30 kD band that was also seen in liver, became very 
prominent. If this is a bona fide TR~1 gene product, the ratio is substantially higher in the 
adult. 
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Figure 12 
Thyroid-honnone-receptor-mRNA expression during fetal kidney development. TRB mRNA is 
expressed in the developing nephrons from EDl6 onwards (B,D,F), whereas TRa mRNA is 
expressed in the surrounding mesenchyme (A,C,E). TRa mRNA is weakly present in the entire 
adrenal at EDl6 (A), but only in a few cells at EDl8 (e). TRB mRNA is only weakly seen in the 
capsule of the adrenals (B,D). (Scalebar represents magnification level) 
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Figure 13 
Thyroid-hormone-receptor-mRNA levels during kidney development. TRa, mRNA levels are 
approximately lO-fold higher than TRa] mRNA levels. mRNA levels of both isoforms peak 
perinatally. TR~] mRNA levels peak after birth, and are approximately 3 times higher than TRa, 
mRNA levels. 
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Figure 14 
Thyroid-hormone-receptor-protein distribution during kidney development. TRal protein is present 
at EDI8 in the collecting tubules (A) and disappears at ND4 (E). No TRu2 protein could be detected 
at both stages (B,F). At EDlS, TR~l protein is detected in the glomeruli and collecting tubules (C). 
After birth TR~l protein disappears from the glomeruli (G). TR~2 protein is only detected in the 
tubules, both before CD) and after birth (H). (Scalebar represents magnification level) 
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Thyroid-honnone-receptor-protein distribution during adrenal development. TRal protein is 
diffusely distributed at EDl8 (A), but is confined to !be adrenal medulla at ND4 (E). TRu2 
protein is confined to islets of cells at EDl8 (B) and becomes also confined to !be adrenal 
medulla after birth (F). TR01 protein is seen in !be adrenal and its capsule at ED 18 (C), but 
becomes confmed to !be adrenal cortex after birth (G). No TR02 proteins is observed in !be 
adrenal. (Scalebar represents magnification level) 
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Adrenals 
In situ hybridization revealed a weak TRa signal in the entire adrenal at ED 16, which had 
become confined to dispersed islands of cells and the capsule at EDl8 (Fig. 12A,C). TR~ 
mRNA levels were low and confined to the capsule (Fig. 12B,D). PCR analysis was not 
performed. Western blot analysis showed prominent bands for both TRa, and TRa, after 
birth (Fig. 3A,B). In addition, a prominent 100 kD TRa, band was observed. This band was 
also observed in human (not shown), but not rat pituitary gland. Only weak bands were 
observed for TR~, and TR~, protein after birth (Fig. 3C,D). Immunohistochemistry revealed 
a highly characteristic distribution of the TR proteins. TRa, protein was diffusely distributed 
at EDI8 (Fig. 15A), but the protein had become confined to the adrenal medulla at ND4 
(Fig. 15E). TRa, protein was already confined to well-defined islets of cells at EDI8 (Fig. 
15B) and became also concentrated in the medulla after birth (Fig. 15F). TR~, protein was 
diffusely distributed in the adrenal tissue and capsule at EDl8 (Fig. 15C), but became 
localized to the adrenal cortex after birth (Fig. 15G). No TR~, protein was observed in the 
adrenals (Fig. 15D,H). 
Although we have no PCR data for the adrenals, the near absence ofTR~ mRNA and 
the easily detectable levels of TR~, protein indicate a high proteinlmRNA ratio for this gene 
product. The expression pattern ofTRa mRNA and TRa, protein coincided. 
Intestines 
Expression of both TRa and TR~ mRNA was observed in the epithelial layer of the 
intestines and in the parenchymal cells of the pancreas from ED16 onward (Fig. 16A-F). The 
small and large intestine were pooled for PCR analysis before birth. TRa, mRNA levels 
peaked just after birth, but were 6-8 times lower than those of TRa, (Fig. 17). TRa, mRNA 
levels were highest perinatally and were lower in the adult (Fig. 17). TR~, mRNA 
concentration followed a similar developmental pattern as TRa" but the observed levels 
were two to three times higher (Fig. 17). 
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Figure 16 
ThyTOid-honnone-receptor-mRNA expression during fetal intestinal development. In contrast to the 
other investigated organs, both TRet and TRB mRNA are co-expressed in the epithelial layer of the 
intestines from EDl6 onwards (A-F). (Scalebarrepresents magnification level) 
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Figure 17 
Thyroid-hormone-receptor-mRNA levels during intestinal development. Both TRa.1 and TRa.z 
mRNA levels peak after birth, although TRa2 mRNA levels are 6-8 times bigher. TR~, mRNA 
levels peak also after birth, but the observed levels are 2-3 times bigher than TRa2 mRNA levels. 
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Thyroid-hormone-receptor-protein distribution during intestinal development No TRUI or TRa2 
protein can be detected in the intestines immunobistochemically (A,B,E,F). TR~l protein is seen in 
the smooth muscle layer of the intestine at ED18 (e), and in the mucosa as well postnatally (G). 
After birth TR~2 protein is present in the same cells. (Scalebar represents magnification level) 
173 
Chapter 6 
Western blotting showed that TRo., protein levels decreased between 5 days before 
and 4 days after birth (Fig. 3A). The opposite was trne for TRo.2 protein (Fig. 3B). Relatively 
low levels of TRj3, protein were found both pre- and postnatally (Fig. 3C). TRJ3z protein 
could not be detected prenatally, but high levels were observed postnatally (Fig. 3D). TRo., 
and TRo.2 protein could not be detected in the intestines immunohistochemically (Fig. 
18A,B,E,F). In contrast, TRj3, protein was observed in the smooth muscle layer of the 
intestine at EDl8 and, in addition, in the mucosa postnatally (Fig. 18C,G). TRj32 protein was 
localized to the same cells as TRj3, protein postnatally, but was undetectable prenatally (Fig. 
18H). 
Remarkable differences between the TR mRNA and protein distribution were 
observed. Thus, TRo. and TRj3 mRNA levels were high to very high in the mucosa at EDI6 
and EDI8 and retracted to the crypts at ED20. However, these mRNAs were hardly 
translated in these cells, since the protein was undetectable in sections before and after birth 
(at the latter age for TRo. only). At the same time, high levels ofTRj3, protein were present 
in the muscle layer without corresponding mRNA. These data suggest that the 
proteinlmRNA ratio for TRo. and TRj3 (before birth only) is relatively low, whereas the 
proteinlmRNA ratio for TRj3 in the smooth muscle layer is high. 
Comparison of TR protein in organs 
Except for the organs discussed, we demonstrated TRo., and TRo.2 protein in Western 
blots of ND4 trachea (including the thyroid), muscle, heart, thoracic cage (bone and 
muscle), testis, epididymal fat pad, and blood cells. The concentrations TRo., protein were 
similar to those found in lung and kidney, except for brain and to a lesser extent spinal 
cord, as well as small intestine, where the TRo., concentration was low, and blood, where 
TRo., was twice as high. TRo.2 levels were relatively high in adrenal and fat pad, 
relatively low in lung, trachea and muscle, and very low in blood. The resulting 
TRo.,/TRo.2 ratio, a parameter for tissue thyroid hormone responsiveness, was relatively 
low for brain, adrenal, pitnitary gland, liver, prenatal heart, thoracic cage, approx. lO-fold 
higher for postnatal lung and trachea, and extremely high for blood. The TRj3, 
concentration was relatively high in heart and testis, whereas TRj32 concentration was 
relatively high in brain, spinal cord, liver, intestine, and heart. 
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Table 1. Expression ofTRa and TR~ mRNA during development of the rat fetus. 
++, +, +/- and - indicate high, medium, low and no mRNA expression, respectively. 
Organ Age (days of TRa TR~ 
gestation) 
Lungs 13 + 
14 + 
15 + +/-
16 + + 
17 ++ ++ 
18 ++ ++ 
19 + +/-
20 + 
Liver 13 + 
14 + 
15 + 
16 + + 
17 + + 
18 ++ ++ 
19 ++ ++ 
20 ++ ++ 
Kidneys 13 + 
14 + 
15 + 
16 + + 
17 + ++ 
18 + ++ 
19 + ++ 
20 + ++ 
Intestines 13 
14 
15 +/-
16 ++ + 
17 ++ + 
18 ++ + 
19 + + 
20 + + 
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Table 2. Expression of TRaj, TRu2, TR~j and TR~z protein expression during 
development of the rat fetus. 
++, +, +/- and - indicate high, mediwn, low and nO protein expression, respectively. 
Age Organ TRa, TRa2 TR~, TR~z 
18 days of gestation Trachea 
Lungs + + 
Liver +/- +/-
Kidneys +/- ++ + 
Adrenals + + ++ 
Pituitary gland + 
Brain ++ + 
4 neonatal days Lungs + + 
Liver + ++ 
Kidneys + ++ 
Adrenals + ++ ++ 
Pituitary gland + + 
Brain ++ 
Comparison ofthe protein/mRNA ratio between organs 
The proteinlmRNA ratio in organs with a similar tissue distribution of mRNA and protein 
was compared, based on the PCR and Western-blot data. The proteinlmRNA ratio for TRaj 
was by far the lowest for brain, followed by the small intestine, and then luog, kidney and 
liver, which were similar. The proteinlmRNA ratio for TRaz was again by far the lowest in 
brain, whereas liver, kidney and luog were similar. The proteinlmRNA ratio for TR~, was 
highest for brain, followed in descending order by liver, luog, and kidney. In intestine, the 
mRNA and protein distribution only partly overlapped, precluding a direct correlation based 
on analysis of extracts. 
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Table 3. Thyroid-hormone receptor-protein levels in organs, expressed as LUMI-imager 
light units. Aliquots of tissue extracts containing 50 J.l.g of protein, were separated on a 
denatuting polyacrylamide gel, blotted unto PDMF membrane and tested for the presence of 
TRub TRu2, TR~b and TR~2' 
TRa" TRa,2 
-5 +4 adult -5 +4 adult 
Liver 8.0 13.0/10.3 4.0/11.3 2.4 3.8 2.7 
Lung 9.0 35.2 1.8 0.7 
Trachea 53.1 1.0 
Muscle 14.3 30.9 1.9 1.4 
Kidney 9.4 27.2120.5 21.8 1.2 2.3 
Adrenal 40.1 16.3 6.4 
Heart 10.3 34.8 3.7 2.1 
Spinal cord 23 1.9 
Brain 1.5 6.2 1.2 1.9 
Testis 36.5 5.3 
Thorax 34.5 4.3 
Fat pad 30.8 10.8 
Jejunum 11.7* 11.7/4.9 1.5' 4.7 
ileum 11.7' 2.7/12.6 1.5* 4.4 
Blood 63.8 0.2 
Pit. gland 20.2 22.1129.1 0.3 
TR/3, TR/3z 
-5 +4 adult -5 +4 adult 
Liver 10.5 15.7/9.6 3.817.6 2.3 16.5/12.7 11.8/10.5 
Lung 18.0 18.7 3.9 4.1 
Trachea 20.4 4.0 
Muscle 18.3 14.4 2.7 3.8 
Kidney 14.6 17.0/14.3 11.0/3.6 4.6 6.3/0.4 1.0 
Adrenal 16.3 13.7/4.6 2.6 1.0 
Heart 21.5 28.5 4.6 29.7 
Spinal cord 45.3 37.7 
Brain 20.7 37.2 14.9 21.5 
Testis 8.3 1.2 
Thorax 4.7 2.1 
Fat pad 4.1 7.0 
Jejunum 13.1 * 1.6/9.8 4.7' 16.0/29.8 
Ileum 13.1* 3.4/11.2 4.7* 22.5/15.1 
Blood 0.7 1.4 
Pit. gland 7.3/16.4 7.116.4 0.2 14.8/5.3 
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6.5 Discussiou 
Although the role of thyroid hormone in organogenesis is undisputed (Oppenheimer and 
Samuels, 1983; Tata, 1993), the respective roles of the TRu and TRj3 receptors that 
mediate the effects of thyroid hormone have remained elusive. Similarly, it is likely that 
epithelial-mesenchymal interactions, a time-honored and important aspect of organ 
development, playa role, because mesenchymal cells are thought to be primary determinants 
of differentiation, growth and morphogenesis of the epithelial cells towards the formed 
organ (Branl, 1990). Using in situ hybridization and immunohistochemistry as 
visualization techniques, and RT-PCR and Western blotting as quantification techniques, 
we observed a highly specific distribution pattern of the TR isoforms. Expression of the 
TRu isoform was observed in the mesenchymal tissues and of the TRj3 isoform in the 
epithelial tissues of many organs. As far as we know, this generalization has not been 
made so far. In addition, we observed extensive pre- and posttranscriptional regulation of 
the expression of the TRs, with differences between organs and between different 
developmental stages of the same organ [cf. also (Lane et al., 1991; Rodd et aI., 1992; 
Schwartz et aI., 1992; Strait et aI., 1990; Weiss et aI., 1998)]. 
The most pronounced complementary expression pattern of TRu and TRj3 was 
observed in the developing lung, liver, kidney and inner ear. Since most epithelia cannot 
differentiate when separated from their associated mesenchyme (Birchmeier and Birchmeier, 
1993; Masters, 1976; Saxen et al., 1986; Saxen and Thesleff, 1992), it is thought that 
epithelial differentiation is under control of its surrounding mesenchyme. Due to extensive 
posttranscriptional control, the respective expression patterns were much more pronounced 
at the mRNA than at the protein level. Although both mRNA and protein levels in the 
organs mentioned reached adult levels perinatally, it is of interest that for those organs for 
which paired samples were available, tissue TRu" TRj31 and TRj3, protein levels had 
already reached the adult level at 5 days before birth, whereas TRul protein levels only 
reached its highest levels after birth. These protein data therefore strongly indicate distinct 
roles of the respective receptor isoforms during the fetal phase of organ development [cf. 
also (Forrest et al., 1991)]. The distinct time-course of TRu and TRj3 also suggests an 
initiating, TRj3-mediated role of the epithelium, followed by a TRu-mediated response of 
the mesenchyme. 
Extensive co-expression of TRu and TRj3 was observed in the developing brain and 
in the intestinal epithelium. Despite the high level of TRUI and particularly TRu2 mRNA in 
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these organs, TRa! protein levels were much lower than, and TRa, protein levels similar to 
those in the other organs investigated. In other words, the organs with co-expression seem to 
be characterized by a very low TR proteinlmRNA ratio. Thus, the proteinlmRNA ratio for 
TRa! was more than 10-fold lower in perinatal brain than in perinatal liver, lung, or kidney 
and that of TRa, more than 50-fold lower in perinatal brain and more than 10-fold lower in 
perinatal lung and kidney than in perinatal liver. In contrast, the proteinlmRNA ratio for 
TRI3! was similar in these 4 organs in the perinatal period, but was very low in intestinal 
epithelium, especially before birth. This implies that in organs with co-expression of TRa 
and TRI3, the translational efficiency of one of the TR mRNAs is much lower, and/or that 
the turnover of TR protein is much higher than that in cells without co-expression. Finally, 
the TRI3, protein levels in brain and intestine are the highest measured (the TRI3, mRNA 
levels were below the detection limit of our assays). These data indicate that the TR-
dependent regulatory cascades function differently in those organs in which the TRa and 
TRI3 genes are characterized by a complementary expression pattern and those in which they 
are co-expressed. 
We observed an apparent discrepancy between the relatively poor visibility of TRa 
proteins in histological sections of all organs except the adrenal, and their strong presence, in 
particularly TRaj, on Western blots. The performance of the antibodies on the Western 
blots, as well as on sections of the adrenals, shows that they were of similar quality as those 
for the TRl3s. Therefore, the TRas are either not well accessible in the tissue sections of 
most organs or, more likely, they are distributed over many more cells, such that the cellular 
concentration remains too low to strongly stain these tissues. The latter possibility is 
suppotted by their presence in the stroma of organs such as liver, lung, bone and kidney. As 
stated before, the low staining intensity in brain and intestine is due to the low protein levels 
in these organs. 
The antibody raised against the TRI3,-specific oligopeptide recognized a protein of 
47 kD, i.e. 11 kD less than that predicted by the reported open reading frame (Hodin et aI., 
1989). We observed an identical apparent size of the TRI3, with 3 other antisera that were 
raised against the same TRI3,-specific oligopeptide. Although the size of the TRI3,-like 
protein corresponds with the recently discovered TR133 isofonn (Williams, 2000), the 
oligopeptide against which the antisera were raised, is located in an exon that is present in 
the TRI3" but not the TR133 isofonn. More likely, the discrepancy should therefore be 
explained by the less than optimal Kozak sequence (Kozak, 1992) that surrounds the first 
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in-frame AUG of the TRJ32 cDNA when compared to the one surrounding the AUG 351 
nucleotides further downstream. Usage of a more downstream AUG is also suggested by 
studies aiming to delineate the transcription initiation site of TRJ32 (Wood et al., 1994). 
Unfortunately, no Western blot data of the TRJ32 oligopeptide-specific antisera that were 
reported in the literature (Lechan et aI., 1993; Schwartz et aI., 1994), are available for 
comparison. As part of the efforts to validate the specificity of our antiserum, we 
determined the isoelectric point of the protein that was recognized (not shown). As 
expected from the amino-acid sequence of TRJ32, the pI of the TRJ32-like protein in liver 
extracts was 7.6, indicating that the protein identified by the antiserum is indeed TRJ32. 
However, the pI of the protein recognized in extracts of the pituitary gland, was 5.0, 
suggesting extensive posttranslational modification in this organ, most likely 
phosphorylation. The strong staining intensity of the TRJ32-like protein in many organs 
implied easily detectable mRNA levels. Nevertheless, we were unable to detect the 
corresponding mRNA with our RT-PCR protocol outside the pituitary in the tissues 
investigated. The limit of detection of this method is less than 0.1 mRNA molecule per 
cell. Extremely low cellular levels of TRJ32 mRNA in association with easily detectable 
TRJ32 protein levels were reported before (Lechan et a!., 1993; Schwartz et a!., 1994) and 
imply either an extremely high translational efficiency or an extremely stabile protein 
(Ercan-Fang et a!., 1996). Another possibility is a pronounced diurnal mRNA rhythm with 
our measurement of the mRNAs in the nadir of the daily wave. We did observe a diurnal 
rhythm for TRJ31 with a nadir at noon (B.Z. Doulabi et aI., submitted), but did not yet 
investigate TRJ3,. We also tested the antisera by staining the pituitary glands of neonatal 
and adult rats. The sections revealed that the TRJ32-like protein concentration was still 
very low in the ND4 pituitary, but was present in the adult organ as described (Li and 
Boyages, 1997). Because TRJ32 is thought to play an important role in the feedback 
regulation of the hypothalarnic-pituitary-thyroid axis (Abel et al., 1999), its absence in the 
neonatal pituitary may serve to accommodate the perinatal rise in circulating thyroid 
hormones in rats (Dubois and Dussault, 1977). 
The expression patterns that we describe generally fit with the observed effects of 
targeted inactivation of the respective TR genes [for a recent review, see (Forrest and 
Vennstrom, 2000)]. Thus, TRJ3, deficiency was found to lead to central resistance to 
thyroid hormone (Abel et aI., 1999; Forrest et al., 1996; Kaneshige et aI., 2000), while we 
observed a delayed appearance of TRJ32 in the pituitary, which we hypothesize to be 
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responsible for the perinatal rise in thyroid hormone production. Similarly, it was shown 
that TR~1 deficiency leads to failure of induction of malic enzyme and spot-14 induction 
in liver (Weiss et al., 1998), while we showed that this receptor is the predominant TR in 
the hepatocytes in which these genes are expressed (BL Doulabi et aI., submitted). In 
contrast to TR~ deficiency, TRa deficiency leads to hypothyroidism and delayed tissue 
maturation (Fraichard et aI., 1997), in accordance with the widespread expression of the 
gene in mesenchymal tissues. However, TRa'/', TRW/' mice survive up to several weeks 
after birth, even though the TRa'/'- and TR~'/' phenotype suggests only a limited 
redundancy ofTRa- and TR~-dependent functions (Gauthier et aI., 1999). In view of the 
pronounced phenotype of hypothyroid neonates, one should perhaps interpret these 
findings as indicating that the absence of TRs interferes less with normal development 
than the presence of unoccupied TRs. Alternatively, thyroid hormones become important 
only after birth, at least in altricial species like most rodents. The latter interpretation 
seems to be supported by the [mdings that experimentally induced prenatal 
hypothyroidism in the mouse (Wallace et aI., 1995) does not lead to major problems until 
after birth (p.J.E. Blommaart et aI., in preparation). 
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7.1 Abstract 
Pulmonary hypoplasia associated with congenital diaphragmatic hernia (CDH) remains a 
major therapeutical problem. Moreover, the pathogenesis of pulmonary hypoplasia in case 
of CDH is controversial. In particular little is lmown about early lung development in this 
anomaly. To investigate lung development separate from diaphragm development we 
used an in vitro modification of the 2,4-dichlorophenyl-p-nitrophenyl (Nitrofen) animal 
model for CDR. This enabled us to investigate the direct effects of Nitro fen on early lung 
development and branching morphogenesis in an organotypic explant system without the 
influence of impaired diaphragm development. Epithelial cell differentiation of the lung 
explants was assessed using surfactant protein-C and Clara cell secretory protein-IO 
mRNA expression as markers. Furthermore, cell proliferation and apoptosis were 
investigated. Our results indicate that Nitrofen negatively influences branching 
morphogenesis of the lung. Initial lung anlage formation is not affected. In addition, 
epithelial cell differentiation and cell proliferation are attenuated in lungs exposed to 
Nitrofen. These data indicate that Nitrofen interferes with early lung development prior to 
and separate from (aberrant) diaphragm development. Therefore, we postulate the dual-hit 
hypothesis, which explains pulmonary hypoplasia in CDH by two insults, one affecting 
both lungs before diaphragm development and one affecting the ipsilateral lung after 
defective diaphragm development. 
7.2 Introduction 
Congenital diaphragmatic hernia (CDH) has a mean prevalence of approximately I in 
3000 newborns (Torfs et al., 1992). Even sophisticated management techniques, such as 
extracorporeal membrane oxygenation (ECMO) and fetal surgery have not significantly 
influenced the mortality rate of CDH in high-risk patients and consequently, CDH 
remains a major problem in Pediatric Surgery and Neonatology. A recent review shows 
that the mortality remains high at 50 to 60% in high-risk patients (Katz et aI., 1998). 
However, other reports suggest a modest reduction in mortality to approximately 30% in 
comparable series of patients (Reickert et al., 1998; Wung et aI., 1995). A combination of 
morphological features characterizing this anomaly: pulmonary hypoplasia and persistent 
pulmonary hypertension, is held responsible for the high mortality. In particular the 
degree of pulmonary hypoplasia is almost impossible to evaluate pre- and immediately 
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postnatal and in most cases the degree of pulmonary hypoplasia is an important 
detenninant of the outcome (Thebaud et aI., 1998). 
The pathogenetic events resulting in the diaphragmatic defect and pulmonary 
hypoplasia are unknown. Classically, the primary defect is believed to be located in the 
diaphragm. Abdominal organs that herniate through this defect will interfere with nonnal 
pulmonary development. This results in a secondary defect: pulmonary hypoplasia and 
abnonnal pulmonary vascular development (Allan and Greer, 1997; Harrison et aI., 1986). 
However, since the introduction of the 2,4-dichlorophenyl-p-nitrophenylether (Nitrofen) 
animal model for CDH, an alternative hypothesis has been suggested (Cilley et aI., 1997; 
Iritani, 1984). This animal model is based on the teratogenic effects of the herbicide 
Nitrofen. When administered in the right dosage and at the right time to pregnant rats and 
mice, Nitrofen interferes with development of the lungs and the diaphragm of the 
offspring (Cilley et aI., 1997; Kluth et aI., 1990; Tenbrinck et aI., 1990). Studies with this 
animal model have suggested that CDH might be due to primary disturbance of 
pulmonary growth into the pleuroperitoneal canal, thereby disturbing the growth of the 
posthepatic mesenchymal plate, the main origin of the diaphragm (Iritani, 1984). After 
exposure to Nitrofen, 100% of the litter has a variable amount of lung hypoplasia, 
whereas depending on animal strain and timing of Nitrofen administration, a smaller 
percentage, varying from 60 to 90% in rats and 40 to 60% in mice, has a diaphragmatic 
hernia as well (Cilley et aI., 1997; Kluth et aI., 1990; Tenbrinck et al., 1990). 
Observations that both the contralateral and ipsilateral lung are hypoplastic suggest that 
proper pulmonary development in CDH is already impaired prior to the failed closure of 
the diaphragm. On the ipsilateral side, growth of the lung is hampered at a later phase by 
the presence of abdominal organs in the thoracic cavity and eventually interference with 
fetal breathing movements. 
We hypothesized that the lungs are the primary target-organ in the pathogenesis of 
pulmonary hypoplasia in case of Nitro fen-induced CDR. This implies that the lungs have 
to be hypoplastic before defective closure of the diaphragm has occurred. In order to test 
this hypothesis, we investigated early pulmonary development in an in vitro modification 
of the Nitrofen model. We have set up a foregut/lung explant system in which it is 
possible to study lung fonnation and branching morphogenesis without the influence of 
nonnal or defective closure of the diaphragm. The direct effects of Nitrofen on early 
pulmonary development in vitro were investigated by culturing explants in the presence 
of Nitrofen. In addition, the effects of removal of physical constraint on branching 
191 
Chapter 7 
morphogenesis after Nitrofen treatment in vivo were tested. We show herein that Nitrofen 
interferes with branching morphogenesis both in vitro and in vivo. In contrast, initial lung 
bud outgrowth is not disturbed. Epithelial cell differentiation is attenuated even before 
effects of a defective closure of the diaphragm could have occurred. Furthermore, the 
interplay between proliferation and apoptosis is disturbed in lungs exposed to Nitrofen 
and therefore contributes to pulmonary hypoplasia. 
7.3 Materials and methods 
Animals 
Female (200-250 g) and male (250-300 g) Wistar rats were obtained from Charles River 
(St. Constant, Quebec, Canada). The animals were kept in a controlled light-dark cycle 
and food and water were supplied ad libitum. Rats were mated overnight and the finding 
of a sperm-positive vaginal smear was designated day 0 of gestation. At 11 and 13 days of 
gestation (term = 22 days of gestation), timed-pregnant rats were killed by cervical 
dislocation after a short exposure to diethyl ether in order to anesthetize them. The fetuses 
were delivered by Caesarian section using aseptic surgical techniques and kept in Hank's 
balanced salt solution (Gibco, Burlington, ON). All protocols were evaluated and 
approved by the Animal Care Committee of the Hospital for Sick Children. 
Explant cultures 
Foreguts and lungs were cultured according to previously reported studies (Souza et al., 
1994). In short, at 11 days of gestation, foreguts and at 13 days of gestation, lungs were 
harvested from fetal rats under a dissection microscope using microsurgical techniques. 
The foreguts and lungs were transferred to porous membrane inserts (4 fill1 pore size) 
from Millipore (Bedford, MA), and incubated in 4-well cell culture plates from Nunc 
(Intermed, Denmark). The membrane inserts were pre-soaked in MEM (Gibco, 
Burlington, ON) for 1 hour before the explants were placed on them. The explants were 
incubated as floating cultures in 200 fll Dulbecco's modified Eagle medium, nutrient 
mixture F-12 (Gibco, Burlington, ON) supplemented with 100 flg/ml streptomycin, 100 
units/ml penicillin, 0.25 mglm1 ascorbic acid and 10% (v/v) heat-inactivated fetal bovine 
serum (Gibco, Burlington, ON). Heat inactivation of the serum was required to support 
long-term culture. The explants were cultured at 37°C in 95% air and 5% CO,. 
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Nitrofen 
The herbicide 2,4-dichloro-phenyl-p-nitrophenylether (Nitrofen) was obtained from 
Rohm & Haas Co. (Philadelphia, PAl. To induce congenital diaphragmatic hemia and 
pulmonary hypoplasia in vivo, 100 mg Nitrofen dissolved in 1 ml olive oil was 
administered orally on day 9 of gestation. To investigate the effects of Nitro fen in vitro, 
the explants were exposed during the first day of culture to a concentration of Nitrofen, 
which is similar to that used in vivo: 0.25 mg.200 J.lrl medium. To mimic the half-life of 
Nitrofen in vivo the explants were exposed to half of this during the second day of culture 
(Costlow and Manson, 1983; Manson, 1986). During the remaining culture period the 
explants were cultured in medium alone. Non-treated explants and explants cultured in the 
presence of vehicle [dimethyl sulphoxide: DMSO] (BDH, Toronto, ON) in the same 
concentration as was used to dissolve the Nitrofen served as controls (see Table 1). Since 
Nitrofen is extremely toxic, all handling was done in a fume hood or laminar flow using 
protective gear to prevent inhalation and contact with the skin. Disposal of all waste 
products containing Nitrofen was done according to local regulations of The Hospital for 
Sick Children and all experimental procedures were approved by the department of 
Occupational Health and Safety of the Hospital for Sick Children. 
Quantification of branching morphogenesis 
During the entire period of culture, lung formation and branching morphogenesis was 
monitored daily by phase-contrast microscopy. At approximately the same time point 
each day, branching morphogenesis was assessed by manually counting the number of 
terminal buds and in addition, the lung explants were photographed. 
Tissue preparation 
After 8 (foregut) or 4 and 6 (lung) days of culture, explants were removed from the inserts 
and fixed in 4% (w/v) paraformaldehyde in phosphate-buffered saline (PBS) at 4°C for 16 
to 18 hours, dehydrated in a graded series of ethanol, cleared in xylene and embedded in 
paraplast (Oxford labware, St. Louis, MO). Sections of 5 J.lffi were cut and mounted on 
Superfrost slides (Fisher Scientific, Unionville, ON) and baked at 42°C for 16 to 18 hours. 
In situ hybridization 
After dewaxing and rehydrating, tissue sections were post-fixed in 4% (w/v) 
paraformaldehyde in PBS and permeabilized with proteinase K (20 J.lg.mr1 in 50 mM 
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TrisIHCI, 5 mM EDTA, pH 8.0) for 15 minutes at room temperature. Following another 
post-fixation step in 4% (w/v) paraformaldehyde in PBS for 5 minutes, the sections were 
carbethoxylated by 0.1 % (v/v) active diethylpyrocarbonate treatment twice for 15 minutes 
in order to reduce background by inactivating RNases in the sections. Subsequently, the 
sections were equilibrated in 5x SSC (NaCl 0.75 mollL, sodium citrate 0.075 mollL) for 
15 minutes and prehybridized for 2 hours at 58°C in 50% (v/v) formarnide, 5x SSC and 
40 fig.ml'! sahnon sperm DNA. The sections were hybridized overnight at 58°C with 
digoxigenin (DIG)-Iabeled Surfactant protein-C (SP-C) and Clara cell secretory protein-
10 (CC-IO) RNA probes in the same hybridization mixture. Rat specific SP-C and CC-IO 
cDNA fragments (330 and 315 bases, respectively) were DIG-labeled according to a 
protocol provided by the manufacturer (Boehringer Mannheim, Montreal, Quebec). The 
next day, sections were washed in 2x SSC for 30 minutes at room temperature, I hour at 
58°C and in O.lx SSC for I hour at 58°C. The DIG Nucleic Acid Detection Kit from 
Boehringer Mannheim was used for immunological detection of the hybridized probe. 
Unspecific labeling was removed in 95% ethanol and the sections were counterstained 
with methylgreen for 1.5 minutes. After dehydration in a graded series of ethanol and 
xylene, the sections were mounted with coverslips using Permount (Fisher Scientific, 
Unionville, ON). 
Immunohistochemistry 
Sections were dewaxed in xylene after heating them at 60°C for 5 minutes and rehydrated 
in a graded series of ethanol. Subsequently, antigen retrieval was performed by boiling the 
sections in a 10 mM sodium citrate solution, pH 6.0 for two periods of 5 minutes in a 
microwave at medium high. Between the boiling periods, the sections cooled down for 20 
minutes. After rinsing the slides in PBS endogenous peroxidase activity was blocked by 
exposing the slides to a 3% (v/v) hydrogen peroxide in methanol solution for a period of 
10 minutes. Following two rinses in PBS, the sections were blocked with 5% (v/v) normal 
goat serum and 1% (w/v) bovine serum albumin in PBS for the period of I hour. The 
sections were incubated overnight at 4°C with I: 1000 diluted primary monoclonal 
antibody to proliferating cell nuclear antigen (pCNA; Santa Cruz Biotechnology, Santa 
Cruz, CAl. The sections were washed in PBS containing 0.05% (v/v) Tween followed by 
two washes in PBS alone. The sections were then incubated with a 200-fold dilution of 
biotinylated anti-mouse IgG for I hour at room temperature. After washing, the sections 
were incubated with avidin-biotin peroxidase complex (Vectastain) kit from Vector 
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Laboratories (Burlingame, CAl for 2 hours at room temperature. Subsequently, after 
washes in PBS and Tris- buffered saline (TBS), the sections were developed using 3,3'-
diaminobenzidine as substrate. Following washes in TBS and PBS, sections were 
counterstained with Carazzi's hematoxylin. Subsequently, the sections were dehydrated in 
a graded series of ethanol and xylene and mounted with coverslips using Permount 
(Fisher Scientific, Unionville, ON). 
Table 1 
Organotypic explant cultures 
Untreated pregnant rats 
1 
Isolation of lungs 
(day!3 of gestation) 
1 
Organotypic explant 
culture (4-6 days) 
/ 1 ~ 
Control medium DMSO Nitrofen 
1 / 
In situ hybridization & 
immunohistochemistry 
Nitrofen-treated rats 
(day 9 of gestation) 
1 
Isolation oflungs 
(day !3 of gestation) 
1 
Organotypic explant 
culture (4-6 days) 
1 
Control medium 
1 
In situ hybridization & 
immunohistochemistry 
Conditions for the organotypic explant cultures. For details see Materials and Methods section. 
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Figure 1 
Lung fonnation and branching morphogenesis of the lung in an explant system of rat foregut. 
Foreguts of rats, II days of gestation, were harvested and cultured in a semi-dry system. Pictures 
representative of a series of experiments of untreated (A-D), vehicle DMSO-exposed (E-H) and 
Nitrofen~exposed (I~L) foreguts developing into branching lungs are shown at culture-day 0 (A, 
E, J), 2 (B, F, J), 6 (C, G, K) and 8 (D, H, L), respectively. The Nitrofen-exposed group was 
exposed to Nitrofen in a concentration similar to that used in vivo: 0.25 mg.200 J-lrl medium on 
the first culture-day, and to half of this on the second culture-day. Lung formation in this group 
occurred at the same time-point as in the control groups (J), which were cultured in medium with 
vehicle DMSO (F) or in medium alone (B). Branching morphogenesis was clearly reduced in the 
explants exposed to Nitrofen during the remaining culture-period (L). (All images at same 
magnification) (Arrow indicates lung) 
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Terminal Deoxyribonucleotidyl TransJerase dUTP Nick-End Labeling (TUNEL) Assay 
After dewaxing and rehydrating, tissue sections were incubated with proteinase K, 20 
Ilg.mr
' 
in 10 mM TrisIHCI, pH 7.6 for 15 minutes at 37°C. Following two washes with 
PBS, the sections were incubated with 25 III TUNEL reaction mixture (Boehringer 
Mannheim, Montreal, Quebec) for 1 hour at 37°C. Subsequently, the sections were 
washed in PBS and mounted with coverslips using Vectashield mounting medium with 
DAPI from Vector Laboratories (Burlingame, CA). 
Data presentation 
All results are expressed as mean ± SE. Statistical significance was determined by one 
way analysis of variance followed by assessment of differences using a Tukey test for 
pairwise multiple comparison procedures (Hochberg and Tarnhane, 1987). Linear 
regression was performed after transformation of the curves in straight lines by changing 
the numerical y-axis scaling into a natural log scale. The rate of branching (slope) was 
depicted by the coefficient ± SE and differences were assessed using Student's t-test. 
Significance was defined as p < 0.05. 
7.4 Results 
Lung formation and branching morphogenesis 
After 72 hours of culture, lung formation was observed in all foregut explants as a 
diverticulum arising from the foregut to form two primary lung buds (see Figure lB, F & 
J ). The timing of lung bud appearance was approximately the same in all explants. The 
same holds true for initial lung bud outgrowth after Nitrofen treatment in vivo, since the 
endodermal part of the lungs in this group appeared similar at the moment of isolation 
(see Figure 2D). However, the mesenchymal parts of the lungs treated with Nitrofen in 
vivo appeared much thicker than the mesenchymal parts of the control lungs (see Figure 
2D). During the remaining period of culture, dichotomous branching was observed in all 
lung explants (see Figure 2E-H). In the Nitrofen exposed explants, only lobular branching 
was observed (see Figure 2G & H), and the rate of branching was reduced (see Figure 3 
and Table 2). The explants exposed to Nitrofen in vitro showed an arrest in branching 
during the first 2 days of culture, the period of exposure to Nitrofen. However, the rate of 
branching was also reduced during the subsequent 2-day culture period (see Figure 3). 
The number of branches of explants exposed to Nitrofen in vitro was significantly 
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reduced when compared to control explants (p<O.05) (Table 2). Exposure to Nitrofen in 
vivo did not result in a statistically significantly reduced number of branches. When only 
the 75% lowest mean numbers of branches were used for comparison, statistical 
significance was reached (Table 2). No significant differences were observed between 
control and DMSO exposed explants. The size of the explants was reduced after exposure 
to Nitrofen, suggesting lung hypoplasia. Nitrofen exposure in vitro resulted in more 
severe reduction in branching and size than exposure in vivo. 
Figure 2 
Branching morphogenesis in a rat lung explant system. At 13 days of gestation, lungs were 
removed from the fetuses and cultured in a semi-dry system. The upper row of pictures are 
representative for lungs at 13 days of gestation at culture day 0 just after isolation of the lungs 
from the fetus. The bottom row of pictures represents lungs after a culture period of 4 days. One 
group was treated with Nitrofen in vivo by administration of the Nitrofen to the mother at 9 days 
of gestation (D, H) Another group was treated with Nitrofen in vitro as described before (G). 
Branching morphogenesis was compared to groups cultured in medium alone (E), and groups 
cultured in medium plus vehicle DMSO (F). In all Nitrofen-exposed explants a statistically 
significant (p < 0.05) reduced number of branches was observed after 4 days of culture (G, H), 
whereas no effects of exposure to DMSO were observed (F)[see also fig. 3. and table 2]. In 
addition, the size of the explants exposed to Nitrofen was clearly reduced (G, H). The effects of 
Nitrofen exposure in vitro were more severe than the effects after Nitrofen exposure in vivo. All 
pictures are representative of a series of experiments. (Scalebar represents magnification level) 
Epithelial cell differentiation 
In the sections of the control explants and DMSO explants, major airways and a 
pseudoglandular aspect were distinguished (see Figure 4A, B, E & F). In the sections of 
Nitrofen exposed explants, large airspaces, due to lobular branching were observed (see 
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Figure 4C, D, G & H). After 4 days of culture, SP-C mRNA was present in the control 
and DMSO exposed explants as well as in the explants exposed to Nitrofen in vivo (see 
Figure 4A, B & D). Expression was observed in the epithelial lining of the distal airways. 
In contrast, no expression was observed in the explants exposed to Nitrofen in vitro (see 
Figure 4C). No differences in the spatial expression pattern of SP-C mRNA were 
observed between DMSO, control and Nitrofen in vivo treated explants. After 6 days of 
culture, the same expression pattern was observed in the explants exposed to Nitrofen in 
vitro (results not shown). After 4 days of culture, CC-10 mRNA expression was only 
observed in the DMSO and control explants in the epithelial lining of the major airways 
(see Figure 4E & F). This time, expression was not observed in any of the explants 
exposed to Nitrofen (see Figure 4G & H). 
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Figure 3 
Branching morphogenesis plotted as a graph. Number of branches, mean ± s.e.m., is plotted 
against days of culture. Explants exposed to Nitrofen in vitro showed an arrest in branching 
during the first 2 days of culture, the period of exposure to Nitrofen. In addition, the rate of 
branching (slope) was also reduced after the first 2 days of culture during the remaining culture-
period. After exposure to Nitrofen in vivo explants showed also a reduced number of branches 
after 3 days of culture and a reduced rate of branching (slope) although to a lesser extent than the 
ones exposed to Nitrofen in vitro. 
199 
Chapter 7 
Proliferation and apoptosis 
To investigate whether the interplay between proliferation and apoptosis played a role in 
the early pathogenesis of Nitro fen-induced pulmonary hypoplasia in vitro, we investigated 
proliferation, using immunohistochemistry with an antibody against PCNA (Takasaki et 
aI., 1981). Apoptotic cells were detected using TUNEL assay (Gavrieli et aI., 1992). 
Proliferating cells (PCNA positive nuclei) were localized mainly in the epithe1iallining of 
the branching terminal lung buds (see Figure SA & B). A smaller number of proliferating 
cells was observed in the mesenchyme (see Figure SA & B). In mesenchyme of the 
Nitrofen exposed explants, attenuated PCNA immunoreactivity was observed (see Figure 
SC). Unexpectedly, in the epithelial lining of the terminal buds, PCNA protein was 
localized perinuclearly and in the cytoplasm, and not in the nuclei (see Figure SC). 
Table 2 
Branching morphogenesis is reduced in Nitrofen exposed rat lung explants, 13 days 
of gestation after 4 days of cultnre 
Treatment No. of branches n Slope 
(means± SE) 
Control 83.278 (S.576) 16 0.63 
DMSO 76.917 (4.008) 12 0.58 
Nitrofen in vitro 49.38S (3.790)* 13 0.49* 
Nitrofen in vivo 64.207 (2.099)* 40 0.60 
The number of branches after 4 days of culture and the rare of branching (slope) were 
significantly reduced in the explants exposed to Nitrofen in vitro. When only the 75% of animals 
with lowest number of branches (corresponding to the frequency of diaphragmatic hernias in the 
animal model) was taken into account for the in vivo treated group, statistical significance was 
also reached for this group. However, the slope in this group remained unchanged. No difference 
was detected between the control explants and the explants exposed to vehicle DMSO. n. number 
oflungs taken from different fetuses of different litters and in different experiments; * ,P<0.05 
In all explants TUNEL positive cells were observed mainly in the mesenchyme, 
and occasionally in the epithelium. Although not quantitated, the number of apoptotic 
cells appeared similar in all explants, including the ones exposed to Nitrofen (see Figure 
SD-F). All nuclei of the cells were shown by staining with DAPI (see Figure SG-I). 
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Figure 4 
Expression of markers for distal and proximal epithelial cell differentiation, SP-C (upper row) 
and CC-I 0 (bottom row) mRNA respectively, in lung explants after 4 days of culture, Expression 
of SP-C mRNA was observed in control, DMSO and Nitrofen in vivo treated explants in the 
epithelial lining of the terminal lung buds after 4 days of culture (A, B & D). No expression was 
observed in the explants exposed to Nitrofen in vitro (C). Expression of CC-IO mRNA was 
observed in control and DMSO explants in the epithelial lining of the major proximal airways. 
(E, F). No expression was observed in the explants exposed to Nitrofen both in vitro (G) and in 
vivo (H). All pictures are representative of a series of experiments. [All images at same 
magnification 1 
7.5 Discussion 
Despite many years of clinical efforts to fmd altemative treatment modalities, the 
mortality rate of CDR has not really changed during the past decades. A poor 
understanding of the pathogenesis of CDR might be partly responsible for this. It is still 
not clear whether the diaphragmatic defect is the cause or result of the pulmonary 
hypoplasia. We hypothesized that the lungs are the primary target-organ in Nitrofen-
induced CDR, and in order to test this hypothesis, we separated the pathogenesis of CDR 
in events happening before and after (defective) closure of the diaphragm. In this study 
we investigated early puhnonary development in an in vitro modification of the Nitrofen 
model 4-6 days before normal closure of the diaphragm (day 17 of gestation) takes place 
in the rat fetus (Kluth et a!., 1996). We studied the direct effects of Nitrofen on lung 
formation, branching morphogenesis and epithelial cell differentiation in our organ 
culture system. 
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Figure 5 
Following a culture period of 4 days, proliferation (A-C) and apoptosis (D-F) were investigated. 
Immunolocalization of PCNA indicates proliferating cells. Strong PCNA immunoreactivity was 
observed in the epithe1iallining of the terminal buds of the control and DMSO explants, and also, 
but lower in the mesenchyme (A, B). Surprisingly immunoreactivity was not observed in the 
mesenchyme and only perinuclear in the explants exposed to Nitrofen (C). Apoptosis in the 
explants was assessed using TUNEL assay. TUNEL positive cells were observed in all explants 
in the mesenchyme only, and the number of TUNEL positive cells appeared similar in all 
explants (D-F). All nuclei were stained using DAPI mounting solution (G-I). All pictures are 
representative of a series of experiments. (All images at same magnification) 
We report here that Nitrofen exposure both in vitro and in vivo reduces branching 
morphogenesis before the time that closure of the diaphragm would normally occur in the 
rat (day 17 of gestation). Only the later phases of branching morphogenesis (i.e. 
dichotomous branching) are affected, since initial lung bud outgrowth (i.e. primary 
monopodial branching) and subsequent formation of the lobar bronchi (i.e. secondary 
branching) were not affected in the Nitrofen -treated explants. The timing and degree of 
interference with branching morphogenesis by Nitrofen are in accordance with case 
reports of CDR in which the number of airway generations were assessed by the group of 
Lynne Reid (Areechon and Reid, 1963; Kitagawa et aI., 1971). Both studies report a 
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reduction in airway generations to about half the normal number. Because development of 
the bronchial tree is normally complete by the 16m week of intrauterine life, timing ofthe 
insult in affected human babies should be early in gestation. 
Although in vivo exposure to Nitrofen at TITSt did not result in a statistically 
significant reduction in the number of branches, the statistical significance was observed 
when the lower 75% of the lungs with reduced branching were considered from among all 
lungs evaluated. In a previous study, we have shown that in our hands administration of 
Nitrofen results in a success rate of up to 80% diaphragmatic defects (Ijsselstijn et aI., 
1997). Therefore, the lower 75% of the lungs with reduced branching might correspond to 
the most severe cases of pulmonary hypoplasia. All these data indicate that Nitrofen has a 
direct effect on branching morphogenesis and Nitrofen treatment might thus result in 
hypoplastic lungs before a diaphragmatic hemia occurs during development. This implies 
that in case of Nitrofen-induced CDH, the existing hypoplastic lungs might even induce 
the diaphragmatic defect, which has been suggested before by Iritani (Iritani, 1984) and 
by Cilley et of. (Cilley et aI., 1997) However, results of the study ofIritani were based on 
experiments performed in the presence of Nitrofen during a period from day 5 of 
gestation until the day of sacrifice. In addition, both studies were done in mice, and the 
effects of Nitrofen were investigated in an in vivo situation, where influences of aberrant 
diaphragm development cannot be ruled out. To our knowledge, our study is the first to 
investigate the effects of Nitrofen on lung branching in vitro and after a limited period of 
exposure to Nitrofen, which is similar to the exposure of Nitrofen in the well established 
in vivo animal model. 
In addition to the effects of Nitrofen on branching morphogenesis, the epithelial 
cell differentiation was also disturbed. Again, the effects of Nitrofen exposure in vitro 
were more severe than exposure in vivo, in that SP-C mRNA expression was not observed 
in the explants exposed to Nitrofen in vitro after 4 days, but only after 6 days of culture. 
In the Nitrofen-treated explants no CC-1O mRNA expression could be observed. Thus, in 
vitro treatment specifically resulted in a delay of epithelial cell differentiation. Whereas, 
apoptotic processes did not change, when evaluated by the number and localization of 
TUNEL positive cells, PCNA immunoreactivity was clearly reduced in the mesenchymal 
component of the Nitrofen-treated explants. In addition, PCNA reactivity was only 
observed perinuclear and in the cytoplasm of epithelial cells of the explants exposed to 
Nitrofen. This unexpected result clearly indicated that proliferation is disturbed in 
explants exposed to Nitrofen. Consequently, a disturbed interplay between cell 
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proliferation and apoptosis may be contributing to the observed hypoplasia in the lung 
explants exposed to Nitrofen. 
Taken together, these data suggest that the primary defect in Nitrofen-induced 
CDR is located in the lungs and that the lungs are already hypoplastic before the 
formation of a diaphragmatic defect in the rat model. Our results corroborate with those of 
Cilley et al. (Cilley et aI., 1997), who demonstrated in their murine model that Nitrofen-
induced puhnonary hypoplasia exists with or without diaphragmatic hernia. The 
asymmetry of both puhnonary hypoplasia and the diaphragmatic defect can be explained 
by the fact that there is a difference in timing of closure of the diaphragms. The right 
diaphragm closes a little earlier than the left (Moore, 1988). It might well be that timing 
of the insult resulting in hypoplastic lungs and a diaphragmatic defect is crucial and 
consequently that it occurs more often on the left than on the right side. Strangely, 
administration of Nitrofen later during gestation results in a higher percentage of 
diaphragmatic defects occurring on the right side (Kluth et aI., 1990; Tenbrinck et aI., 
1990). In addition, the right lung is much bigger and consists of more lobes (4 in the rat 
and 3 in the human) than the left lung (1 in the rat and 2 in the human). This might result 
in a right lung providing a more sufficient basis for communication between the lungs and 
the diaphragm when the lungs grow into the pleuroperitoneal canal, which is disturbed in 
CDR as suggested by Iritani (Iritani, 1984). Another possibility is that CDR should be 
considered as the result of a shared or a separate mechanism that affects, for instance, the 
mesenchyme of the lungs and diaphragm in a similar way. Although these problems are 
not clarified yet, it is clear that the occurrence of a diaphragmatic defect and pulmonary 
hypoplasia requires a sensitive and crucial interplay between several factors not yet 
identified. 
Besides isolated or familial case reports describing chromosomal aberrations, until 
now a genetic origin or an etiological-environmental factor for CDR has been lacking 
(Bos et aI., 1994). Therefore, the pathogenesis of puhnonary hypoplasia in the Nitrofen 
model of CDR should be extrapolated to the human situation with a fair amount of 
reserve. We postulate that the crucial event resulting in human CDR takes place during 
early branching morphogenesis in a susceptible genetic environment. There have been 
reports of families with a higher incidence of CDR, suggesting that a genetic defect is in 
part responsible for the etiology of the CDR cases (Enns et aI., 1998; Tibboel and Gaag, 
1996). Therefore, more research efforts to unravel the genetic defects in this anomaly are 
justified and will lead to a better understanding of the pathogenesis of CDR. 
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Finally, we would like to postulate a new hypothesis describing the pathogenesis of 
puhnonary hypoplasia in case of CDH: the dual-hit hypothesis. In this hypothesis the 
pathogenesis of puhnonary hypoplasia in case of diaphragmatic hernia is explained by two 
developmental insults. The first insult occurs early on in development, before diaphragm 
development, given a still unidentified background of genetic and environmental factors. 
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Figure 6 The Dual-hit hypothesis: pulmonary hypoplasia in case of CDH is explained by two 
developmental insults. The first hit affects both lungs prior to and separate from diaphragm 
development in a background (unidentified until now) of genetic and environmental factors. The 
second hit affects ouly the ipsilateral lung after defective development of the diaphragm because 
of interference of the herniated abdominal organs with fetal breathing movements of this lung. 
This insult affects both lungs during branching morphogenesis in a similar fashion. After 
defective development of the diaphragm, the second insult affects the ipsilateral lung only 
at a later stage of development. In this scenario herniated abdominal organs will interfere 
with fetal breathing movements of the ipsilateral lung resulting in greater impairment of the 
development of the ipsilateral lung than of the contralateral lung (see Figure 6). 
In our view, this hypothesis best describes the pathogenesis of puhnonary hypoplasia 
in case of CDH based on current available data, which were obtained mainly from studies 
in the Nitrofen model. However, more research will be necessary both in humans and in 
the Nitrofen model to solve the chicken-or-egg question that is still associated with this 
anomaly. In conclusion, in the Nitrofen model of CDH, puhnonary hypoplasia precedes 
the diaphragmatic defect and rnight even be the cause of the diaphragmatic defect, instead 
of the result. This insight in the pathogenesis of puhnonary hypoplasia in case of CDH 
leads to a different perspective on the hypoplastic lungs that are characteristic of this 
anomaly. 
205 
Chapter 7 
References 
Allan, D. W. and Greer, J. J. (1997). Pathogenesis of nitro fen-induced congenital diaphragmatic hernia 
in fetal rats. J Appl Physiol83, 338-47. 
Areechon, W. and Reid, L. (1963). Hypoplasia oflung with congenital diaphragmatic hernia. Br MedJI, 
230-3. 
Bos, A. P., Pattenier, A. M., Grobbee, R. E., Lindhout, D., Tibboel, D. and Molenaar, J. C. (1994). 
Etiological aspects of congenital diaphragmatic hernia: results of a case comparison study. Hum Genet 94, 
445-6. 
Cilley, R. E., Zgleszewski, S. E., Krummel, T. M. and Chinoy, M. R. (1997). Nitrofen dose-dependent 
gestational day-specific murine lung hypoplasia and left-sided diaphragmatic hernia. Am J Physiol 272, 
L362-71. 
Costlow, R. D. and Manson, J. M. (1983). Distribution and metabolism of the teratogen nitrofen (2,4-
dichloro-4'- nitro diphenyl ether) in pregnant rats. Toxicology 26, 11-23. 
Enns, G. M., Cox, V. A., Goldstein, R. B., Gibbs, D. L., Harrison, M. R. and Golabi, M. (1998). 
Congenital diaphragmatic defects and associated syndromes, malformations, and chromosome anomalies: 
a retrospective study of60 patients and literature review. Am J Med Genet 79,215-25. 
Gavrieli, Y., Sherman, Y. and Ben-Sasson, S. A. (1992). Identification of programmed cell death in situ 
via specific labeling of nuclear DNA fragmentation. J Cell BioI 119. 493-501. 
Harrison, M. R., Adzick, N. S., Nakayama, D. K. and deLorimier, A. A. (1986). Fetal diaphragmatic 
hernia: pathophysiology, natural history, and outcome. Clin Obstet Gynecol29, 490-501. 
Hochberg, Y. and Tamhane, A. C. (1987). Multiple comparison procedures. New York: John Wiley & 
Sons. 
Ijsselstijn, H., Pacheco, B. A., Albert, A., Sluiter, W., Donahoe, P. K., De Jongstt\, J. C., Schnitzer, J. 
J. and Tibboel, D. (1997). Prenatal hormones alter antioxidant enzymes and lung histology in rats with 
congenital diaphragmatic hernia. Am J PhysioI272, LI059-65. 
lritani, I. (1984). Experimental study on embryogenesis of congenital diaphragmatic hernia. Anat 
Embryol (BerO 169, 133-9. 
Katz, A. L., Wiswell, T. E. and Baumgart, S. (1998). Contemporary controversies in the management of 
congenital diaphragmatic hernia. Clin Perinatol25, 219-48. 
Kitagawa, M., Hislop, A., Boyden, E. A. and Reid, L. (1971). Lung hypoplasia in congenital 
diaphragmatic hernia. A quantitative study of airway, artery, and alveolar development. Br J Surg 58, 342-
6. 
206 
Dual-hit hypothesis explains pulmonary hypoplasia in the !\itrofen model of congenital diaphragmatic hernia 
Kluth, D., Kangah, R., Reich, P., Tenhrinck, R., Tibboel, D. and Lambrecht, W. (1990). Nitrofen-
induced diaphragmatic hernias in rats: an animal model. J Pediatr Surg 25, 850-4. 
Kluth, D., Keijzer, R., Hertl, M. and Tibboel, D. (1996). Embryology of congenital diaphragmatic 
hernia. Semin Pediatr Surg 5, 224-33. 
Manson, J. M. (1986). Mechanism of nitro fen teratogenesis. Environ Health Perspect 70, 137-47. 
Moore, K. L. (1988). Development of body cavities, primitive mesenteries, and the diaphragm. In The 
Developing Human; Clinically Oriented Embryology, (ed. M. Wonsiewicz), pp. 159-169. Philadelphia: 
W.B. Saunders Company. 
Reickert, C. A., HirschI, R. B., Atkinson, J. B., Dudell, G., Georgeson, K., Glick, P., Greenspan, J., 
Kays, D., Klein, M., Lally, K. P. et al. (1998). Congenital diaphragmatic hernia survival and use of 
extracoIporeallife support at selected level III nurseries with multimodality support. Surgery 123, 305-10. 
Souza, P., Sedlackova, L., Kuliszewski, M., Wang, J., Liu, J., Tseu, I., Liu, M., Tanswell, A. K. and 
Post, M. (1994). Antisense oligodeoxynucleotides targeting PDGF-B mRNA inhibit cell proliferation 
during embryonic rat lung development. Development 120, 2163-73. 
Takasaki, Y., Deng, J. S. and Tan, E. M. (1981). A nuclear antigen associated with cell proliferation and 
blast transfonnation. J Exp Med 154, 1899-909. 
Tenbrinck, R., Tibboel, D.,. Gaillard, J. L., Kluth, D., Bos, A. P., Lachmann, B. and Molenaar, J. C. 
(1990). Experimentally induced congenital diaphragmatic hernia in rats. J Pediatr Surg 25, 426-9. 
Thebaud, B., Mercier, J. C. and Dinh-Xuan, A. T. (1998). Congenital diaphragmatic hernia. A cause of 
persistent pulmonary hypertension of the newborn which lacks an effective therapy. BioI Neonate 74, 323-
36. 
TibboeI, D. and Gaag, A. V. (1996). Etiologic and genetic factors in congenital diaphragmatic hernia. 
Clin Pennatol23, 689-99. 
Torfs, C. P.,. Curry, C. J., Bateson, T. F. and Honore, L. H. (1992). A population-based study of 
congenital diaphragmatic hernia. Teratology 46, 555-65. 
Wung, J. T., Sahni, R..,. Moffitt, S. T., Lipsitz, E. and Stolar, C. J. (1995). Congenital diaphragmatic 
hernia: survival treated with very delayed surgery, spontaneous respiration, and no chest tube. J Pediatr 
Surg 30, 406-9. 
207 

Chapter 8 
Steroid hormone receptor superfamily expression is not altered in 
pulmonary hypoplasia in case of Nitrofen-induced 
congenital diaphragmatic hernia in rats. 
Based on: 
Keijzer, R., Blommaart, P.J.E., Lamers, W.H., and Tibboel, D. Steroid honnone receptor 
superfamily expression is not altered in puhnonary hypoplasia in case of Nitro fen-induced 
congenital diaphragmatic hernia in rats. (submitted) 
Chapter 8 
8.1 Abstract 
Antenatal administration of glucocorticoids will soon be evaluated in a multicenter 
clinical trial as a new treatment modality for pulmonary hypoplasia associated with 
congenital diaphragmatic hernia (CDH). However, not much information is available 
about the sensitivity of hypoplastic lungs for glucocorticosteroids. We and others have 
suggested that changes in thyroid hormone metabolism are involved in the pathogenesis 
of Nitrofen-induced CDH associated with pulmonary hypoplasia. Hence, the aim of this 
study was to determine the expression patterns of the relevant nuclear receptors, that is, 
the glucocorticoid receptor (GR), the TRs (TR) alpha and beta, and their preferred 
partners of dimerization, the retinoid-X receptor (RXR) alpha and beta in normal and 
Nitrofen-induced hypoplastic lungs by in situ hybridization. TR alpha was specifically 
expressed in the developing mesenchyme and TR beta in the developing epithelium. A 
comparable expression pattern was observed for both the RXRs, whereas the GR was 
ubiquitously expressed in both germ layers. No differences in timing or localization were 
observed between normal and hypoplastic lungs. Consequently, clinical trials using 
antenatal hormonal modulation of pulmonary growth are justified in the light of steroid 
hormone receptor expression patterns in the hypoplastic lung. In addition, modulation of 
timing of steroid drugs in prenatally diagnosed CDH is not warranted based on the 
expression pattern of the steroid hormone receptors in the developing lung. 
8.2 Introduction 
During the past decades congenital diaphragmatic hernia (CDH) and its underlying 
pathology, pulmonary hypoplasia and persistent pulmonary hypertension, have been 
investigated with great effort in order to acquire new treatment modalities for this 
anomaly (Beresford and Shaw, 2000; Desfrere et aI., 2000; IJsselstijn and Tibboel, 1998; 
Kays et al., 1999). Although a number of recent publications suggest significant changes 
in survival rate, a great variety in survival rate is still reported. One of the reasons for this 
lack of progress may well be that the pathogenesis of CDH is still not completely 
understood (Katz et aI., 1998; Skari et aI., 2000). Recently, two new strategies have been 
put forward to supplement the already broad spectrum of sophisticated treatment 
modalities, which include extracorporeal membrane oxygenation (ECMO) and fetal 
surgery. The first is prenatal fetoscopic modulation of pulmonary growth by tracheal 
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clipping. This approach can only be used in selected cases and is nowadays subject to an 
NIH sponsored trial (Harrison et aI., 1998). The second is prenatal hormonal modulation 
of pulmonary growth using preferentially glucocorticoids (Keijzer et aI., 2000). The first 
strategy can only be implemented in specialized centers and, moreover, has not proven to 
be superior to conventional treatment modalities in cases without liver up (Harrison et al., 
1998). In contrast, the second strategy was adapted from a widely and successfully used 
therapy for the treatment of Respiratory Distress Syndrome (RDS) in Pediatrics and 
Obstetrics [for review see (Crowley, 2000)]. In case of inuninent premature delivery the 
mother is treated with glucocorticoids, which dramatically reduces the risk of RDS. More 
recently, a debate has started about the risks and benefits of repeated dosages and the long 
term effects on neurodevelopmental outcome (Matthews, 2000; Smith et al., 2000). We 
and others have demonstrated beneficial effects of prenatal administration of 
glucocorticoids (with or without thyrotropin-releasing hormone) on pulmonary 
development in both the 2,4-dichlorophenyl-p-nitrophenyl ether (Nitrofen) rat model and 
the surgical sheep model for CDH (Hedrick et al., 1997; IJsselstijn et aI., 1997; Losty et 
aI., 1996; Losty et al., 1995; Schnitzer et al., 1996; Suen et aI., 1994a; Suen et al., 1994b). 
Based on these observations, an international multicenter clinical trial is forthcoming to 
evaluate the effects of antenatal corticosteroids on CDH-associated pulmonary hypoplasia in 
humans. However, up till now nO published data are available on the ontogeny of the 
sensitivity to hormonal modulation in developing (hypoplastic) lungs. Since 
corticosteroids exert their effects via specific nuclear receptors [for review see (Evans, 
1988)], a study of the spatio-temporal distribution of these receptors in (hypoplastic) 
lungs was warranted. 
In addition to this, we investigated a hypothetical explanation for the teratological 
effects of Nitrofen on pulmonary and diaphragm development. Nitrofen is widely used in 
a rodent model for CDH, in which administration of Nitro fen to a pregnant dam results in 
a high incidence ofCDH in the progeny (Kluth et aI., 1990; Tenbrinck et aI., 1990). Since 
the original toxicological studies, the connection between Nitrofen and thyroid hormones 
has been made. First, the chemical structure of Nitrofen resembles that of thyroid 
hormones. Second, when thyroid hormones are administered in addition to the exposure 
to Nitrofen, the percentage of anomalies in the litter decreases (Manson et aI., 1984). 
Recently, our group showed that the same holds true for vitamin A and Nitrofen, because 
antenatal treatment with vitamin A significantly reduces the incidence and severity of 
CDH and pulmonary hypoplasia (Thebaud et aI., 1999). In addition to this, we showed 
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before that Nitrofen decreases binding of thyroid hormone to the alpha 1 and beta 1 form 
of the thyroid hormone receptor (TR) in a non-competitive way (Brandsma et al., 1994). 
Therefore, the purpose of this study was to investigate the mRNA expression pattern of 
the TR alpha and beta in normally developed lungs and compare this to the distribution of 
these receptors in hypoplastic lungs in case of Nitro fen-induced CDR. Others have shown 
that upon binding of thyroid hormone to the TR, this hormone/receptor complex binds to 
DNA as dimers composed of two different TRs or in combination with other receptors of 
the steroid hormone receptor superfamily, preferentially the 9-cis retinoic-acid receptors 
(RXRs) (Rosen et al., 1993; Wahlstrom et al., 1992; Yen et al., 1992). Therefore, the 
expression patterns of the RXR alpha and beta were included in our studies. 
We demonstrate a specific heterogeneous spatio-temporal mRNA expression pattem 
for the TRs alpha and beta, the RXRs alpha and beta and the glucocorticoid receptor (GR). 
TR alpha mRNA was observed in developing pulmonary mesenchyme, whereas TR beta 
mRNA was observed in developing pulmonary epithelium. A comparable distribution was 
observed for the RXR alpha mRNA and beta mRNA, respectively, but for the RXR beta 
mRNA expression was also observed in the mesenchymal part of the lung. Finally, GR 
mRNA expression was ubiquitously observed in the lung, but was pronounced in the 
developing pulmonary epithelium. When we investigated expression of these receptor 
mRNAs in (hypoplastic) lungs of fetuses exposed to Nitrofen, we did not observe any 
changes in either localization or timing of expression of these mRNAs, indicating that 
Nitrofen-induced CDR is not resulting from a change in the expression neither in time or 
tissue localization of the investigated receptors. In addition, investigating prenatal honnonal 
modulation with glucocorticoids of hypoplastic lungs in CDR is justified. 
83 Materials and methods 
Animals 
Adult Wistar rats were obtained from the RSD animal fann in Zeist, The Netherlands. The 
animals were kept in a controlled light/dark cycle and food and water were supplied ad 
libitum. Rats were mated at the end of the morning. The day of finding a spenn-positive 
vaginal smear was designated day 1 of gestation. Fetuses were delivered by Caesarian 
section at 15, 18, and 20 days of gestation. To induce congeuital diaphragmatic hernia and 
pulmonary hypoplasia, 100 mg of 2,4-dich!oro-phenyl-p-uitrophenylether (Nitrofen) 
dissolved in 1 rul olive oil, was administered to the mother rats by gavage on day 10 of 
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gestation (Kluth et al., 1990; Tenbrinck et al., 1990). This regime is known to result in 60 to 
90 % diaphragmatic hernias and 100 % pulmonary hypoplasia in the offspring. 
Tissue isolation and preparation 
Fetuses of 15 (pseudoglandular stage oflung development) and 18 (canalicular stage oflung 
development) days of gestation were fixed in toto. Fetuses of 20 days of gestation (saccular 
stage of lung development) were decapitated. After removal of limbs and pelvis, their skin 
was removed and their body cavities were opened for optimal penetration of the fixative. All 
tissues were fixed in 4% phosphate-buffered formaldehyde (wt/vol) at 4°C for 16-18 hours, 
dehydrated in a graded series of ethanol, cleared with iso-butanol and embedded in Paraplast 
Plus (Monoject, Kildare, Ireland). 7 I'm serial frontal sections were cut, and mounted onto 
RNAse-free 3-arninopropyltriethoxysilane (Sigma A3648) coated slides. From the group 
treated with Nitrofen, only fetuses with a diaphragmatic hernia were selected and included in 
this study. 
Specification and preparation oj RNA probes 
GR eDNA (2.4 kb) was isolated from rat liver and recloned in pBluescript SK + in the 
BamBI restriction site of the multiple cloning site (kind gift of Dr. Paul Godowski). The 
antisense probe was generated with T3 RNA polymerase after linearization with PstL As 
probes for the TR alpha and beta mRNA detection, EcoRl-HindIll eDNA fragments of the 
clones rc-erbA-a (nucleotide -29 to nucleotide +1821) and rc-erbA-J3 (nucleotide -37 to 
nucleotide +2165) were used, respectively. The fragments contain the coding region of the 
gene and recognize both the TR alphal and TR alpha2 and TR betal and TR beta2 isoforms. 
Both eDNA fragments were obtained from H.c. Towle (Bradley et al., 1992; Murray et aI., 
1988). The [a-35SjUTP labeled anti-sense probes for both TR alpha and beta were generated 
with Sp6 RNA polymerase, after linearization of the plasrnids with HindIll. RXR alpha and 
RXR beta mRNAs were detected using an EcoRl-EcoRl eDNA fragment (1850 bp) and a 
EcoRl-HindIll cDNA fragment (1360 bp), respectively, containing the coding sequences 
obtained by anchored PCR from a total eDNA library of mouse embryos of II and 14 days 
of gestation (Leid et aI., 1992). The RXR alpha eDNA fragment was subcloned from the 
expression vector pSG5 into the EcoRl site of pBluescript SK + and the RXR beta cDNA 
fragment from the expression vector pTLI into EcoRl and HindIll sites ofpBluescript SK+. 
The [a-35SjdUTP labeled anti-sense probes of RXR alpha and RXR beta were generated 
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with T7 RNA polymerase after linearization of the plasmids with Pst! and EcoRI, 
respectively. 
All plasmids were linearized by enzyme digestion using enzymes of GibcofBRL (Life 
Tecbnologies B.V., The Netherlands). Radioactively labeled RNA-transcripts were obtained 
using either T3, T7 (GibcofBRL, Life Tecbnologies, The Netherlands) or Sp6 CRT 
Biotecbnology ltd., Cambridge, England) RNA polymerases in the presence of 50 flCi [0.-
35S]UTP (Arnersham, United Kingdom). After degradation of the full-length transcripts by 
alkaline hydrolysis, the fragments were purified by phenol-chloroform extraction and 
ethanol precipitation. 
In situ hybridizalion 
In situ hybridization was carried out as described (Moorman et al., 2000). In short, after 
deparaffination in xylene and rehydration in a graded series of ethanol, sections were treated 
with 0.2 M HCI for 20 minutes at room temperature (RT). Subsequently, the sections were 
washed in bidistilled water and incubated in 2x standard saline citrate (SSC; Ix SSC 
contains 0.15 M NaCI and oms M Na citrate, pH 7.2) for 10 minutes at 70°C. This step 
improves pepsin digestion, unfolding of the target RNA, and RNA accessibility in the tissues 
in the next steps. The proteins in the sections of rat fetuses were digested with pepsin (Sigma 
P7000); 0.1 % (wtlvol) in om M HCI for 7 minutes (15 days of gestation), for 10 minutes 
(18 days of gestation) and for IS minutes (20 days of gestation) at 37°C. Digestion was 
stopped with 0.2% (voVvol) glycine in phosphate-buffered saline (PBS), 30 seconds at RT. 
The sections were postfixed in 4% phosphate-buffered formaldehyde (wtlvol) for 20 minutes 
at RT, treated with 10 mM EDTA for 5 minutes at RT to dissociate the ribosomes from the 
RNA and incubated in 10 mM dithiothreitol (DTT) for 5 minutes at 4°C to reduce the tissue 
and therefore lower the background. Subsequently, the sections were air-dried and 
hybridized with the [35S]-labeled anti-sense RNA probes for 16-18 hours at 54'C in a 
mixture containing 50% (voVvol) deionized formamide, 10% (wtlvol) dextran sulphate, 2x 
SSC, 2x Denhardt's, 0.1% (voVvol) Triton X-100, 10 mM DTT and 200 ng.flrl herring 
sperm DNA. The probe concentrations were approximately 50 pg.flrl hybridization mixture 
and 6-12 fll of hybridization mixture was applied per section. The specific activity of the 
anti-sense RNA probe was approximately 500 dpm.pg-I. After hybridization the sections 
were washed and treated with RNAse A (10 flg/ml in 10 mM Tris-HCl (PH 8.0), 5 mM 
EDT A and 500 mM NaCl) for 30 minutes at 37°C to reduce nonspecific binding. The 
sections were dehydrated in a graded series of ethanol containing 0.3 M ammonium acetate 
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and air-dried. Subsequently, the sections were exposed to photographic emulsion (llford 
Nuclear Research Emulsion G-5). After developing, the sections were counterstained with 
nuclear fast red, dehydrated in a graded series of ethanol and xylol and mounted in Malinol 
(Chroma-Gesellschaft, Schmidt Gmbh+Co, Kongen, Germany). 
8.4 Results 
Expression of glucocorticoid receptor mRNA during normal pnlrnonary development 
The lung primordium, an outgrowth of foregut endoderm, appears in rat embryos at 10 to 11 
days of gestation. Subsequently, the primordium develops into two lung buds. During the 
next two days, dichotomous branching forms conducting airways, while the puhnonary 
epithelium is growing into a conspicuous mass of mesenchyme. In control rats, expression 
of GR mRNA was flIst observed in the endodermal part of the developing conducting 
airways at 15 days of gestation (Figure IA). From 18 days of gestation, GR mRNA 
expression was observed more ubiquitously in both epithelium and mesenchyme, albeit 
more pronounced in the epithelium (Figure 2A). A similar, but more faint distribution was 
observed at 20 days of gestation (Figure 3A). 
E:'1}ression of retinoid-X receptor alpha and retinoid-X receptor beta mRNAs during 
normal pnlrnonary development 
At IS days of gestation, mRNA expression of both RXRs was observed in both 
mesenchyme and epithelium. However, RXR alpha mRNA expression was more 
pronounced in the mesenchyme (Figure I C), whereas RXR beta mRNA expression was 
more pronounced in the epithelium (Figure IE). Three days later in gestation, RXR alpha 
mRNA was observed predominantly in the mesenchyme (Figure 2C) and RXR beta mRNA 
in the epithelium (Figure 2E). At 20 days of gestation, distinguishing between mesenchymal 
and epithelial distribution of RXR mRNAs was more difficult, because of thinning of 
mesenchymal tissue. However, both RXR mRNAs appeared to be distributed over both 
germlayers, but again, RXR alpha was more pronounced in the mesenchyme (Figure 3C), 
and RXR beta in the epithelium (Figure 3E). 
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Control Nitrofen 
GCR 
RXRa 
RXR~ 
THRa 
THR~ 
Figure 1 Steroid honnone receptor expression in normal and Nitrofen-induced hypoplastic 
lungs at 15 days of gestation. GR (A,B), RXR alpha (C,D), RXR beta (E,F), TR alpha (G,H) and TR 
beta (I,J) expression in nonnal (A,C,E,G,I) and hypoplastic (B,D,F,H,J) lungs at 15 days of 
gestation. GR mRNA is observed in the endodenn lining the branching airways (A,B). RXR alpha 
mRNA (C,D) and RXR beta mRNA (E,F) were observed in both genn layers, but the fonner was 
more pronounced in the mesenchyme, whereas the latter was more pronounced in the epithelium. 
TR alpha mRNA (G,H) was exclusively expressed in the mesenchyme. In contrast, TR beta mRNA 
(I,J) was exclusively expressed in the epithelium. No differences in steroid honnone receptor 
expression were observed between normal and hypoplastic lungs. All pictures are representative of a 
series of experiments and were taken at the same magnification. 
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Control Nitrofen 
GCR 
RXRa 
RXR~ 
THRa 
THR~ 
Figure 2 Steroid honnone receptor expression in nonnal and Nitrofen-induced hypoplastic 
lungs at 18 days of gestation. GR (AB), RXR alpha (C,D), RXR beta (E,F), TR alpha (G,H) and TR 
beta (I,J) expression in nonnal (AC,E,G,I) and hypoplastic (B,D,F,H,J) lungs at 18 days of 
gestation. At this stage, GR mRNA was faintly expressed in the entire lung (A,B). RXR alpha 
mRNA expression (CD) appeared higher in the mesenchyme, whereas RXR beta mRNA (E,F) was 
predominantly observed in the epithelium. Again, TR alpha mRNA (G,H) was exclusively 
expressed in the mesenchyme at this stage. In contrast, TR beta mRNA (I,J) was exclusively 
expressed in the epithelium. No differences in steroid honnone receptor expression were observed 
between nonnal and hypoplastic lungs. All pictures are representative of a series of experiments and 
were taken at the same magnification. 
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Expression of TR alpha and TR beta mRNAs during normal pulmonary develop men t 
From 15 to 18 days of gestation, during the canalicular stage of pulmonary development, 
expression of TR beta mRNA became detectable, predominantly in the pulmonary 
epithelium of the distal conducting airways (Figures II & 21). Expression of TR alpha 
mRNA was confined to the pulmonary mesenchyme surrounding the conducting airways 
(Figures I G & 2G). At 20 days of gestation the prominence of the interstitial tissue is 
decreased (Figure 3). At this time-point expression of TR beta mRNA was more difficult 
to observe in the pulmonary epithelium (Figure 31), whereas expression of the TR alpha 
mRNA remained present in the developing pulmonary mesenchyme (Figure 3G). An 
accurate description of the expression patterns became more difficult near tenn because 
the walls of the airways become very thin due to expansion of the gas-exchange surface. 
Expression of TR beta mRNA was observed at all time points in pulmonary arteries 
(Figures II, 21 & 31), while expression ofTR alpha mRNA was continuously observed in 
pulmonary veins (Figures IG, 2G & 3G). 
Expression of thyroid hormone receptor alpha, thyroid hormone receptor beta, 
retinoid-X receptor alpha, retinoid-X receptor beta and glncocorticoid receptor 
mRNAs during abnormal pulmonary development in case of congenital diaphragmatic 
hernia 
In approximately 60-90% of the fetuses a left-sided diaphragmatic hernia with pulmonary 
hypoplasia and herniated abdominal organs (in particular the liver) developed upon 
treatment of the darns with Nitrofen at day 10 of pregnancy. For all investigated receptors, 
an expression pattern comparable to that observed in nonnally developed lungs was 
observed (Figures lB, D, F, H, J; Figures 2B, D, F, H, J and Figures 3B, D, F, H, J). Both 
timing of expression and localization of the mRNAs were similar in the nonnal and 
hypoplastic lungs. In addition, nO differences were observed in expression patterns of the 
receptors between the ipsilateral and contralateral lung in case of congenital diaphragmatic 
hernia. 
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Control Nitrofen 
OCR 
RXRa 
RXRJ3 
THRa 
THRJ3 
Figure 3 Steroid hormone receptor expression in normal and Nitrofen-induced hypoplastic 
lungs at 20 days of gestation. GR (A,B), RXR alpha (C,D), RXR beta (E,F), TR alpha (G,H) and TR 
beta (I,J) expression in nonnal (A,C,E,G,I) and hypoplastic (B,D,F,H,J) lungs at 20 days of 
gestation. Because of thinning of mesenchymal tissue, differences between expression in the 
mesenchyme and epithelium were more difficult to distinguish at this stage. GR rnRNA was faintly 
expressed in the entire lung (A,B). RXR alpha mRNA expression (C,D) and RXR beta mRNA (E,F) 
were appeared more evenly distributed at this stage. Again, TR alpha mRNA (G,H) was exclusively 
expressed in the mesenchyme at this stage. In contrast, TR beta mRNA (I,J) was exclusively 
expressed in the epithelium. No differences in steroid hormone receptor expression were observed 
between normal and hypoplastic lungs. All pictures are representative of a series of experiments and 
were taken at the same magnification. 
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8.5 Discussiou 
A multicenter clinical trial incorporating 300 prenatally diagnosed CDR-fetuses to evaluate 
the therapeutical benefits of antenatal hormonal modulation on pulmonary growth in case of 
CDR-associated hypoplastic lungs is underway. The study was inspired by the promising 
results obtained with prenatal glucocorticoids in both the Nitrofen rat and surgical sheep 
model for CDR. Rowever, the presence of the GR in hypoplastic lungs has never been 
shown despite speculations about it. 
In this study, we demonstrate that the GR is indeed expressed in a similar fashion in 
Nitrofen-induced hypoplastic lungs as in normally developed lungs. This finding justifies the 
start of a multicenter trial to evaluate the beneficial effects of prenatal glucocorticoids on 
pulmonary growth. Awaiting the results of the trial we speculate that this form of antenatal 
lung "surgery" may offer a good contribution to the array of treatment modalities for this 
poorly treatable anomaly. 
Since the first teratological studies with Nitrofen, a relation between Nitrofen and 
thyroid hormone metabolism has been suggested (Manson et aI., 1984). In order to gain 
more insight in the pathogenesis of the Nitrofen model for CDR, we performed in situ 
hybridization studies to localize transcripts of the TRs. TRs belong to the steroid hormone 
receptor superfamily and bind preferably to DNA as dimers composed of two different TRs 
or in combination with other receptors of the superfamily, the 9-cis retinoic-acid receptors 
(RXRs) (Rosen et aI., 1993; Wahlstrom et aI., 1992; Yen et aI., 1992). Interestingly, a link 
between vitamin A and CDR has been made as early as 1953 when Wilson et aL reported a 
high incidence of CDR in offspring from rats on a vitamin A-deficient diet (Wilson et aI., 
1953). Recently, vitamin A was again related to CDR in a report from Thebaud et aI. Their 
studies showed that antenatal treatment with vitamin A has a positive effect on the incidence 
and severity of CDR in the Nitrofen rat model (Thebaud et aI., 1999). 
In this manuscript, we report specific heterogeneous spatio-temporal expression 
patterns for both the TR alpha and beta and the RXR alpha and beta. The TR alpha is 
expressed in the mesenchyme throughout development of the lung and the TR beta is 
expressed in the epithelium during the late pseudo glandular and canalicular phase of lung 
development. The expression patterns were not changed in hypoplastic lungs of fetuses 
with Nitrofen-induced CDR. This clearly indicates that induction of pulmonary 
hypoplasia in Nitrofen-induced CDR is not the result of an alteration in expression of the 
investigated receptors. This is in contrast to a study from Causak et aI., who reported 
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reduced expression of a part of the TR gene, which was found by differential display 
(Causak et aI., 1998). Another report by Tovar et al. showed decreased plasma T3 and T4 
levels without changes in thyroid stimulating hormone (TSH). However, the levels ofT3, 
T4 and TSH were not changed in tissues (Tovar et aI., 1997). Hence, the conclusion of 
their study was that Nitrofen-induced pulmonary hypoplasia is not related to a decrease in 
tissue thyroid hormone levels. Since we found no changes in TR expression, our study 
complements these results. 
An explanation for this could be that redundant factors mask the interference of 
Nitrofen with thyroid hormone metabolism. The TRs belong to the steroidJTR superfamily 
of ligand-dependent transcription factors, which share highly conserved DNA-binding 
domains (Evans, 1988). It is therefore possible that one receptor of the superfamily replaces 
another receptor of which the function is hampered by for instance Nitrofen. This would 
explain the normal tissue levels of thyroid hormone and unaltered TR expression in 
Nitrofen-induced hypoplastic lungs. 
Taken together, our data suggest that hypoplastic lungs are as sensitive to 
corticosteroids as normally developed lungs as for the expression of the glucocorticoid 
receptor is concerned. This observation justifies the initiated multicenter clinical trial in 
which the effects of prenatal hormonal modulation of pulmonary growth in CDH are 
evaluated. Furthermore, we demonstrate that an alteration of TR expression is not causing 
pulmonary hypoplasia in case of Nitro fen-induced congenital diaphragmatic hernia. 
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9.1 Introduction 
The description of the DNA double helix structure by Watson and Crick in the fifties 
(Watson and Crick. 1953) began the era of molecular biology. Since the seventies when it 
became possible to manipulate pieces of DNA and study animal models for human 
genetic diseases (and congenital anomalies). This completely new research line in the life 
sciences has resulted in a better comprehension of many biological processes. In 
particular neuroscience and developmental biology have benefited from these approaches. 
For example, we are increasingly able to understand the morphogenesis of complex 
organs and structures such as the lungs and limbs [for review see (Hogan, 1999)]. In sharp 
contrast with this is the relatively minimal progress that has been made in understanding 
abnormal developmental processes: congenital anomalies of organs which result in a high 
mortality and increasing long term morbidity in childhood and sometimes even into 
adulthood. One of the major congenital anomalies, congenital diaphragmatic hernia and 
the associated pulmonary hypoplasia forms the basis of this thesis. With an average 
prevalence of approximately 1 in 3000 newborns (Torfs et aI., 1992), CDH is a common 
problem in children's hospitals. Despite the large arsenal of sophisticated and available 
treatment modalities, such as inhalated Nitric Oxide (NO) with or without High 
Frequency Oscillation (HFO), BCMO and liquid ventilation, children with early onset of 
respiratory insufficiency in CDH still experience a high mortality. The clinical problems 
in case of CDH: puhnonary hypoplasia, persistent pUlmonary hypertension and the 
sequelae of artificial ventilation are responsible for this. Hence, the studies described in 
this thesis were designed to gain more insight into developmental regulation of normal 
and abnormal pUhnonary development in CDH. Led by the philosophy that one first needs 
to understand normal development in order to better understand abnormal development, a 
large portion of the studies were designed to increase our understanding of developmental 
processes of normal puhnonary formation. The aims of the described studies were as 
follows: 
1. To specifY the role of the transcription factor GATA6 during fetal pulmonary 
development; 
2. To investigate the relative role of and the balanced interplay between proliferation 
and apoptosis during normal lung morphogenesis and abnormal puhnonary 
development; 
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3. To evaluate the role of the thyroid hormone receptors during fetal organogenesis 
and pulmonary development; 
4. To examine the direct effects of Nitrofen on pulmonary development, and the 
relation to the diaphragmatic defect in CDH; 
5. To investigate the expression of members of the steroid hormone receptor 
superfamily in Nitrofen-induced hypoplastic lungs and compare this with normal 
lungs. 
9.2 Interpretations and implications of the studies 
The transcription factor GATA6 has been implicated in pulmonary endoderm 
specification (Morrisey et aI., 1998; Whitsett and Tichelaar, 1999) (see also Figure 1). 
This assumption was based on data in the literature describing the expression pattern of 
GATA6 in mice, one chimeric experiment in mice and extrapolation of results for GAT A 
homologues obtained in lower organisms, such as C. Elegans (Kalb et aI., 1998; Morrisey 
et aI., 1996; Morrisey et aI., 1998). Using a chimeric approach again, we found that 
GATA6 is not involved in pulmonary endoderm specification, but plays a more extensive 
role in branching morphogenesis and epithelial cell differentiation of the lung. The 
discrepancy between our results and the results of the other group could be explained by 
the different approach we took to generate the chimeric mice. As opposed to the usual 
chimeric experiment (Hogan et aI., 1994), we used up to double the amount of mutant 
embryonic stem cells in order to generate highly chimeric embryos. This enabled us to 
investigate the role of GATA6, because absence of GATA6 resulted in abnormally 
branched and differentiated endoderm or epithelium. 
In our study we did not address some important remaining questions concerning 
GATA6 and pulmonary development. For instance, we could not conclude whether the 
observed phenotype was due to direct effects of missing GATA6 in the endoderm, or was 
the result of secondary effects through defective epitheliaVmesenchymal signaling. To 
investigate this aspect, tissue recombination studies would be informative. For example, 
epithelium derived from GATA6-/- lungs can be recombined with wild-type 
mesenchyme, and vice versa. Another important issue which was not addressed in our 
studies is the question which genes in the developing lungs are the target for 
transcriptional regulation by GATA6. Are only the known "master" genes for pulmonary 
development, such as FGF-IO, BMP-4 and SHH, involved or do other, not yet identified 
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genes, play an important role? Of interest is the fact that, GATA6 is the only GAT A 
factor expressed in pulmonary endoderm, whereas another GAT A factor, namely GATA5 
is expressed in pulmonary mesenchyme (Morrisey et aI., 1997). To date, no relationship 
between these two GATA factors have been demonstrated in relation to pulmonary 
development. 
Following another approach, we used a lung specific promoter to overexpress 
GATA6 in distal pulmonary epithelium during pnlmonary development. We found that 
overexpression of GATA6 results in abnormal lung development characterized by 
disturbed branching and epithelial cell differentiation. These results suggest that 
overexpression of GATA6 in pnlmonary endoderm leads to a block of differentiation in 
this endoderm and are in accordance with results from studies in which other GATA 
factors have been overexpressed (Briegel et aI., 1993; Hendriks et al., 1999; Pevny et aI., 
1991; Whyatt et al., 1997; Zheng and Flavell, 1997). However, this study was not 
conclusive in determining the exact mechanism by which GATA6 acts during pulmonary 
development, nor in identifying the target genes that are transcriptionally regulated by 
GATA6 during pulmonary development. Hence, the two studies on GATA6 and 
pulmonary development described in this thesis have partly revealed the role of GATA6 
in fetal pulmonary development and more studies on this subject are currently planned in 
our laboratory. 
In another study we investigated the interplay between proliferation and apoptosis 
during morphogenesis of the lung. Employing a cell recombinant model for fetal 
pulmonary development, we demonstrated that both proliferation and apoptosis are 
developmentally regulated, and in addition, that mesenchymal apoptosis during late 
pulmonary development occurs as the result of a loss of inhibition by the neighbouring 
epithelium. Although this study was in principle descriptive, the results clearly indicate 
that for normal lung morphogenesis to occur, a tight regulation of the ratio between 
proliferating and apoptotic cells is required. Our main finding is that the massive 
apoptosis that normally occurs in prenatal mesenchymal cells is due to intrinsic 
properties, but can be inhibited by immature epithelial cells. We did not identify any 
molecular factors involved in either proliferation or apoptosis, and therefore, more studies 
aimed at unraveling the molecular mechanisms involved in these processes are warranted. 
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Based on chimeric experiments using GATA-6-/- ES cells, we demonstrate that GATA-6 is not 
involved in pulmonary endodenn specification, but branching morphogenesis and epithelial cell 
differentiation of the lung. 
In the final study on aspects of normal pulmomuy development, we described the 
specific heterogeneous expression of thyroid hormone receptors both at the mRNA and 
protein level during (pulmonary) organogenesis. We found that thyroid hormone receptor a 
mRNA was expressed in developing mesenchyme, whereas thyroid hormone receptor ~ 
mRNA was predominantly expressed in developing epithelia of the investigated organs. This 
result suggests that thyroid hormone receptors are very important for epithelial-
mesenchymal interactions. Up until now it was clear that thyroid hormones play an 
important role during organogenesis, but whether the effects of thyroid hormones were 
direct or indirect was not established. Our study indicates that the dynamic expression of the 
different isoforms of the thyroid hormone receptors might be the underlying mechanism. All 
different isoforms (plus the combinations) of the thyroid hormone receptors have been 
knocked out in transgenic mice (Fraichard et aL, 1997; Gauthier et al., 1999; Weiss et al., 
1997; Wikstrom et al., 1998). Surprisingly, these mutant mice exhibit very mild phenotypes. 
These results were uot anticipated because the abseuce of thyroid hormoue results in severe 
disturbance of normal development in particular of the central nervous system after birth. 
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The toxicity of unoccupied thyroid hormone receptors that are normally expressed in the 
absence of thyroid hormone may have negative influences on normal organogenesis. 
However, when the thyroid hormone receptors are mutated, the effects are relatively mild. 
Another very interesting aspect of our study was the large discrepancy between the 
rnRNA expression patterns and the protein expression patterns. In some organs high levels 
of rnRNA were measured, whereas no protein could be detected, and in other organs the 
opposite situation was observed. This observation suggests that besides the dynamic 
expression of thyroid hormone receptors, the effects of thyroid hormones on organogenesis 
are regulated at the translational and posttranslational level. Although another study had 
already demonstrated that the rnRNA content and thyroid hormone binding capacity are 
different (Strait et al., 1990), we demonstrated for the first time that the distribution of 
thyroid hormone receptor rnRNA can be very different from the distribution of its protein. 
Despite its descriptive character, this study enhances our knowledge on how thyroid 
hormones and their receptors influence normal organogenesis. More detailed studies on 
translational and posttranslational regulation of thyroid hormone receptor expression during 
fetal development are warranted, however, they are beyond the scope of this thesis. 
Classical hypothesis 
Figure 2 Based on our experiments, puhnonary hypoplasia in case of Nitro fen-induced CDH can 
only be explained by the alternative hypothesis. 
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In the third part of this thesis some aspects of abnonnal pulmonary development are 
described. In the first study we utilized the Nitrofen rat model for CDH to investigate 
abnormal pulmonary development and the direct effects of Nitrofen on pulmonary 
development. With the first description of the Nitrofen model in mice by Iritani in 1984, it 
was suggested that the lungs are the primary target organ in CDH, and that abnonnal 
development of the lungs might be the cause of abnonnal diaphragm development (Iritani, 
1984). This fonned the basis for the alternative view on pulmonary hypoplasia associated 
with CDH. However, because of the sustained administration of Nitro fen in the experiments 
of Iritani, his alternative view was not generally accepted. Our results are conclusive in 
identifying pulmonary hypoplasia as the primary defect at least in the Nitrofen model of 
CDH (see Figure 2). Using an organ explant system we investigated Nitrofen induced 
pulmonary hypoplasia separate from abnonnal diaphragm development. We were able to 
demonstrate that Nitrofen directly influences pulmonary development in a negative manner. 
The results are consistent and supported by the results of other studies that were published 
around the same time using the same animal model (Guilbert et al., 2000; Jesudason et al., 
2000). 
As a consequence of our in vitro organotypic experiments, pulmonary hypoplasia in 
case of Nitrofen-induced CDH can be explained by the dual-hit hypothesis (see Figure 3). 
The first hit occurs prior to and separate from abnonnal diaphragm development in an, up to 
this moment, unidentified environment of genetic and environmental factors. This hit affects 
both lung anlagen in a similar way and results in diminished branching morphogenesis. The 
second hit takes place after occurrence of the diaphragmatic defect and affects only the 
ipsilateral lung with resulting higher severity of pulmonary hypoplasia It is the result of 
interference of the herniated abdominal organs with fetal breathing movements, which are 
required for nonnal pulmonary development. In our opinion based on the currently available 
data, this hypothesis best explains pulmonary hypoplasia associated with CDH. However, 
the group of Greer advocates a different opinion. Based on their studies on embryological 
development of the diaphragm in the Nitrofen-model, they state that the early diaphragm, in 
particular the pleuroperitoneal fold (PPF), is the primary affected structure in Nitrofen-
induced CDH (Allan and Greer, 1997). The PPF is a pyramid-shaped tissue that extends 
medially from the lateral cervical wall to the esophageal mesentery and fuses ventrally with 
the septum transversum. Three-dimensional reconstruction studies demonstrated that the 
malformations of the PPF were limited to the dorsolateral part of the caudal regions of the 
PPF, the region where the diaphragmatic defect is localized in CDH (Greer, et aI., 2000). It 
233 
Chapter 9 
is tempting to suggest that all these results can be explained and combined by considering 
pulmonary hypoplasia and the diaphragmatic defect as part of a syndrome called CDR. 
Extrapolation of results obtained in the Nitrofen model to the human situation should 
be done with a certain amount of reserve, since they are based on the teratogenic effects of 
Nitrofen as a CDR model. At this moment no direct correlation between Nitrofen as a 
teratogen and the etiology of human CDR can be made. Another point of criticism of our 
and all other studies using Nitrofen to induce CDR is that the exact working mechanism of 
Nitrofen remains obscure. Alterations in thyroid hormone metabolism have been held 
responsible for the teratogenic effect, however, there is still no direct evidence available for 
this. To come to an explanation of the mechanism of action of Nitrofen it will be very 
helpful when the target genes of Nitrofen are known. In addition, since there is a different 
sensitivity for Nitrofen between different rat and mice strains it should be relatively easy to 
employ techniques such as quantitative trait loci in order to clone the responsible gene(s). At 
the present time, such a laborious project is probably too big for the different small research 
groups working on this subject worldwide. 
Figure 3 
Dual-hit hypothesis 
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Dual-hit hypothesis explains puhnonary hypoplasia in case of CDR with two insults. The first 
affects both lungs before (abnormal) diaphragm development occurs. The second affects only the 
ipsilateral lung and occurs after the diaphragmatic defect bas occurred. 
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In the second study we touched on the mechanism of action of Nitrofen. As stated 
before, our group has previously demonstrated that Nitrofen decreases the binding of thyroid 
hormone to its receptor in vitro (Brandsma et aI., 1994). Combining Nitrofen administration 
with thyroid hormone results in a decrease in observed abnormalities (Manson et al., 1984) 
which led us to hypothesize that Nitrofen influences expression of the thyroid hormone 
receptors. Using in situ hybridization, we could not demonstrate a change in distribution or 
expression of the thyroid hormone receptors and their preferred partners of dimerization, the 
retinoid-X receptors. In our studies we included another member of the steroid hormone 
receptor superfamily, namely the glucocorticoid receptor. The implementation of antenatal 
hormonal modulation with corticosteroids as a suggested new treatment modality for CDR-
associated pulmonary hypoplasia was another argument. From the fact that we did not 
observe any major changes in localization or expression of all investigated receptors 
between control and Nitrofen lungs, we concluded that Nitrofen does not function through 
alteration of the expression of these members of the steroid hormone receptor superfamily. 
Furthermore, it is not necessary to alter the proposed protocol for antenatal hormonal 
modulation in case of hypoplastic lungs, since there is no change in the expression of the 
glucocorticoid receptor in these lungs. 
9.3 Future research 
As stated in the introduction, molecular approaches and animal models have increased our 
understanding of many basic biological processes, such as organogenesis of the lung. 
Recently, new milestones in biology have been accomplished with the completion of the 
human genome sequence. The knowledge gained from the human genome will have an 
enormous impact on how research will be done in the near future. And although the 
function of all the genes is not known yet, the cloning of genes responsible for certain 
processes such as organogenesis, but also for· diseases and congenital anomalies will be 
done behind the personal computer, instead of the laboratory bench. This will certainly 
alleviate the research aimed at understanding multifactorial diseases or anomalies such as 
CDR. 
Another promising new technique is the use of micro arrays or "gene chips", which 
is currently establishing a stable position in the laboratory (Schena et aI., 1995). This will 
make it easily possible to compare sets of genes from affected (for instance CDR) and 
unaffected (control) tissues, thereby identifYing the genes responsible for the observed 
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phenotypes. Preliminary experiments have been undertaken with this new technique in the 
CDH model (Malah Chinoy, personal communication). However, the biggest problem of 
this technique at present, is the difficulty in analyzing and interpreting the huge amount of 
information that is generated. Bioinformatics will probably bring solutions for this in the 
near future. 
The final promising recent discovery, which is in my opinion of importance for 
future research in the field of lung development is the use of human or mouse 
(embryonic) stem cells. It is becoming increasingly clear that (embryonic) stem cells can 
be forced to take on the identity of almost every cell of the human body. Although there is 
no data available yet on the forced differentiation of stem cells into puhnonary cells, I 
believe that this will be possible in the near future. It is tempting to speculate whether it 
would come to the point that we understand the process of lung development and stem 
cell differentiation in such a way that we are able to grow lungs in culture starting with 
embryonic, but preferably somatic stem cells. Although I am aware that we are at present 
not even able to mimic three-dimensional growth in culture, let alone the growth of 
complete organs, I believe that it will be possible in the not so far away future. 
Finally I would like to put these "science fiction" ideas into a bit more down-to-
earth perspective. One should not forget that at present we still do not know which genes 
are essential for the transition of a group of endoderm foregut cells into primary 
endodermal lung buds. Some of the lung "master" genes appear to have been identified. 
However, FGF -10 which is thought to be one of the pivotal genes is not necessary for 
development of the trachea, indicating that the earliest onset of lung development occurs 
normally in these mice (Min et aI., 1998; Sekine et aI., 1999). Moreover, we do not even 
know which particular group of cells from the foregut are responsible for the formation of 
the future lung. Therefore, a start has to be made in the process of identifYing the cells of 
the foregut that are responsible for the formation of the future lung. This will provide new 
insights into very early pulmonary development. As a result we will be able to better 
understand the processes involved in lung organogenesis, and I believe that such an 
understanding will eventually lead to the prevention and improved treatment of congenital 
lung anomalies. 
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10.1 Summary 
Pulmonary hypoplasia, underdevelopment of the lung. remains an important cause of 
mortality and morbidity in the Neonatal Intensive Care Unit. It is either an isolated entity 
based on for example oligohydramnios, or part of a larger problem, such as Congenital 
Diaphragmatic Rernia (CDR). The minimal improvement of outcome following intensive 
treatment of pUhnonary hypoplasia associated with CDR rnight be partly due to poor 
understanding of the processes involved in normal puhnonary development. Consequently, 
the mechanisms by which disturbances in normal puhnonary development result in 
puhnonary hypoplasia are not understood at all. 
This thesis consists of four parts; Part I (Chapter 1 and 2) forms the introduction, 
Part II (Chapter 3 to 6) describes the studies on mechanisms of normal puhnonary 
development, Part III (Chapter 7 and 8) describes the studies on mechanisms of abnormal 
puhnonary development associated with CDR, and Part IV (Chapter 9 and 10) contains 
the discussion and sununaries. 
Chapter 1 reviews the literature on various aspects of normal pUhnonary 
development. First, the respiratory structures of several organisms are described and 
compared. Next follows a description of the developmental anatomy and embryology of 
normal mammalian pulmonary development, starting from puhnonary endoderm 
specification. Finally, the most important genes, transcription and growth factors, 
extracellular matrix proteins and hormones involved in normal pulmonary development 
are discussed. 
Chapter 2 introduces aspects of abnormal puhnonary development, and in 
particular pUhnonary hypoplasia associated with CDR. The pathogenetic and clinical 
background of CDR and pulmonary hypoplasia is discussed, and the animal models used 
for investigation of this congenital anomaly are reviewed. The chapter ends with the aims 
of the studies and the questions addressed in this thesis. 
Chapter 3 and Chapter 4 describe studies on the role of the transcription factor 
GATA6 during normal pUhnonary development. The expression pattern of GATA6 
mRNA, predominantly in the pulmonary endoderm and epithelium, suggested 
involvement of GATA6 in branching morphogenesis of the lung. Antisense 
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oligonucleotides against GATA6 abrogated branching morphogenesis of organotypic lung 
explants. This role of GATA6 in branching morphogenesis was more extensively 
investigated with loss-of-function experiments using GATA6-/- chimeric embryos. The 
lungs of these embryos showed diminished branching morphogenesis, both in vitro and in 
vivo. In addition, the lungs displayed disturbed epithelial cell differentiation as indicated 
by diminished SP-C and CC-lO expression, markers for proximal and distal pulmonary 
epithelial cell differentiation, respectively. In contrast, TTF-l expression (a marker for 
pulmonary endoderm specification) was not disturbed. We concluded therefore, that 
pulmonary endoderm specification occurred normally in the chimeric embryos. This 
phenomenon had already been demonstrated by the fact that the chimeric embryos had 
lungs, albeit abnormal lungs. Chimeras generated in a ROSA26 background showed that 
endodermal cells in the abnormally branched areas were derived from GATA6 mutant ES 
cells, indicating that the defect is intrinsic to the endoderm. From these studies we 
concluded that GATA6 is essential for branching morphogenesis and epithelial cell 
differentiation during fetal pulmonary development. 
In Chapter 4 studies are described in which the opposite approach, "gain-of-
function" is used to investigate the role ofGATA6 in pulmonary development. Following 
on the studies described in Chapter 3, a well-characterized lung-specific promoter was 
used to maintain high levels of GATA6 protein during fetal pulmonary development. This 
resulted in a phenotype comparable to that seen in the GATA6 -/- chimeras. The 
transgenic lungs displayed diminished branching morphogenesis as well as a lack of distal 
epithelial differentiation (absent or abnormal SP-C expression), whereas proximal 
epithelial cell differentiation was unaffected (normal CC-lO expression). This was 
confirmed at the ultrastructural level and with glycogen staining, which both indicated 
that transgenic lungs lacked differentiation into mature type II cells. Taken together, 
GATA6 might function as an anti-differentiation factor for pulmonary epithelial cell 
development, in analogy to the other GAT A factors effecting the differentiation of blood 
cells. 
Chapter 5 describes studies on the balanced interplay between proliferation and 
apoptosis during epithelial-mesenchymal interactions of the developing lung. An in vitro 
cell model served to recombine various combinations of mesenchymal cells, fibroblasts, 
endodermal cells and epithelial cells. During culture of the cell clumps, we observed 
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alveolization-like morphogenesis. Most proliferating cells were observed in homotypic 
recombinants of early cells and this appeared to be intrinsic to, in particular, the epithelial 
cells. In the homotypic recombinants oflate cells, most apoptotic cells were seen between 
fibroblasts, but this was not observed when these fibroblasts were cultured together with 
early endodermal cells. This led us to conclude that apoptosis of late fibroblasts was due 
to loss of inhibition by late epithelial cells, which does not occur with early endodermal 
cells. 
In Chapter 6 studies on the role of thyroid hormone receptors during (pulmonary) 
organogenesis are presented. Using different visualization and quantitation techniques, 
RNA and protein expression combined with RNA and protein levels are described during 
organogenesis of liver, lung, bone and kidney. These organs are dependent upon 
epithelial-mesenchymal interactions for their development. We found that the TRa 
isoform was expressed in mesenchymal tissues, and TR~ in epithelial tissues. The 
expression patterns were more pronounced at the mRNA than at the protein level, which 
we contributed to extensive posttranscriptional control. TR~ protein levels reached adult 
levels before TRa}, suggesting an initiating, TR~-mediated signalling from the 
epithelium, followed by a TRa-mediated response from the mesenchyme. TRa and TR~ 
were co-expressed in the developing brain and intestine. In addition, these organs had a 
very low translational efficiency of TR mRNA or higher degradation of TR protein, 
which was indicated by a very low TRa and TR~ proteinlmRNA ratio. We concluded 
from these studies that there must be a TR-dependent regulation which functions 
differently in organs with complementary or co-expression ofTRa and TR~ genes. 
Both Chapter 7 and Chapter 8 describe studies on mechanisms of abnormal 
puhnonary development. In both chapters the Nitrofen rat model for CDR is used to 
investigate puhnonary hypoplasia associated with CDR. In Chapter 7 an in vitro 
modification of the Nitrofen model was used to investigate the direct effects of Nitrofen 
on early lung development before and separate from abnormal diaphragm development. 
This was done using an organotypic lung explant system. We found that Nitrofen 
negatively influences branching morphogenesis, epithelial cell differentiation (SP-C and 
CC-1O expression) and proliferation of the lung, whereas apoptosis did not appear to be 
affected. Therefore, we postulate the dual-hit hypothesis to explain puhnonary hypoplasia 
in CDR with two insults. The first hit affects both lungs before (abnormal) diaphragm 
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development and the second affects only the ipsilateral lung after defective diaphragm 
development. 
In Chapter 8 two aspects of CDR and pulmonary hypoplasia were investigated. In 
the fIrst part of the study the expression of the glucocorticoid receptor in hypoplastic 
lungs was compared with that in control lungs. In the second part a possible mechanism 
of action of Nitrofen in producing CDR and pulmonary hypoplasia was investigated. 
Radioactive in situ hybridization was used in order to investigate the expression patterns 
of the glucocorticoid receptor, thyroid hormone receptors, together with their preferred 
partner of dimerization, the retinoid-X receptors in the Nitrofen model. TRa was 
specifIcally expressed in the developing pulmonary mesenchyme, and TR/3 in the 
developing pulmonary epithelium. A comparable expression pattern was observed for the 
retinoid-X receptors, whereas the glucocorticoid receptor was ubiquitously expressed in 
both germ layers. No differences in timing or localization were observed between normal 
and hypoplastic lungs. This suggests that hypoplastic lungs are as sensitive to 
glucocorticoids as normally developed lungs. In addition, an alteration of thyroid 
hormone receptor expression is not the underlying cause of pulmonary hypoplasia in case 
of Nitro fen-induced congenital diaphragmatic hernia. 
In conclusion, the studies presented in this thesis have supplied the following new 
insights into some aspects of normal and abnormal pulmonary development: 
GATA6 is not involved in endoderm specifIcation, but plays a role in branching 
morphogenesis and epithelial cell differentiation of the lung; 
a developmentally regulated interplay between proliferation and apoptosis IS 
essential for normal pulmonary morphogenesis; the former is cell or tissue intrinsic, 
whereas the latter is dependent on epithelial-mesenchymal interations; 
nonnal organogenesis requires developmental changes in the expression of the 
thyroid hormone receptors alpha and beta in rat tissues; this might function via extensive 
post-transcriptional regulation; 
Nitrofen interferes with early pulmonary development before and separate from 
(aberrant) diaphragm development; 
steroid hormone receptor superfamily expression is not ai"ttiod in pulmonary 
hypoplasia in case of Nitro fen-induced CDR in rats. 
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10.2 Samenvatting 
Pulmonale hypoplasie, onvolkomen ontwikkeling van de long, is nog steeds een 
belangrijke oorzaak van morbiditeit en mortaliteit op de Pediatrische Intensive Care. De 
aandoening kan op zichzelf staan, zoals in het geval van oligohydramnios, of deel 
uitrnaken van een syndroom zoals congenitale hernia diafragmatica (CHD). De minimaal 
verbeterde uitkomst na intensieve behandeling van pulmonale hypoplasie (in combinatie 
met CHD) is waarschijnlijk te wijten aan onvoldoende kennis van de normale 
longontwikkeling. De mechanismen die betrokken zijn bij afWijkende longontwikkeling 
en die lei den tot pulmonale hypoplasie zijn Diet bekend. 
Dit proefschrift bestaat uit vier delen: Deel I (hoofdstuk I en 2) vormt de 
introductie, Deel II (hoofdstuk 3 tot en met 6) beschrijft de onderzoeken naar 
mechanismen van normale longontwikkeling, Deel III (hoofdstuk 7 en 8) beschrijft de 
studies naar mechanismen van abnormale longontwikkeling in combinatie met CHD, en 
Deel IV (hoofdstuk 9 en 10) bevat de discussie en samenvattingen. 
Hoofdstuk 1 geeft een overzicht van de literatuur over verschillende aspecten van 
de normale longontwikkeling. Allereerst worden de ademhalingsstructuren van diverse 
organismen beschreven en met elkaar vergeleken. Dit wordt gevolgd door een 
beschrijving van de anatomie en de embryologie van de normale longontwikkeling bij 
zoogdieren te beginnen bij hoe het primitieve voordarmendoderm zich specificeert tot 
longendoderm. Tenslotte worden de belangrijkste genen, transcriptie- en groeifactoren, 
extracellulaire matrix eiwitten en hormonen die een rol spelen bij normale 
longontwikkeling besproken. 
Hoofdstuk 2 geeft een inleiding op aspecten van de abnormale longontwikkeling, 
met name pulmonale hypoplasie bij CHD. De achtergronden bij CHD en pulmonale 
hypoplasie worden beschreven en de diermodellen die gebruikt worden om deze 
aangeboren afWijking te bestuderen worden besproken. Dit hoofdstuk eindigt met een 
opsomming van de doelstellingen van de diverse onderzoeken, alsmede de 
onderzoeksvragen die behandeld worden in dit proefschrift. 
Hoofdstuk 3 en Hoofdstuk 4 
transcriptiefactor GATA6 tijdens 
beschrijven het onderzoek naar de rol van de 
de normale longontwikkeling. Gezien het 
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expressiepatroon van GATA6 mRNA in longendoderm en -epitheel, werd aangenomen 
dat GATA6 een rol speelt bij het vroege vertakken van de luchtwegen in de long. Het 
bleek mogelijk om dit vertakken in long kweken te blokkeren met behulp van antisense 
oligonucleotiden tegen GATA6. Deze functie van GATA6 werd verder onderzocht in 
"Ioss-of-function" onderzoeken met GATA6-/- chimere embryos. De longen van deze 
embryos vertoonden minder vertakkingen van de luchtwegen dan normale longen, zowel 
in vitro als in vivo. Daarnaast was de differentiatie van deze longen afwijkend, zoals bleek 
uit de afwijkende SP-C en CC-IO expressie, wat betekent dat de proximale en distale 
differentiatie van longepitheel anders verloopt. Daarentegen was de expressie van TTF-l 
niet afwijkend, en dit betekent dat de specificatie van longendoderm normaal verloopt. 
Dit werd al vermoed, aangezien de chimere embryos longen hadden, zij het abnormale. In 
chimere embryos, gemaakt met behulp van een ROSA26 genetische achtergrond, bleek 
dat de endodermale cellen uit de gebieden met abnormale vertakkingspatronen afkomstig 
waren van gemuteerde GATA6 embryonale stamcellen. Derhalve is het probleem 
gerelateerd aan het endoderm. We concludeerden dat GATA6 essentieel is bij het vroege 
vertakken van de luchtwegen en de differentiatie van luchtwegepitheel tijdens de foetale 
longontwikkeling. 
In Hoofdstuk 4 wordt onderzoek beschreven waarin een tegenovergestelde aanpak 
wordt gebruikt om de rol van GATA6 tijdens long ontwikkeling te onderzoeken, namelijk 
"gain-of-function" onderzoeken. Naar aanleiding van de resultaten van het onderzoek uit 
Hoofdstuk 3 werd nu een longspecifieke promoter gebruild: om het GATA6-eiwit gehalte 
kunstrnatig hoog te houden tijdens de foetale longontwikkeling. Dit resulteerde in een 
fenotype dat vergelijkbaar was met dat van de GATA6-/- chimere embryos. Transgene 
longen vertoonden minder vertakkingen van de vroege luchtwegen en geen distale 
epitheeldifferentiatie (afwezige of abnormale SP-C expressie), terwijl de proximale 
epitheeldifferentiatie normaal verliep (normale CC-IO expressie). Dit werd bevestigd met 
behulp van elektronenmicroscopie en een kleuring voor glycogeen. Beide toonden aan dat 
er in de transgene longen gebrekkige differentiatie naar volwaardige type II cellen 
plaatsvindt. Samenvattend, het zou kunnen zijn dat GATA6 functioneert als een anti-
differentiatie factor voor de ontwikkeling van longepitheel-cellen, net zoals andere GAT A 
factoren in relatie tot bloedcellen. 
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Hoofdstuk 5 beschrijft onderzoek naar de relatie tussen proliferatie en apoptosis 
gedurende epitheliale-mesenchymale interacties van de zich ontwikkelende long. Er werd 
een in vitro recombinatiemodel van mesenchymale cellen, fibroblasten, endodermale 
cellen en epitheelcellen gebruikt om verschillende combinaties van de genoemde cellen te 
maken. Tijdens het kweken van de groepjes cellen werd morphogenese waargenomen die 
leek op normale alveolarisatie. De meeste prolifererende cellen werden gezien in de 
homotypische recombinanten van langer ontwikkelde cellen, de meeste apoptotische 
tussen de langer ontwikkelde fibroblasten. Dit laatste werd echter niet gezien als de 
fibroblasten gecombineerd werden met vroege endodermale cell en. Daarom 
concludeerden wij dat apoptosis van langer ontwikkelde fibroblasten het gevolg was van 
een verlies van inhibitie door langer ontwikkelde epitheel cell en, en dit gebeurt dus niet 
als de fibroblasten gecombineerd worden met vroege endodermale cellen. 
In hoofdstuk 6 wordt onderzoek naar de rol van schildklierhormoon-receptoren 
tijdens de (long) organogenese beschreven. Met behulp van verschillende visualiserings-
en kwantificeringstechnieken werden RNA- en eiwitexpressie samen met de RNA- en 
eiwitgehaltes vastgesteld gedurende de organogenese van de lever, longen, bot en de 
nieren, allen organen, die afhankelijk zijn van epitheel-mesenchym interacties voor hun 
ontwikkeling. TRa bleek met name tot expressie te komen in mesenchymale weefsels, en 
TR~ met name in epitheliale weefsels. De expressiepatronen waren op RNA-niveau 
duidelijker dan op eiwit-niveau, en dit werd toegeschreven aan uitgebreide 
posttranscriptionele regulatie. TR~ eiwit gehaltes bereikten volwassen waardes voordat 
TRa gehaltes dit deden, wat doet vermoeden dat er een initieel TR~ geleid signaal vanuit 
het epitheel gevolgd wordt door een TRa-geleid antwoord van het mesenchym. TRa en 
TR~ kwamen samen tot expressie in de zich ontwikkelende hersenen en darmen. 
Daarnaast hadden deze organen een zeer lage translatie-efficientie voor TR-rnR,"'A of een 
hoge degradatie van TR-eiwit, vanwege de zeer lage TRa en TR~ eiwitIRNA ratio. We 
concludeerden dat er een TR-afhankelijke regulatie moet bestaan die anders functioneert 
in organen met tegenovergestelde expressie van TRa en TR~ genen dan in organen met 
co~expressIe. 
Zowel hoofdstuk 7 als hoofdstuk 8 beschrijven onderzoeken naar de mechanismen 
van abnormale longontwikkeling. In beide hoofdstukken wordt het Nitrofen-rattenmodel 
gebruikt om pulmonale hypoplasie bij CHD te bestuderen. In Hoofdstuk 7 wordt een in 
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vitro modificatie van het Nitrofenmodel gebruikt om de effecten van Nitrofen op vroege 
longontwikkeling voorafgaande aan en los van de abnormale ontwikkeling van het 
middenrif te onderzoeken. Hierbij werd gebruik gemaakt van een longkweek-systeem. 
Het bleek dat Nitrofen het vroege vertakken van de luchtwegen, de differentiatie van 
epitheel cellen (SP-C en CC-lO expressie) en de proliferatie van de long negatief 
beInvloedde, terwijl het op apoptosis geen effect had. Naar aanleiding hiervan 
postuleerden wij de dual-hit hypothese om pulmonale hypoplasie bij CHD tijdens de 
ontwikkeling te verklaren met twee problemen. De eerste hit tref! beide longen en treedt 
op voorafgaande aan (abnormale) ontwikkeling van het middenrif. De tweede hit tref! 
alleen de long aan de aangedane zijde en treedt op nadat er een gat in het middenrif is 
ontstaan. 
In Hoofdstuk 8 werden twee verschillende aspecten van CHD en pulmonale 
hypoplasie onderzocht. Ten eerste werd onderzocht of hypoplastische longen de 
glucocorticoidreceptor net zo tot expressie brengen als controlelongen. Ten tweede werd 
een mogelijk werkingsmechanisme van Nitrofen voor het veroorzaken van CHD en 
pulmonale hypoplasie onderzocht. Er werd gebruik gemaakt van radioactieve in situ 
hybridisatie om de expressiepatronen van de glucocorticoid receptor, de 
schildklierhormoon-receptoren en hun voorkeurspartner voor dimerizatie, de retinoid-X-
receptoren in het Nitrofen model te onderzoeken. TRa kwam met name tot expressie in 
het longmesenchym, en TR~ met name in het longepitheel. Een vergelijkbaar 
expressiepatroon werd gezien voor de retinoid~X-receptoren, terwijl de glucocorticoid 
receptor meer in beide kiemlagen tot expressie kwam. Tijdstippen en plaats van expressie 
verschilden niet tussen nonnale en hypoplastische longen. Dit suggereert dat 
hypoplastische longen net zo gevoelig zijn v~~r glucocorticoYden als nonnaal ontwikkelde 
longen. Daarnaast bleek dat een veranderde expressie van de schildklierhormoon 
receptoren niet de onderliggende oorzaak is van pulmonale hypoplasie als gevolg van 
CHD geInduceerd door Nitrofen. 
Samengevat heef! dit proefscbrif! de volgende nieuwe inzichten verschaft in bepaalde 
aspecten van normale en abnormale ontwikkeling van de long: 
GATA6 is niet betrokken bij de specificatie van endoderm, maar speel! een rol in 
het vroege vertakken van de luchtwegen en de differentiatie van epitheelcellen van de 
long; 
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een ontwikkelingsgebonden relatie tussen proliferatie en apoptosis is van belang 
voor de normale morpho genese van de long; het eerste is wezenlijk voor het weefsel of de 
cel, en het laatste is afhankelijk van epitheel-mesenchym interacties; 
voor normale organogenese is het van belang dat er ontwikkelingsgebonden 
veranderingen in de expressie van de schildklierhormoon receptoren alpha en beta 
optreden in weefsels van de rat; dit zou kunnen plaatsvinden door middel van uitgebreide 
post-transcriptionele regulatie; 
Nitrofen verstoort de vroege longontwikkeling voorafgaande aan en los van de 
(abnormale) ontwikkeling van het middenrif; 
de expressie van de steroidhormoon-receptor superfamilie is onveranderd bij ratten 
met pulmonale hypoplasie en eHD gelnduceerd door Nitrofen. 
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